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Mammalian telomere length is regulated in a dynamic manner through multi-factorial
elements. This project focuses on specific aspects of both extrinsic and intrinsic factors
that govern telomere length.
Expression of the human telomerase reverse transcriptase (hTERT) gene in sheep
fibroblasts reconstitutes telomerase activity and extends their lifespan. Although
stabilization of telomere length is directly correlated to hTERT expression level, this
was not reflected in telomerase activity. Data presented here shows that overexpression
of non-catalytic domains decreased telomerase activity, compromised senescence bypass
status and did not enhance telomere maintenance, which may result from competitive
binding to sheep TR molecules and/or disruption of hTERT homodimeric structure.
These results are consistent with the notion that telomere maintenance requires a
functional telomerase complex which contains an inter-dependent hTERT homodimeric
structure.
The single-stranded 3' G-rich overhang has been implicated as a key feature with a
telomeric end-protection configuration. Data presented here show that the 3' overhang is
eroded during culture of sheep fibroblasts, indicating that the 3' overhang length
shortens prior to replicative senescence in cultured sheep fibroblasts. Furthermore, a
correlation between hTERT expression level, karyotypic stability and 3' overhang length
is observed.
This project also demonstrated the first application of the Quantitative-FISH (Q-FISH)
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Chapter 1 - Introduction
1.1 A preface to telomere and telomerase biology
Often in nature things are not how they at first appear: a rock on the seafloor may be
a poisonous fish and a beautiful flower in a garden may be a carnivorous insect lying
in wait for prey. At one time, the DNA at the ends of chromosomes seemed to be
static, yet in most organisms that have been studied, these tips, called telomeres, are
actually ever changing; they shorten and lengthen repeatedly. Modern interest in
telomeres and telomerase has its roots in experiments carried out in the 1930s by two
remarkable geneticists: Barbara McClintock, then at the University of Missouri at
Columbia, and Hermann J. Muller, then at the University of Edinburgh. Working
separately and with different organisms, both investigators realized that
chromosomes bore a special component at their ends that provided stability. Muller
coined the term "telomere," from the Greek for "end" (telos) and "part" (meros).
McClintock noted that without these end caps, chromosomes stick to one another,
undergo structural changes and misbehave in other ways (McClintock 1939). Fast
forward to the present day and we regard telomeres as key genetic elements in the
regulation of the cellular ageing process, with telomere shortening in part, serving as
a 'molecular clock' for replicative lifespan certainly in vitro and plausibly in vivo.
Paradoxically a finite cellular lifespan may represent a primitive eukaryotic tumour
suppression mechanism. In support of this, Mother Nature's counter mechanism to
increase replicative lifespan, an enzyme known as telomerase, is not detected in most
adult somatic tissues, but yet readily activated in the vast majority of tumours studied
to date and is ever present in germline cells. Hence ageing and cancer may be two
sides of the same coin, with telomeres and telomerase being more than mere bit part
players. The net result over the past 25 years is seminal biological observations in the
2
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field hinting at the possibility and feasibility of targeting both telomeres and
telomerase components for therapeutic gain. Namely, strategies to target and inhibit
telomerase in cancer settings and conversely to reactivate telomerase in tissues
impacted upon by cellular ageing, have been a recent lure.
1.2 Telomere structure
1.2.1 Eukaryotic telomeres
Telomeres are specialized and essential DNA-protein complexes located at the ends
of linear chromosomes, the nucleotide sequences of which were first revealed in
1978 by Elizabeth Blackburn, who found that the telomeres of the ciliated protozoan,
Tetrahymena thermophila, consisted of a simple sequence of hexameric repeats of
the nucleotides TTGGGG (Blackburn E.H & Gall, J.G 1978). In all vertebrates,
telomere repeats are conserved as TTAGGG (Meyne et al., 1989) and similarly
consist of proteins and reiterated Guanosine-rich repeats. The majority of telomeric
DNA is double helical, with the GT-rich sequence paired with its CA complement,
but in all eukaryotes studied, this G-rich 3'-end of the DNA protrudes as a single-
stranded overhang. In humans, telomeres are comprised of a ~ 3-20kb array of
duplex TTAGGG repeats, ending in a 100-500 nucleotide 3' protrusion (Harley et al.,
1990; reviewed in de Lange 2004; Fig.1.1). Telomeres are essential elements that
protect chromosomal termini from nuclease degradation and interchromosomal
fusion and promote proper portioning of chromosomes during mitosis and meiosis,
thereby contributing to genomic stability, (Counter et al., 1992, Hackett et al., 2001).
3




Figure 1.1 Classical human telomere structure. A typical human telomere (3-20kb)
is depicted showing upstream sub-telomere associated repeats and downstream 3'
protrusion of the G-rich strand.
1.2.2 Telomere structure - the new synthesis
Despite the important role of proper telomere function, it has become increasingly
clear that telomeres do not simply function as a buffer zone that prevents loss of
essential sequences. A large body of evidence dating back to the work of McClintock
(McClintock 1939) is more consistent with the view that the telomeric complex
allows cells to distinguish random chromosome breaks and natural chromosome ends.
The classical view of linear chromosomes did not easily explain how telomeres are
presumably 'protected' from DNA damage repair machinery. A recent seminal study
from Jack Griffith and Titia de Lange revealed how mammalian chromosomes may
overcome this burden: these studies used electron microscopy to demonstrate how
the 3' single-strand telomeric overhang may invade the duplex repeat array thus
4
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forming a Terminal (T)-loop structure at chromosomal termini and a displacement (D)
loop further upstream (Griffith et ah, 1999, commentary in Greider 1999). This
proposed structure would give a mechanistic basis for how telomere ends may be
protected from DNA damage surveillance systems (Fig. 1.2).
Hinfl/Rsal








75-200 nt ss DNA
Figure 1.2. Mammalian telomeres end in a large duplex loop. (A-B) A telomeric
DNA model containing 3kb of unique sequence DNA followed by ~2kb of
TTAGGG repeating sequence with a 150-200nt 3' G-strand overhang. (DNA
analyzed from HeLa cells). (C) The classical linear view of mammalian telomeres
has been rejected in favour of a proposed T-loop structure whereby the single-
stranded 3' overhang from the G-rich strand invades the telomere double-strand array,
thus forming a telomere end-capping structure (figure adopted from Griffith, J.D et al
1999).
5
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1.3 Telomere end-protection
1.3.1 Telomeric-loop (T-loop)
Telomere integrity thus plays a crucial role in the capacity for continuous cell
proliferation. Both extrinsic and intrinsic factors facilitate in maintaining this
integrity of telomeres. Furthermore, chromosome termini must be 'capped' in order
to protect chromosomal ends from nuclease degradation, interchromosomal end
fusions and improper recombination and repair, thereby contributing to genomic
stability. Conversely, telomeres can lose integrity via loss of protection of the end
structure (uncapped telomeres), which triggers immediate telomere instability, or by
gradual attrition of telomeric DNA (loss of telomerase function). At the time of their
switch to linear genomes, eukaryotes must have evolved a mechanism to manage
their chromosome ends, creating two major problems: the first was the 'end
replication' dilemma discussed in section 1.4.2 and the second problem lies in the
ability of cells to distinguish natural chromosomal ends from sites of DNA damage.
The finding that mammalian telomeres terminate in a duplex loop (T-loop), where
most of the 3' overhang is tucked inside the telomere double-stranded array (Griffith
et ah, 1999; Fig. 1.2) hints at the structural basis for this end-protection function.
Indeed T-loop structures are a conserved feature of telomere structure and are found
not only in vertebrates, but also in ciliates (Murti K, G & Prescott D, M 1999) and
trypanosomes (Munoz-Jordan et al., 2001). The size of the T-loop is highly variable
and might not be important for telomere function. More likely the key function of the
T-loop is the sequestration of the 3' overhang. Thus T-loops seem to be a good
strategy to protect chromosome ends from fusion. In support of this, electron
6
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microscopy observations on chicken erythrocyte and mouse lymphocytes, revealed
that the T-loop is wrapped in telomere chromatin fibres in the form of closed
terminal loops, which correspond to the T-loop structures adopted by telomere DNA
(Nikitina T. & Woodcock C. 2004). Wrapping the T-loop in chromatin proteins
probably hides the 3'-overhang from agents that detect free ends. However, how T-
loops might allow cells to distinguish chromosome ends from DNA damage is less
clear. We must also infer that the T-loop (or any non-canonical end structure) is to
some extent dynamic at least through S-phase transition, to permit the telomerase
complex (a specialized cellular ribonucleoprotein (RNP) reverse transcriptase
complex consisting of an RNA template unit (TR) and a core catalytic subunit with
reverse transcriptase activty (TERT), that synthesizes TTAGGGn telomeric repeats
onto chromosomal ends (Greider & Blackburn 1987, Lingner et ah, 1997, discussed
in detail in section 1.8) and associated factors access to the telomere substrate
(Mastuomi et ah, 2003). Indeed the Bloom's syndrome helicase (encoded by the
BLM gene that is defective in Bloom's syndrome), homologous to the RecQ
subfamily of helicases, which functions as a 3'-5' DNA helicase in vitro and which
requires a short 3' region of single-stranded DNA to unwind G4 DNA (four-stranded
DNA), has been thus implicated to function at the telomere substrate (Sun et ah,
1998, Huber et ah, 2002). A number of key questions remain to be resolved
regarding telomeric loops: what are the factors regulating T-loop dynamics; what
percentage of mammalian telomeres carries this structure; does T-loop size vary
between and within chromosomes in a chromosome complement; is the T-loop
altered at replicative senescence? The latter hypothesis will be discussed in section
1.5.3. Moreover, a recent observation implicated T-loops as presenting a danger to
7
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chromosome ends: low levels of telomeric circles were detected in normal human
cells, indicating that telomere deletion by homologous recombination may be a
feature of normal telomere metabolism (Wang et ah, 2004). Hence protective T-
loops may themselves represent a telomeric double-edged sword.
1.3.2 Telomere-associated factors and end capping
The ability of telomeres to evade the DNA-damage response is a consequence of
their association with a set of protein complexes that protect chromosome ends and
maintain telomere homeostasis. Loss of these factors leads to telomere uncapping
and subsequent telomere dysfunction (reviewed in Harrington 2004). Some of these
protecting factors bind along the duplex array of telomeric repeats whereas others
bind to single-stranded telomeric DNA. Among these proteins, Telomere-repeat
binding factor 1 (TRF1) and Telomere-repeat binding factor 2 (TRF2) directly bind
double-stranded telomere DNA and interact with a number of proteins to maintain
telomere structure (de Lange 2002, Iwano et al., 2004, and reviewed in Kim S, H et
al., 2002). These two factors differ in their N-termini, which are rich in either acidic
residues (TRF1) or basic residues (TRF2) and have both been shown to homdimerize
through their Myb-related DNA-binding domains (Chong et al., 1995, Broccoli et al.,
1997).
TRF1 was the first mammalian telomeric protein isolated, based on its in vitro
specificity for double-stranded TTAGGG repeats (Zhong et al., 1992) and it has been
shown that the amount of telomere-bound TRF1 correlates with telomere length.
Overexpression of TRF1 shortened telomeres in human cells, whereas dominant-
8
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negative TRF1 led to elongated telomeres (van Steensel et al., 1997, Smith, S. et ah,
2000, Smogorzewska et ah, 2000). Additionally, conditional TRF1 null mutant
mouse embryonic stem (ES) cells showed growth defects and chromosomal
instability (Iwano et al., 2004). Thus TRF1 binding to double-stranded telomere
DNA functions as a negative regulator of telomere length and confers telomere end-
protection.
TRF2 was subsequently identified as a paralog in the mammalian genie database.
Based on in vitro and in vivo studies, TRF2 promotes T-loop formation by binding
near the 3' telomeric overhang and is thus implicated in remodeling telomeres into T-
loops (Griffith et al., 1999, Stansel et al., 2001). Overexpression of dominant-
negative TRF2 activates the ATM/p53 or pl6/RB pathways and induces cellular
senescence or apoptosis (Karlseder et al., 1999, Smogorzewska et al., 2002).
Moreover, inhibition of TRF2 induces end-to-end fusions and chromosomal
instabilities (van Steensel et al., 1998, Karlseder et al., 2002). These data strongly
suggest that TRF2 is a key player in functional telomere structure.
In addition to TRF1 and TRF2, several other associated telomeric proteins have been
shown to be regulators of telomere length, such as POT1, RAP1, TPP1 - previously
called PTOP1 (Liu D et al., 2004) - and TIN2 (de Lange 2002, Kim SH et al., 1999
& 2004, Liu, D. et al., 2004, Ye, J. & de Lange 2004). Both inhibition of endogenous
POT1, RAP1, TPP1 and TIN2 expression through RNAi and expression of
dominant-negative forms of these four proteins have been demonstrated to result in
elongated telomeres in cultured cells (Loayaza et al., 2003, Ye, J. et al., 2004,
9
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O'Connor et al., 2004, Ye J. et al., 2004). These observations suggest that POT1,
RAP1, TPP1 and TIN2 may function in the same pathway and all therefore appear to
facilitate negative regulation of telomere length. All four proteins directly or
indirectly, associate with TRF1 or TRF2 (Ye, J. et al., 2004, Liu, D. et al., 2004, Li,
B et al., 2000). The convergence of this data indicated that the TRF1/2 proteins may
interact with each other and with the POT1, RAP1, TIN2 and TPP1 proteins to form
a multi-subunit complex at mammalian telomeres. Co-immunoprecipitation
experiments validated this hypothesis to show that TRF1 and TRF2 are in fact
subunits of a telomere-associated high molecular weight complex, recently termed
'shelterin', also previously referred to as the mammalian 'telosome', (Liu, D. et al.,
2004 and reviewed in de Lange 2005; discussed in section 1.3.4).
TRF1 has been shown to associate with additional factors called Tankyrase 1 and 2
(Smith S. et al., 2000). These are poly(ADP-ribose) polymerases that target TRF1
and induce progressive telomere lengthening via the dissociation of TRF1 from
telomeric structures in human cells in a reaction that requires the catalytic activity of
the PARP domain (Cook et al., 2002). Thus, Tankyrase 1 and 2 contribute to
telomere homeostasis through its indirect function as a positive regulator of telomere
length.
1.3.3 POTl-RAPl-TIN2-TPPl-mediated telomere regulation
Experiments deciphering the specific roles of POT1, RAP1, TIN2 and TPP1 aid our
understanding of how a multi-subunit protein complex at the telomere substrate may
regulate telomere length.
10
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POT1
As the TRF1 complex binds to the duplex DNA of the telomere, it was unclear how
it can affect telomerase, which acts on the single-stranded 3' overhang. TRF1
mediated-regulation of telomere length implies that this complex functions as a
measuring device to assess telomere length. However, for telomere length
homeostasis to be effective, information about the length of the telomere needs to be
relayed from the TRF1 complex to the single-stranded part of the telomere. Recently
it was shown that the TRF1 complex interacts with the single-stranded telomeric
DNA-binding protein, 'protection of telomeres 1' (POT1) - and that human POT1
controls telomerase-mediated telomere elongation (discussed in section 1.8). hPOTl
was identified based on sequence homology to telomere-end-binding factors in
unicellular eukaryotes (Baumann et al., 2001) and is the most conserved of the
telomere-associated factors. A mutant form of hPOTl lacking the DNA-binding
domain, abrogated TRF1-mediated control of telomere length and induced rapid and
extensive telomere elongation. (Loyaza et al., 2003). That hPOTl binds to single-
stranded telomere DNA exclusively, suggests two possible mechanisms for its role in
telomere regulation: the TRF1 complex may recruit hPOTl to the telomeric
chromatin and facilitate its accumulation on the single-stranded DNA at the nearby
telomere terminus. Once tethered there, hPOTl may sequester the telomere terminus
and thus directly block telomerase from elongating the telomeric DNA; alternatively,
the recruitment hPOTl to the telomeric chromatin could facilitate its binding to the
single-stranded DNA (D-loop) at the base of the T-loop, thus stabilizing telomeres in
the T-loop configuration and thereby inhibiting telomerase by indirect sequestration
of the 3' terminus. Intriguingly, recent evidence has suggested that hPOTl may in
11
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fact permit telomerase-mediated telomere elongation at the telomere substrate due to
a configuration change of hPOTl (Songyang Z. et al. personal communicaton).
Whether hPOTl functions as both a positive and a negative regulator of telomerase
will have to be validated with additional experiments. POT1 may also highlight a
specific caveat of the mouse as a human model for telomere end capping, plus a
general caveat in extrapolating across species with respect to telomere-associated
proteins. Although POT1 deficiency in the mouse initiated DNA damage checkpoint
activation and erroneous homologous recombination at telomeres, recent reports
have demonstrated that there are two distinct POT1 paralogues (Pot la and Potlb) in
the mouse in contrast to a single POT1 locus in the human genome. Potla knockout
results in embryonic lethality whereas Potlb knockout mice are viable and fertile. In
the absence of both proteins, 70-80% of telomere protection is lost; this proportion
falls to 30% when only Potla is deleted, whereas Potlb does not have any affect on
its own (Wu L. et al., 2006, Hockemeyer et al., 2006). Therefore the relationship
between POT la and POT lb in repressing the DNA damage signal is not simple and
the mechanism remains to be reconciled.
RAP1
'Human Repressor activator protein 1' (hRapl) was discovered in a yeast two-hybrid
screen with TRF2 as bait (Li B. et al., 2000) and shown to interact with multiple
proteins that are involved in DNA damage response pathways, including Rad50,
Mrell, Ku70/86, and Tankyrase 1 PARP. Rad50 and Mrell are members of the
MRN complex which, similar to the Ku70/86 complex, is known to regulate double-
stranded DNA break repair and homologous recombination (Connely et al., 2002,
12
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reviewed in Hopfner et al., 2002), whereas Tankyrase 1 PARP modulates chromatin
structure in response to stress (Smith S. et al., 2001). Thus, hRapl together with
TRF2 may function to recruit the DNA damage response proteins for telomere
maintenance. The exact role of these DNA-damage-response proteins at mammalian
telomeres remains to be determined. Interestingly, knockdown of endogenous hRapl
expression by small hairpin interference RNA resulted in longer telomeres,
implicating hRAPl as a negative regulator of telomere length (Connely et al., 2002).
TIN2
TIN2 was identified using a two-hybrid screen with TRF1 as bait (Kim S-H et al.,
1999). Truncated TIN2 proteins extended telomeres, thus implicating this factor as a
negative regulator of telomere length (Kim S-H et al., 1999). TRF1 may recruit TIN2
to the telomere, where TIN2 acts to dampen telomere elongation by telomerase. In
support of this notion, TIN2 has been shown to modulate the Tankyrase 1 PARP in
the TRF1 complex, suggesting that TIN2 could facilitate the stable association of
Tankyrase 1 with the TRF1 complex (Ye J. et al., 2004) and conversely the
controlled dismantling of the telomeric complex during S phase. The temporary
removal of the TRF1 complex may be necessary for replication fork progression and
telomerase-mediated telomere elongation.
TPP1
TPP1 previously known as TINT1 (Houghtaling et al., 2004), PTOP (Liu D 2004)
and PIP1 (Ye J. et al., 2004) has been shown (in conjunction with TIN2) to be
required to bridge the TRF1 and TRF2 subcomplexes. Specifically, TPP1 helps to
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stabilize the TRF1-TIN2-TRF2 interaction and promote a six-protein complex
formation. Consistent with this model, overexpression of TPP1 enhanced TIN2-
TRF2 association. Conversely, knocking down TPP1 reduced the ability of
endogenous TRF1 to associate with the TRF2 complex (O' Connor et ah, 2006).
Such coordinated interactions among TPP1, TIN2, TRF1, and TRF2 may ensure
robust assembly of the Shelterin complex, telomere targeting of its subunits, and
ultimately, regulated telomere maintenance.
Collectively, these factors contribute to telomere homeostasis by either positively or
negatively regulating telomere length, mainly through governing the accessibility of
telomerase to the 3' terminus (reviewed in Evans & Lundblad 2000). Further studies
will be required to fully understand how these factors (and others?) and their
homeostatic feedback loops, co-ordinate the regulation of mammalian telomere
length.
1.3.4 The shelterin protein complex
The elucidation of specific roles of telomere-specific proteins aids our understanding
of systemic telomere length regulation - undoubtedly novel factors yet to be
identified may have direct or indirect roles in telomeric regulation. The shelterin
complex was so coined by Titia de Lange (de Lange 2005) with analogy to other
chromosomal protein complexes such as condensin and cohesion. Three shelterin
subunits, TRF1, TRF2 and POT1 directly recognize TTAGGG sequences and are
interconnected by three additional shelterin subunits, TIN2, TPP1 and Rapl. These
factors combine to allow cells to distinguish telomeres from sites of DNA damage.
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Shelterin components are defined by their exclusive functional role at telomeres,
although a number of non-shelterin components (thus categorized due to their
additional non-telomeric functions) directly interact with shelterin and contribute to
telomere function (discussed in section 1.6.2). Shelterin determines the structure of
the telomere terminus, it is implicated in the generation of T-loops and it controls the





long telomere/more shelterin short telomere/iess shelterin
Telomerase blocked Telomerase not blocked
Figure 1.3. Proposed modeling of telomeres by shelterin. (A) Schematic of
shelterin on telomeric DNA. For simplicity, POT1 is only shown as binding the
single-strand site closest to the duplex telomeric DNA (D-loop), although it can bind
to the single-strand 3' end. (B) Speculative model for shelterin-mediated T-loop
formation. TRF1 has the ability to loop and pair telomeric DNA and TRF2 can
mediate T-loop formation (both in vitro). (C) Model for telomere length regulation
by shelterin. As the t-loop configuration is unlikely to be a substrate for telomerase,
telomeres are shown in the 'open' state, which could be generated during S phase.
The number of shelterin complexes may be proportional to the amount of telomere.
Long telomeres may have more shelterin bound, increasing the loading of POT 1 onto
the 3' overhang and thus blocking telomerase action (left). Conversely, short
telomeres with less shelterin, reduce the chance that POT1 loads onto the 3'overhang,
leading to a greater chance that telomerase can elongate the telomere (right)
(modified from de Lange 2005).
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Since the TRF1, TRF2 (both homodimers and double-strand binding) and POT1
(single-strand binding) subunits are connected through protein interactions, shelterin
has the capacity to recognize telomeric DNA with at least five DNA-binding
domains. As a consequence, shelterin is uniquely qualified to distinguish telomere
ends from all other DNA ends (de Lange 2005). Evidence for DNA remodeling
activities comes from in vitro studies demonstrating that TRF2 can remodel an
artificial telomeric substrate into loops (Griffith et al., 1999, Stansel et al., 2001). As
this reaction is not efficient, it is likely that TRF2 requires the assistance of other
factors to generate T-loops in vivo. Regarding the proposed function of telomere
synthesis control, it is easy to speculate how the single-strand binding activity of
POT1 could block telomerase from gaining access to the 3' telomeric terminus and in
vitro, such inhibitory activity has been noted (Kelleher et al., 2005, Lei et al., 2005).
Based on these data, the current model predicts that the amount of shelterin on a
telomere determines the likelihood that its POT1 component can position itself on
the 3' terminus and block telomerase, thus providing one mechanistic description of
how telomerase regulation is governed.
1.4 Telomeres and cellular ageing
1.4.1 Cellular ageing and the Hayflick limit
Almost 45 years ago, Leonard Hayflick discovered that cultured human cells have
limited replicative capacity to undergo rounds of DNA replication and divide, after
which cells enter an irreversible non-dividing state termed 'replicative senescence' (a
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cellular growth arrest also now referred to as the Ml stage (Shay & Wright 2005). In
the absence of cell-cycle checkpoint pathways (e.g. p53 and or pl6/Rb), cells bypass
Ml senescence and telomeres continue to shorten, eventually resulting in crisis (also
called the M2 stage). M2 is characterized by many 'uncapped' chromosome ends,
end-fusions, chromosome breakage fusion-bridge cycles, mitotic catastrophe and a
high fraction of apoptotic cells (Shay & Wright 2005). The widespread phenomenon
of cultured diploid cells to undergo a specific number of population doublings has
become known as the 'Hayflick limit' (Hayflick & Moorehead 1961), which
specifically describes the finite capacity of normal cells as opposed to cancerous
cells which usually become immortal. The existence of an intrinsic cellular counting
mechanism was further implied by Hayflick's observation that cryogenically
preserved cells can 'remember' how many times they have divided when they were
frozen (Hayflick 1984). This putative molecular event counter was designated the
'replicometer' by Hayflick and in 1975, Woodring Wright showed that the molecular
replicometer and cellular control of ageing was located in the nucleus (Wright &
Hayflick 1975).
1.4.2 The 'end-replication' problem
Although the presence of telomeres on chromosome tips had been noted previously,
(McClintock 1939), the property and function of these structures was unclear. The
molecular basis of the replicometer was theorized independently by Alexy
Olovnikov (Olovnikov 1973) and James Watson (Watson 1972) in the early 1970s
when DNA replication mechanisms were better understood. It was realized that the
properties of DNA replication prevent the ends of linear DNA to be fully copied and
17
Chapter 1 - Introduction
thus telomere sequences may be lost during each successive round of cell division.
The first hints that human telomeres might shorten appeared in 1986 when it was
shown that telomere lengths are not the same in all tissues (Cooke et ah, 1986).
These studies culminated in the demonstration that telomeres shorten as normal
human fibroblasts divide in culture (Harley et ah, 1990). That telomere shortening is
indeed a faithful cell division counter was recently demonstrated by results showing
that replicative lifespan and telomere shortening rate in sheep fibroblast strains are
not altered by nuclear transfer and cloning of foetuses, although foetal development
resets the telomere clock (Clark et ah, 2003).
The molecular basis of telomere shortening was referred to as the 'end replication'
problem by James Watson. During DNA replication, the leading strand is
synthesized as a continuous molecule that can potentially replicate through to the
termini of a linear template. DNA polymerase requires an RNA primer to initiate
synthesis in the 5'-3' direction. The lagging strand however, is synthesized as a
discontinuous set of short Okazaki fragments, each requiring a new primer to be laid
down on the template, that are then ligated to form a continuous strand. Without
DNA to serve as template for a new primer, the replication machinery is unable to
synthesize the sequence complementary to the final primal event. The result is the
"end-replication problem" in which a telomere segment is lost at each round ofDNA
replication (Fig. 1.4). The leading strand is subsequently processed after completion
of S phase to generate a 3' overhang.
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Figure 1.4. The end replication problem. Continuous replication of the leading
strand proceeds to chromosomal termini. Discontinuous replication of the lagging
strand through a series of Okazaki fragments results in a gap at the 5' end of the C-
rich strand after removal of the last RNA primer.
The lowest shortening rates in human fibroblasts are around 10-20bp per population
doubling (Lorenz et ah, 2001). This shows that polymerase can position the most
distal primer very close to the physical end of the chromosome. However the length
of the G-rich telomeric overhang in some human cells has been shown to be 100-
500nt in length (Makarov et ah, 1997, Wright et ah, 1997, McElligott et ah, 1997,
Stewart et ah, 2003), suggesting that either the final RNA primer for lagging strand
synthesis is not placed at the very distal end of the G-rich strand or that nucleolytic
processing of the C-rich strand is extensive. Possible roles of oxidative stress and
culture shock upon telomere shortening will be discussed in section 1.5.4.
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1.5 Replicative senescence
The paradigm of cellular replicative senescence currently resides as a circular
argument of cause and consequence - it remains unclear as to what factors are
ultimate causes and what factors are proximate causes of senescence. Conventional
dogma (section 1.4.1) states that telomere shortening provides the counting
mechanism for the cellular 'mitotic clock'. In this regard, replicative senescence
occurs as a consequence of progressive shortening of the TTAGGG repeat tract at
chromosome ends (Hayflick & Moorehaed 1961, Harley et al., 1990, Bodnar et al.,
1998, Wight & Shay 2002), when telomere length falls below a critical threshold to
preserve replicative capacity that is presumably species- and cell-type specific.
Human telomeres are programmed to lose ~100 base pairs per population doubling
(PD), resulting in senescence after -50 PDs (Harley et al., 1990, Counter et al., 1992,
Shay & Wright 2000). This shortening rate is faster than expected from the end-
replication problem (~10-20bp; Watson 1972, Olovnikov 1973, Lundbald et al., 1989,
Singer et al., 1994; section 1.4.2), suggesting active nucleolytic attack on
chromosome ends. Replicative senescence can be induced by either the p53 or the
pl6-retino blastoma (RB) tumour suppressor pathways, the breakdown of which may
be the basis for the escape from in vitro cellular senescence and subsequent
immortalization (Shay et al., 1991, Hara et al., 1991). In mammalian cells, telomeric
foci containing multiple DNA damage response factors are assembled in a subset of
senescent cells and signaled through ATM kinase to p53, upregulating p21 and
causing G1 phase growth arrest (Herbig et al., 2004). But how these pathways are
activated in cells with short telomeres though, is not known. Of what upstream
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molecular trigger of senescence may these associated pathways be subsequently
activated?
1.5.1 'Subset of short telomeres' hypothesis
The understanding that one of the major functions of telomeres is to hide the ends of
the chromosomes from being recognized as double-strand breaks needing repair (de
Lange 2002), has led to the hypothesis that a DNA damage signal from 'too-short'
telomeres causes cellular senescence (Greider 1990, Harley 1991; section 1.7). This
concept is reinforced by demonstrations that at senescence, DNA sequences adjacent
to telomeres co-precipitate with yH2AX antibodies (di Fagagna et al., 2003) and that
induced telomere dysfunction can cause telomere co-localization with DNA damage
foci (Takai et al., 2003). Cell biological approaches have shown that the shortest
telomeres determine the onset of replicative senescence in human cells (Ouelette et
al., 2000, Steinert et al., 2000), an observation confirmed with respect to end-to-end
fusions in murine cells (Hemann et al., 2001). However the pending question was
whether specific telomeres produced this result, as these studies did not distinguish
between one or a few short telomeres and did not identify specific telomeres
involved. This was the rationale for a study to obtain direct evidence about the role
of specific telomeres in senescence. Using quantitative in situ analysis of telomere
lengths in normal human fibroblasts, this pivotal study showed that the shortest
telomeres (as judged by a signal-free end using a telomere-specific probe) co-
localized with yH2AX-positive DNA damage foci in senescent cells. Furthermore, in
normal fibroblasts where cell cycle arrest has been blocked, 10% of telomeres with
the shortest ends are involved in 90% of all end-fusions (Zou Y. et al., 2004). This
finding argues against the existence of a sentinel telomere or random telomeres to
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monitor telomere shortening but rather that a subset of telomeres is being used to
time the onset of replicative senescence in the population of cells. Presumably a short
telomere has to find a partner to form an end-association before growth arrest occurs,
which would invoke more than one short telomere. An interesting side observation to
this latter study indicated that -85% of metaphase spreads from near-senescent
cultures contained more than one signal-free end. This establishes that normal cells
are still able to divide in the presence of telomeres sufficiently short to produce no
hybridization signal (which may not be short enough to initiate a DNA damage
response). This does however underline a caveat - signal-free ends are an arbitrary
assignment due to technical limitations that does not necessarily imply a true absence
of telomere repeats.
1.5.2 The 'altered telomere state' hypothesis
A general counter argument to telomere loss on one or more chromosomes as being
the ultimate trigger of replicative senescence states that the main event heralding the
end of replicative life of cells is a failure in the protective function of critically
shortened telomeres. Clues for this trajectory come from studies manipulating the
duplex binding protein TRF2, known to protect chromosome ends from end-to-end
fusions (Broccoli et al., 1997, Bilaud et al., 1997, van Steensel et al., 1998, Karlseder
et al., 1999, de Lange 2001). Overexpression of TRF2 increased the rate of telomere
shortening in primary human cells without accelerating senescence. Thus TRF2
protected critically short telomeres from fusion by repressing chromosome end-to-
end fusions in pre-senescent cultures (Karlseder et al., 2002). If the senescence signal
were due to one or more chromosome ends lacking telomeric DNA altogether, TRF2
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would not be expected to repress this signal and alter the senescence checkpoint. The
implication is that critically shortened telomeres in senescent cells no longer bind
sufficient TRF2 to achieve a protective state such as the T-loop configuration.
Alternatively, binding of TRF2 may facilitate the recruitment of other proteins
required for telomere end-protection and suppression of senescence. Therefore it
follows that replicative senescence may be induced by a change in the protected
status of shortened telomeres rather than a complete loss of telomeric DNA.
1.5.3 The '3' telomeric overhang' hypothesis
With the development of the Telomere-Oligonucleotide Ligation Assay (T-OLA),
the G-rich strand 3' overhang has been subject to measurement (section 2.2.17).
Using this approach, a recent study argued for evidence indicating that the telomeric
3' overhang is eroded at replicative senescence in primary human cells (Stewart et ah,
2003). This data suggested that during senescence, most overhangs drop to below
lOOnt, potentially disrupting the T-loop or another non-canonical telomeric end
structure. The kinetics of overhang loss differed from those of overall telomere
shortening. Telomere shortening rate in the lines studied were in accordance with
shortening rates reported previously (Harley et ah, 1990, Allsopp et ah, 1995,
Huffman et ah, 2000). In contrast telomeric overhang lengths remained constant
during early and mid-point passages of culture and dropped abruptly at senescence
(Stewart et ah, 2003). Thus the authors claimed that overhang length is not a direct
reflection of overall telomere length, but rather that overhang loss is the specific
molecular alteration that occurs at the telomere in association with replicative
senescence. This challenges the paradigm of telomere shortening as the molecular
23
Chapter 1 - Introduction
clock that limits cellular lifespan. Nevertheless, it is imperative to state that others
have shown using the same cell type as used in this study, that the 3' telomeric
overhang is eroded only at crisis and therefore represents a consequential event to
upstream senescence activation (Chai et ah, 2005). This may represent technical
variations between laboratories or may reflect clonal variations of the particular cell
lines studied. For the role of the 3' overhang in replicative senescence (causal or
consequential) to be fully understood, studies on telomeric overhang will have to
incorporate a number of cell types and be widespread across species. With the
conservation of telomere repeat tract sequences across eukaryotes and the functional
similarity with key associated proteins and telomerase, it is tempting to speculate that
the molecular trigger of replicative senescence is a general one.
1.5.4 The 'physiologic stress' hypothesis
The simple 'mitotic' clock' hypothesis cannot easily accommodate the marked
intrinsic heterogeneity of replicative lifespan that is evident among the individual
cells of a population in culture (Smith J. et ah, 1980, Jones R. et al., 1980, Martn
Ruiz et al., 2004). It is this heterogeneity within a population that indicated that the
correlation between average telomere length and population doubling might not be
sufficient to sustain the notion of telomeres as replication counters at the individual
cell level. There is good evidence to show that the telomere-driven checkpoint is not
the only one, if activated, to induce a senescence-like growth arrest. For example,
human epithelial cells encounter a telomere-independent pl6-dependent growth
arrest that may be triggered due to sub-optimal culture conditions (Stampfer et al.
2003). Overexpression of oncogenes such as activated RAS or RAF, induces a
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senescence-like growth arrest in primary human and mouse cells (Lin A. et al., 1998,
Dirnri et ah, 2002, Ferbeyre et ah, 2002). In addition, DNA-damaging stress induces
cellular growth arrest, which may originate from different types of radiation
(Herskind et ah, 2000), drugs generating DNA double-strand breaks (Robles et al.,
1998) and different means to generate oxidative stress such as increasing ambient
oxygen tension (Balin et al., 1977, von Zglinicki et al., 1995) and treatment with
hydrogen peroxide (Chen Q. et al, 1994, Frippiat et al, 2001). Thereby with
increasing replicative age cells become more sensitive to environmental stress, in
part due to changes in gene expression (Luce et al., 1992, Cristofalo et al., 1989).
Semantics plays a part regarding descriptions of 'senescence'. Telomere-independent
growth arrest, which reflects inadequate culture conditions, has been referred to as
STASIS by Woodring Wright and Jerry Shay to distinguish between true senescence
as determined by the replicometer.
Molecular oxygen plays a pivotal role in cellular respiration and is an absolute
requirement for aerobic life; however, it is also toxic. Oxygen toxicity is believed to
result from changes in the rates of cellular generation of reactive oxygen species
(ROS). Faster telomere shortening rates (than that predicted from the end-replication
problem) have been observed in human cell lines which have high levels of peroxide,
indicating less efficient anti-oxidant defence (Lorenz et al., 2001, von Zgliniicki et
al., 2000). The clear implication is that the contribution to telomere loss caused by
oxidative damage is, in many cases, much greater than the contribution from the end-
replication problem (reviewed in von Zglinicki 2003 and 2003). Ageing and telomere
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shortening in bulk culture may therefore reflect a consequential event of the balance
between oxidative stress and anti-oxidative defence.
Cause and consequence?
Collectively the current evidence regarding the causal and consequential events of
cellular replicative senescence resides in a circular event. My opinion is that a subset
of short telomeres, once a critical minimum length is reached, is the ultimate trigger
of replicative senescence. Deprotection of telomere terminal structures due to
sufficient shortening of the 3' overhang would therefore be viewed as a
consequential epi-phenomenal event of overall telomere shortening in this subset.
Loss of a T-loop configuration would presumably be necessary and sufficient to
allow p53-dependent and associated senescence program pathways to be activated
via signaling stemming from the terminal and exposed telomere substrate. However
the evidence is convincing that telomere shortening counts not only mitotic divisions
but also cumulative mutations that are dependent on culture shock conditions.
Therefore we may consistently observe telomere-driven senescence occurring
prematurely in vitro owing to imperfect protection from damage such as that induced
by oxidative stress. From an evolutionary perspective, telomere-driven senescence
becomes more plausible as a tumour suppressor mechanism if it limits proliferation
not merely as a result of a predetermined number of cell divisions but also in
response to possible damage to the genome.
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1.5.5 Telomere length and cell viability
It is widely regarded that loss of telomere function can lead to genetic instability and
cancer progression - whether short telomeres per se predispose cells to be cancerous
is unclear. Whereas normal cells maintain chromosome stability, cancer cells are
characterized by chromosomal changes (Lengauer et ah, 1997), the sort ofwhich was
elucidated by McClintock, in studies observing the consequence of telomere loss
(McClintock 1939). In a population of cells, there is a distribution of telomere
lengths collectively representing each individual chromosome end, the establishment
and maintenance of which requires telomerase. While the consequences of telomere
dysfunction are well characterized (section 1.6.2), the primary determinant of the
cellular response to global telomere shortening is poorly understood. One hypothesis
is that average telomere length contributes to the cellular responses to telomere
shortening (Blackburn 2000). In support of this idea, average telomere length has
been shown to correlate with the lifespan of human cells in culture (Allsopp et al.,
1992, 1995) and numerous studies have argued that it is the average telomere length
in a cell that determines the proliferative potential of a cell line in the absence of
telomerase (Lansdorp 2000, Martens et al., 2000). These models anticipate that as
telomeres shorten, the probability of all telomeres losing function increases. An
alternative hypothesis is however emerging from more recent studies. Rather than
average telomere length, it is predicted that individual telomeres are recognized as
DNA damage and it is those that elicit a cellular response. Support for this comes
from studies using transgenic mice that are null for the telomerase RNA subunit gene,
mTR, (mTK~) or are heterozygous (mTR+/~). Inter-generational crosses (mTR+l~)
revealed that telomerase-mediated restoration of telomere function occurs without a
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considerable increase in average telomere length (Hemann et ah, 2001). Although a
wild-type telomere length distribution was not restored in the F1 generation,
telomere function was restored. Similarly, studies using mouse embryonic stem (ES)
cells heterozygous for the telomerase reversere transcriptase gene, TERT, (mTERT^'~)
argued for the preferential maintenance of critically short telomeres (Yie L 2002).
Here, although average telomere length in mTERT*1' ES cells declined to a similar
level as mTERT-null ES cells, mTERT*1' ES cells retained a minimal telomeric DNA
signal at all chromosome ends. Consequently no end-to-end fusions and genomic
instability was observed in the latest passages of these lines. This further revealed a
distinct dosage requirement for the maintenance of long and short telomeres -
despite haploinsufficiency for the maintenance of long telomeres, mTERT*' mice
retain minimal telomere DNA at all chromosome termini and did not exhibit the
infertility typical of telomerase-deficient strains (Erdmann et al., 2004). Thus, the
essential role of telomerase may not be the maintenance of an average telomere
length, but rather the maintenance of telomere function at critically shortened
telomeres. In this regard critically short telomeres are both necessary and sufficient
for telomere dysfunction to manifest. Moreover, it has been shown that chromosomes
frequently involved in fusions have the shortest telomeres (Blasco et al., 1997). This
preferential elongation of short telomeres to maintain cell viability and chromosome
stability, may explain previous findings in which limiting amounts of telomerase
maintained telomere lengths at the shortest telomeres, despite decreases in overall
telomere length within the population (Chiu C. et al., 1997, Zhu J. et al., 1999
Ouelette et al., 2000). This process may represent an uncoupling of telomere length
maintenance from the maintenance of telomere function. If distinctions between long
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and short telomeres are to be made, the presumable inference is that telomerase has a
sophisticated mechanism to preferentially elongate short telomeres that are close to a
minimum threshold required for chromosome stability.
1.6 Telomere length and organismal ageing
Although it is well established that telomere length is a crucial factor in cellular
replicative senescence, it will be of greater importance to determine whether
organisms with longer telomeres live longer. An insight regarding this question
comes from studies in C. elegans where overexpression of the telomere single-strand
binding protein HRP-1, by gradually increasing telomere length, resulted in worms
with a longer lifespan. This was confirmed as due to longer telomeres rather than
overexpression of HRP-1 per se as nontransgenic progeny who retained the longer
telomeres, also lived longer (Fiset et ah, 2001, Joeng et ah, 2004). Additionally, it
has been observed that telomeres shorten more slowly in long-lived birds than in
short-lived ones (Hausmann et al., 2003). It will be interesting to determine whether
this holds true for mammals; the mouse may not be a suitable model for such a study
due to their long telomeres, so long-term studies in domesticated animals such as
sheep may be more informative. Recently it was shown that people with long
telomeres, although with independent genetic backgrounds, have lower mortality
rates than those with short telomeres (Cawthon et al., 2003). Furthermore, not only is
there evidence that human chromosome-specific telomere lengths may be inherited
(Londono-Vallejo et al., 2001, Graajkaer et al., 2003 & 2004) but, by directly
comparing telomere lengths in children and their parents, that allele-specific
telomere lengths are transmitted by meiosis (Graajkaer et al., 2006). It will be
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necessary to replicate these sorts of studies in numerous population cohorts of large
population size but the implication is that telomere length may be a predisposition to
certain age-related diseases in organs impacted upon by senescence and may thus
serve as one predictor of longevity. Lengthening telomeres in adult somatic cells by a
means that does not result in deleterious side effects, could in theory help mammals,
including humans, to live longer, or certainly compress the period ofmorbidity in the
elderly.
1.7 Telomeres, genome stability and the DNA damage response
It was long suspected that telomeres remain 'hidden' from DNA damage signaling
pathways. Evidence that dysfunctional telomeres activate the DNA damage response
pathway first emerged from experiments in which the TRF2 shelterin subunit was
inhibited with a dominant-negative allele (van Steensel et al., 1998). The loss of
TRF2 function results in telomeric-end fusions and activates the ATM kinase
(Ataxia-Telangiectasia Mutated) DNA damage response pathway, leading to p53 up-
regulation and p21-mediated Gl/S cell cycle arrest and consequent apoptosis
(Karlseder et ah, 1999). Interestingly activation of the ATM pathway was not due to
the secondary damage that can be generated when cells with dicentric chromosomes
progress through mitosis (formed by end-to-end fusion). Rather, it is the damage at
the telomere itself that appears to activate the ATM pathway. Telomere dysfunction
can lead to either apoptosis or senescence depending on the cell type; upon TRF2
inhibition, human fibroblasts undergo senescence whereas apoptosis is a more
prominent outcome in lymphocytes and epithelial cells (Karlseder et al., 1999).
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The argument that deprotected telomeres activate the DNA damage response has
been strengthened by the direct observation of DNA damage factors at telomeres.
After inhibition of TRF2 or when telomeres become critically short, 53BP1, y-H2AX,
phosphorylated ATM and the Mrel 1/Rad50/Nbsl (MRN) complex, accumulate at
chromosome ends (di Fagagna et ah, 2003, Takai et ah, 2003). The cytological
structures formed by these DNA damage factors are referred to as 'Telomere
dysfunction Induced Foci' (TIFs) (Takai et ah, 2003). TIFs are also formed when
other shelterin components such as TIN2 and POT1 are inhibited (Kim S-H et ah,
2004, Hockemeyer et ah, 2005; Fig. 1.5). Intriguingly, there is current evidence
suggesting that the converse holds true, where telomeric proteins are involved in a
DNA damage response elsewhere in the genome. TRF1, TRF2 and TIN2 appear to
be involved in an early DNA damage response after induction of double-strand
breaks at defined regions within the nuclei of human fibroblasts (Bradshaw.P et al,
personnal communication).
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Figure 1.5. DNA damage response at dysfunctional telomeres. Telomeres lose
end-protection after inhibition of shelterin subunits (e.g. TRF2, TIN2 and POT1) or
due to telomere erosion. Upon loss of protection, telomeres become associated with
DNA damage response factors, forming Telomere dysfunction Induced Foci's (TIFs).
Telomere damage activates the ATM kinase which leads to a p53-dependent Gl/S
cell cycle arrest and can induce either apoptosis or senescence (from de Lange 2005).
Of particular interest is the presence of the MRN complex at the telomere substrate
and indeed the Mrel 1, Rad50 and Nbsl proteins have been shown to co-purify with
TRF2 (Zhu X. et al., 2000). These proteins were previously characterized for their
role in non-homologous end joining (NHEJ), a process that can result in the ends of
two telomeres joining to form a dicentric chromosome (reviewed in Flarrington
2004). In addition, homologous recombination (HR) between telomeres could
generate aberrant telomere length and recombination between telomeres and
interstitial telomeric sequences could result in deletions, inversions and
translocations. Presumably base excision repair, nucleotide excision repair and
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mismatch repair are used to maintain fidelity of the TTAGGG repeat sequence, just
as they function for bulk DNA. In support of this, the recombination/repair protein
RAD51D has shown to be present at mammalian telomeres and required for telomere
maintenance (Tarsounas et ah, 2004). It remains to be established whether
recombination is required for telomere elongation or for protection of the telomeric
single-strand overhang. This leads to the question of how shelterin in conjunction
with DNA repair factors, functions to prevent improper recombination and repair?
The obvious suggestion is that telomeres are protected from these events by the
shelterin-mediated T-loop configuration (Fig. 1.6). In this regard, RAD51 D-mediated
telomere maintenance would be via its role in telomere capping.
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Figure 1.6. Proposed model of how telomere ends may avoid a DNA damage
response. Shelterin DNA-binding factors and the DNA-repair factors they recruit to
mammalian telomeres may function to inhibit, rather than promote a variety of repair
processes, such as Non-homologous End Joining (NHEJ) and aberrant homologous
recombination (HR) (adapted from de Lange 2005 and Wright & Shay 2005).
Collectively the data argue that dysfunctional telomeres are detected by the canonical
DNA damage response and there is no evidence that a telomere-specific checkpoint
or specific signaling pathway is invoked. Hence, damaged telomeres do appear to
share molecular characteristics of a localized DNA damage response. The evidence
indicates that the shelterin complex is not a static structural component of the
telomere, but rather a protein complex with DNA remodeling activity that acts in
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coercion with several associated DNA repair factors to alter the structure of
telomeric DNA, thereby protecting chromosome ends. So, although telomerase is
generally required for the synthesis of telomeric repeats, the enzyme is not required
for telomere protection per se as long as there is enough telomeric DNA (Blasco et
ah, 1997). A recent seminal observation has shown that chromosome ends of normal
human primary fibroblasts are recognized as double-strand breaks at the G2 phase
and recruit the ATM, NBS1 and Mrel 1 DNA damage response factors (Verdun et ah,
2005). This leads to the intriguing hypothesis that a localized DNA damage response
at 'functional' telomeres after replication may be necessary and essential for
recruiting the processing machinery that promotes formation of a chromosome end
protection complex.
1.8 Telomere homeostasis and telomerase
1.8.1 Telomerase holoenzyme structure
If short telomeres limit the rate of cell growth, there had to be a counter-mechanism
to the telomere problem in the germline cells and potentially highly proliferative
tissues (e.g. stem cells, some progenitors,) of higher organisms and in immortal and
cancerous cells. The solution again originated in studies with Tetrahyema by Carol
Greider and Elizabeth Blackburn (Greider & Blackburn 1985), where Greider and
Blackburn discovered the enzyme 'telomerase' that maintains and elongates
telomeres. Telomerase was later found in extracts of immortal human cell lines
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(Morin et al., 1989) and in most human tumours (Kim N-W et al., 1994) and is now
known to be almost universally conserved in eukaryotes.
Telomerase is a specialized cellular ribonucleoprotein (RNP) reverse transcriptase
complex that synthesizes TTAGGGn telomeric repeats onto chromosomal ends
(Greider & Blackburn 1987, Lingner et al., 1997). Telomerase consists minimally of
two main components that are required for core enzymatic activity. These are a
telomerase RNA (TR), used as a template to dictate the addition of de novo telomeric
repeats onto the 3' end and a catalytic protein subunit with reverse transcriptase
activity (TERT). It has recently been shown that human telomerase is a multimer
containing two cooperating hTR molecules (Wenz et al., 2001) and generally thought
to most likely contain two hTERT molecules. The human telomerase holoenzyme is
large (~1000kDa; Schnapp et al., 1998) and mammalian telomerase activity is
associated with a number of proteins that may be implicated in ribonucleprotein
assembly, processing and stability such as: TP1 (Harrington et al., 1997); p23 and
Hsp90 (Holt et al., 1999); Est2 (Lingner et al.,1997 and Mitchell et al., 1999); (see
section 1.8.2). However, human telomerase that is affinity purified under stringent
salt conditions has a molecular mass of 600kDa, consistent with a minimal complex
composed of two hTERTs and two hTRs (Wenz et al., 2001). The secondary
structure of telomerase RNA was proposed based on phylogentic comparative
analysis. Four structural domains were conserved across vertebrates - the pseudoknot
domain, the CR4-CR5 domain, the Box H/ACA domain and the CR7 domain. Each
conserved structural domain in the consensus structure might play a distinctive role
in either the function, stability, processing, or localization of telomerase RNA. These
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regions are also good candidates as binding sites for TERT or other telomerase
accessory proteins (Romero & Blackburn 1991, Chen J. et al., 2000, reviewed in
Nugent & Lundblad 1998 and Smogorzewska & de Lange 2004). Indeed some
studies have implicated the pseudoknot and CR4-CR5 domains as essential for
telomerase activity that interact separately with hTERT (Chen J. et al., 2002, 2003
and 2003, Martin-Rivera et al., 2001, Tesmer et al., 1999). Studies from
Tetrahymena have shown that the templating region of the telomerase RNA can be
dissected into two functionally seperable regions (Autexier et al., 1994 and 1995,
Gilley et al., 1996). The hTERT gene is located on the distal arm of chromosome 5p
and is in fact the most distal marker (Meyerson et al., 1997, Bryce et al., 2000, Shay
& Wright 2000). The hTERT promoter contains a number of regulatory sites
including two c-Myc binding sites (Wang J. et al., 1998) and may also contain a site
that negatively regulates its expression in a p53-dependent manner (Kanaya et al.,
2000). In support of the notion that proper hTERT function may also require a
homodimeric structure, studies have shown that two separate catalytically inactive
hTERT proteins can complement each other in trans to reconstitute telomerase
activity (Beattie et al., 2001, Arai et al., 2002). hTERT has been shown to consist of
two physically separable functional domains: a polymerase domain, containing RNA
interaction domain 2 (RID2), reverse transcriptase (RT) and C-terminal sequences,
and a major accessory domain consisting of RNA interaction domain 1 (RID1)
(Moriarty et al., 2004; Fig 1.7). Further support of this notion of an hTERT multimer
was provided by a study using recombinant hTERT which demonstrated that hTERT
monomers oligomerize and that two independent regions are required for its
oligomerization and telomerase activity (Arai et al., 2002). Mutation screens of
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hTERT are permitting a dissection of the functional organization of the subunits of
this unique reverse transcriptase. Both N-terminal and C-terminal subunits of hTERT
contain regions essential for in vitro and in vivo enzymatic activity, and both regions
contain a DAT domain that "dissociates activities of telomerase", mutations in which
render the hTERT enzyme catalytically active but unable to function in vivo
(Armbruster et ah, 2001 and 2004, Bachand et ah, 2001, Banik et ah, 2002, Huard et
ah, 2003). These findings support the notion that hTERT subunits out with the RT





Figure 1.7. A schematic depicting conserved hTERT regions. The hTERT N-
terminus can be subdivided into two regions, RNA interaction domains 1 and 2
(RID1 and RID2, respectively), which are separated by a nonconserved linker that is
not required for telomerase activity (Armbruster B 2001, Moriarty T 2002, Xia, J
2000). This forms two physically separable domains of hTERT, the polymerase
domain (RID2, RT, C) and major accessory domain (RID1). Numbers indicate the
amino acid boundaries defined from recent studies. A 'dissociates activities of
telomerase' (DAT) domain is found in both the RID1 motif of the N-terminal domain
and in the C-terminal domain. RID1/2, RNA-interacting domain 1/2; RT, reverse
transcriptase domain; C, Carboxy-terminal (adopted from Moriarty T, J. 2004).
1.8.2 Telomerase complex: associated proteins
A large numebr of telomerase-associated proteins have been identified in ciliates,
yeasts and vetrtebrates. However, only a few are common to all telomerases and
discussion here will be restricted to those. One of the first TERT interacting proteins
identified was the p23 chaperone (Holt et al., 1999), which is required, along with
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Hsp90, for the efficient assembly of active telomerase both in vitro and in vivo.
Contrary to the association of chaperones with most proteins, p23 and Hsp90 remain
stably associated with active telomerase following assembly and may therefore
contribute additional regulatory functions at telomeres (Forsythe et ah, 2001).
A number of additional proteins may regulate TERT activity through direct binding.
Ku is a heterodimer composed of two subunits - Ku70 and Ku80 - that binds to
DNA in a sequence dependent manner. In all systems studied, Ku has been shown to
facillitate the repair of DNA double-strand breaks by non-homologous end joining
(NHEJ) (Downs et ah, 2004). Interestingly, the human heterodimeric Ku complex
was shown to be linked to telomere maintenance through its interaction with
telomeric DNA and TRF1 and TRF2 (Downs et ah, 2004). More recent studies
suggest that the complex can also independently associate with hTERT and hTR. Ku
binds specifically to a stem-loop in the telomerase RNA and may promote the
localization of telomerase to telomere termini (Chai W. et al., 2002, Ting NSY et ah,
2005).
hESTIA and hESTIB are both human homologs of the yeast telomerase subunit
ESTlp. Yeast ESTlp mediates the recruitment of telomerase to telomere ends by
binding to both telomerase RNA and CDC13p, a telomere end-binding protein
(Pennock et ah, 2001). However, direct interaction between Estlp and yeast TERT
has not been detected. In contrast, both hESTIA and hESTIB were shown to bind
hTERT independently of the RNA subunit when expressed in vitro (Snow et ah,
2003) Only hESTIA has been functionally linked to telomere maintenance in vivo;
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overexpression of hESTIA results in telomere uncapping and elevated levels of
chromosomal fusion and, in combination with hTERT overexpression, can provoke
substantial telomere elongation (Snow et ah, 2003).
1.8.3 Telomerase-mediated telomere maintenance
The processive addition of telomeric repeat sequences by telomerase is repetitive,
whereby telomerase undergoes a translocation reaction and repositions the 3' end of
the telomeric DNA in concert with recognition of the 3' template boundary (see Fig.
1.8). In humans, the telomerase holoenzyme is preferentially expressed in germ-line
cells and in early embryonic tissues but is not detected in most somatic cells (Wright
et al., 1996), although it has recently been shown to be present at low levels in
cycling human fibroblasts (Mastuomi et al., 2003). hTERT has been indicated as a
key factor limiting telomerase activity in human somatic cells because the RNA
subunit is constitutively expressed at a low basal level in cells (Feng et al., 1995).
However studies from the mouse have shown that the expression of telomerase RNA
template, but not telomerase reverse transcriptase, is limiting for telomere length
maintenance in vivo. TERT+ ~ heterozygotes had no detectable defect in telomere
elongation compared to wild-type controls, whereas TR+/" heterozygotes were
deficient in telomere elongation, indicating that both TR and TERT are essential for
telomere maintenance and elongation but that gene copy number and transcriptional
regulation of TR, but not TERT, are limiting for telomerase activity in vivo. (Lingner
et al., 1997, Chiang et al., 2005). In addition the telomerase RNA template has been
shown to be a determinant of telomere repeat extension rate in humans (Drosopoulos
et al., 2005). The caveat in this mouse study concerns the fact telomerase is
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expressed at high levels in an array of somatic murine tissues (Greenberg et al.,
1998), hence a deficient phenotype in mTERT+" may not be evident.
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Figure 1.8. Model for processive elongation by telomerase. Reiterative extension
of telomeric DNA is postulated to entail (a) binding of telomeric DNA to the TR unit
RNA template and to other domains of the RNP (e.g. the anchor site(s); (b)
successive addition of nucleotides to the 3'end of the DNA; (c) upon reaching the 5'
template boundary, translocation and repositioning of the 3' end of telomeric DNA in
concert with recognition of the 3' template boundary; and (d) subsequent repeat
rounds of elongation. (Figure adopted from Aiitexier & Lue 2006).
When it was demonstrated that human primary fibroblasts could be immortalized by
transfeetion of human TERT (hTERT), the catalytic subunit of telomerase (Bodnar et
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al., 1998), telomere shortening was firmly established as a biological clock for
cellular senescence. However, it has more recently become clear that it is unlikely to
be telomere shortening per se that triggers a senescent arrest, but rather that other
non-canonical structures and a number of extrinsic factors may be key determinants
regarding the onset of senescence (section 1.5). In this respect, telomere shortening
may be a proximate rather than an ultimate cause of cellular senescence.
1.9 Extra-curricular roles of telomerase
The possibility of telomere-independent telomerase function is intriguing. Various
lines of evidence suggest that telomerase may have yet undiscovered roles. As
discussed previously, despite the ample telomere reserve in murine cells, telomerase
is upregulated in a spectrum of tumour types (Blasco 1996, Greenberg et al., 1999,
Cao Y. et al., 2002; reviewed in Chang S. et al., 2002), suggesting that telomerase
may confer enhanced proliferative and survival potential during tumourigenesis,
independent of its role in telomere maintenance. Similarly, telomerase extends the
lifespan of virus-transformed human cells without net telomere lengthening,
indicating a protective function of telomerase that allows cell proliferation (Zhu J et
al., 1999), perhaps by conferring karyotypic stability by 'capping' chromosomes.
Furthermore, descriptive studies have shown hTERT localization not only in the
nucleus, but in the cytosol, reinforcing the notion of telomere-independent functions
(reviewed in Chung H 2005).
On the basis that low levels of hTERT are detected in S phase of normal human
fibroblasts (Mastuomi et al., 2003), a recent study investigated the effects of hTERT
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suppression in these cells. Strikingly, an impaired DNA damage was observed in
response to ionizing radiation, implicating hTERT as a critical regulator of the DNA
damage response (Mastuomi et al., 2005). Moreover the sustained loss of hTERT
expression through several rounds of cell division alters the overall state of
chromatin into a configuration that inhibits the activation of the DNA damage
response (Mastuomi et al., 2005). Hence hTERT may regulate the DNA damage
response through its actions on chromatin structure, in a manner independent from its
role in telomere maintenance.
Two recent seminal studies, through investigating the role of telomerase in stem cell
compartments, showed that conditional transgenic induction of TERT in mouse skin
epithelium causes a rapid transition from telogen (the resting phase of the hair
follicle cycle) to anagen (the active phase), thereby facilitating robust hair growth.
This new function for TERT does not require the telomerase RNA component, and
therefore operates through a mechanism independent of its activity in synthesizing
telomere repeats (Flores et al., 2005, Sarin et al., 2005; reviewed in Flores et al.,
2006). Indeed changes in telomere length were absent from these overexpression
studies. This study has been further exemplified in small intestinal stem cells, corneal
stem cells and brain stem cell compartments (Blasco. M et al, personnal
communication). These data indicate that, in addition to its well established role in
extending telomeres, TERT can promote proliferation and mobilization of resting
stem cells through a non-canonical pathway. This raises the question as to what role
telomerase may have during metastases?
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1.10 Telomerase, telomeres and cancer
Due to the degree of conservation of telomere repeat sequences across phyla
(TTAGGGn in vertebrates and TTTAGGGn in many plants; reviewed in Fajkus et ah,
2005), it is tempting to suggest that telomere-dependent replicative senescence may
be the hallmarks of a primitive tumour suppressor mechanism that may pre-date
sophisticated protein-mediated tumour suppression. A pre-programmed cessation of
proliferation would inevitably protect against uncontrolled cell growth and unwanted
genetic abnormalities. Presumably, the pre-determined replicative capacity of early
multicellular organisms provided a safe buffer zone in which to propagate their
selfish genetic units of inheritance. This window for replicative capacity would thus
be stable and selected for, with this tumour suppressor strategy inadvertently leading
to cellular ageing and possibly contributing to organismal ageing - a cellular double-
edge sword. However, it is important to stress, with respect to our own species that
although replicative senescence may be a potent tumour suppressor mechanism, this
may be an inadvertent phenomena and unlikely to have been an adaptation; we may
simply be observing this phenomenon due to our current longevity compared to our
early Homo sapiens ancestors.
1.10.1 Telomerase reactivation
It is easy to speculate that cell division is potentially a risky strategy and organisms
with renewable tissues have evolved to limit the maximal number of permissible cell
divisions. Presumably the optimal cell turnover for the expected lifespan of humans
has been reduced to a number set in the wild (i.e. Stone Age Homo sapiens). Modern
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medicine has allowed us to live far longer than is necessary for high reproductive
fitness (Selfish Gene theory - Richard Dawkins, 1976) and therefore cancer is a
phenomenon that may have no scope to be selected against.
Cancer is a disease of cellular ageing and impaired genome stability - and several
lines of evidence have confirmed that the maintenance of telomeres and reactivation
of telomerase participate actively in the pathogenesis of cancer (reviewed in Maser et
ah, 2002, Mastuomi & Hahn 2003, Shay & Wright 2005 and Bailey et ah, 2006).
Although telomere shortening appears to limit replicative lifespan of human cells and
suppress cell transformation, telomere shortening also eventually leads to critically
short telomeres and the onset ofM2 stage crisis. Whereas most cells that enter crisis
are eliminated by apoptosis (Shay & Wright 1989, era-Bloch et ah, 2002), sporadic
cells (~ 1 x 10"7) survive crisis and become immortal (Shay & Wright 1989). Such
immortal cells typically exhibit aneuploidy and extensive chromosomal
translocations indicating that telomeres lose their protective function at lengths
associated with crisis (Counter et al. 1992). Crucially, telomeres in -90% of cancers
studied are maintained by the activation of telomerase (Kim N W et ah, 1994,
Counter et ah, 1994). This stabilization of telomere length permits immortalization
and facilitates further malignant progression. Although catalytic activity is necessary,
telomere elongation alones seems insufficient to explain the requirement of
telomerase in a tumour setting, as average stabilized telomere lengths are often
shorter that the corresponding wild-type tissue (Hastie et ah, 1990, Counter et ah,
1994). At present the additional mechanism(s) by which telomerase activation
contributes to tumourigenicity remains undefined. It has been proposed that lines
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with catalytically active hTERT are more resistant to apoptosis (Gorbunova et al.,
2002, Forsythe H. et al., 2002) and/or that catalytically active hTERT may serve as a
physical cap for the (exposed?) telomere (Zhu J et al., 1999, Blackburn 2001). Thus
telomere shortening and telomerase activation can act both to suppress and facilitate
tumour development depending on the timing and context of these related events - a
molecular double-edged sword (Fig. 1.9).
1.10.2 Alternative Lengthening of Telomeres (ALT) pathway
Although most human cancers use telomerase as their telomere maintenance
mechanism, some (~7-10%) use an alternative lengthening of telomeres (ALT)
mechanism (Fig. 1.9). The latter especially include specific subtypes of soft tissue
sarcomas where ALT occurs most often in tumors with complex karyotypes,
astrocytic brain tumors and osteosarcomas (Bryan T. et al., 1997, Muntoni et al.,
2005). Some ALT cells have atypical features, suggesting that there is more than one
ALT mechanism. ALT cells are characterized by high rates of telomeric
recombinational exchange (Dunham et al., 2000). One of the hallmarks of the ALT
mechanism is the presence of ALT-associated PML bodies (APBs), which are
subnuclear structures where PML protein colocalizes with telomeric DNA, telomere-
binding proteins and several proteins involved in DNA synthesis and recombination
(Yeager et al., 1999). The latter include the Mrel 1/Rad50/Nbsl (MRN) complex
which appears to be required for ALT. The existence of ALT raises the possibility
that telomerase-positive tumors undergoing anti-telomerase therapies may escape by
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Figure 1.9. A model for crisis induced by telomere attrition. Shortened telomeres
elicit replicative senescence in vitro, blocking further proliferation unless checkpoint
responses are disrupted. Continued cell division will eventually cause telomere
dysfunction and crisis. The early stage of crisis can be averted by loss of p53.
Eventual emergence from late stage crisis requires not only p53 inactivation but the
acquisition of telomere maintenance mechanisms, be it telomerase-dependent or
telomerase-independent. (Adapted from Maser & de Pinho 2002 and Shay & Wright
2005).
1.10.3 Lessons from the mouse
A telomerase-deficient mouse model was generated by the elimination of the gene
encoding the murine Terc (TR) gene (reviewed in Blasco 2003). Only a limited
number of generations of these mice could be derived before loss of viability due to
telomere exhaustion and increased end-to-end fusions (Blasco et al., 1995 and 1997;
Herrera et al., 1999). Terc mice show telomere dysfunction pathologies in most
tissues and is characterized by decreased cell proliferation and/or increased apoptosis
(Rudolph et al., 1999, Franco et ah, 2002, Samper et ah, 2002). As human telomeres
(~15kb) are much shorter than those of the laboratory mouse (~50kb) and as
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telomerase is absent in most human somatic tissues, telomere shortening in humans
may lead to a similar failure of the organism as that described in the late generation
telomerase-deficient mouse. Importantly, telomerase introduction in these mice is
able to elongate critically short telomeres thus preventing the pathologies associated
with end-to-end fusions (Samper et al., 2001). This hints at the possible use of
telomerase in gene therapy of premature ageing syndromes such as Werner syndrome
(reviewed in Collins et al., 2002) and dyskeratosis congenita (DC) (Vulliamy et al.,
2001 and 2004), the latter of which is a multi-system bone marrow failure syndrome
that may be X-linked (mutation in the DKC1-encoded protein) or autosomal
dominant (mutation in Terc) (Walne et al., 2005), resulting in short telomeres.
Telomerase activity is upregulated during murine tumourigenesis despite mice
having long telomeres (Broccoli et al., 1996, Artandi et al., 2002) suggesting that
telomerase may promote tumourigenesis at two levels: by signaling proliferation and
promoting growth independently of telomere length, and by rescuing tumour cells
with critically short telomeres.
1.10.4 Telomeres and telomerase in cancer stem cells
Recent evidence suggests that only a subset of cells within some tumours, the so-
called cancer stem cells, may drive the growth and metastasis of these tumours. Thus
tumours are regarded as heterogeneous in nature rather than a homogenous
population of rapidly dividing cells. The first evidence of a putative tumour-initiating
cell came from studies of the haematopoietic system and the identification of
leukaemic stem cells (Lapidot et al., 1994, Bonnet et al., 1997; reviewed in
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Harrington 2004 and Huntly & Gilliland 2005). The identification of tumour-
initiating cells in solid tumours such as brain (Singh S et al., 2003, 2004) and breast
(Al-Hajj M. et ah, 2003) shatters much dogma in the field of cancer biology and the
implications of the cancer stem model are profound. A key upstream mutation(s)
causing the breakdown of self-renewal regulation may until now have been
overlooked. If cancer stem cells represent the sole population with tumourigenic
potential then the failure of conventional chemotherapy may be readily explained;
like their normal stem cell counterpart, cancer stem cells most probably exist in a
quiescent state, removed from the cycle of division and thus are not targeted by
chemotherapeutic drugs that target rapidly dividing cells. In this regard, non-
tumourigenic progeny from the cancer stem cell will be killed, but the small
population of cancer-initiating cells will remain, hence relapse. Nevertheless, it is
still a matter of debate whether solid cancers derive from stem cells or their
progenitors that have acquired the ability to self-renew through mutation. It may well
be that the cancer cellular culprit differs in each tumour setting as each is dependent
on a tissue-specific microenvironment.
In light of these findings it appears of great importance to elucidate the role of
telomeres and telomerase in cancer stem cells. In one respect, telomere shortening
might be involved in the development of chromosomal instability and transformation
of stem cells. In another respect, tumour stem cells might require telomerase
activation to achieve immortal self-renewal capacity (reviewed in Ju Z 2006). The
fact that stem cells and tumour cells express similar levels of telomerase indicates
that somatic cells may be target cells for malignant transformation (Morrison et al.,
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1996). The identification of better surface markers on cancer-initiating populations,
that could help unequivocally identify a 'cancer stem cell', could help to characterize
telomerase activity and telomere shortening in these compartments. Since telomere
dynamics represents the mitotic history of highly proliferating organs, analyzing
telomere length, telomerase activity and cytogenetic profiles may be helpful to
exploit the origin of tumour-initiating cells and the history of tumour formation.
Finally from a clinical view, it will be vital to determine whether telomeres and
telomerase represent promising targets to attack cancer stem cells. Two concepts are
promising: (i) telomerase is an attractive target for inhibition strategies that may limit
proliferation and induce apoptosis in cancer stem cells. Preliminary studies of
telomerase inhibition in a variety of tumor cell types have been conducted using the
novel telomerase template antagonist GRN163L (Asai et al., 2003, Djojosubroto et
al., 2005). The caveat of course is that normal tissue stem cells express telomerase,
so a specific targeting method will be required; (ii) stabilization of telomeres in pre-
malignant diseases may inhibit the evolution of chromosome instability and
transformation of cancer stem cells. The obvious paradox here is that this strategy
will require controlled reactivation of telomerase. Thus the telomere and telomerase
model for cancer stem cell initiation may supplement one of the most intriguing areas
of future cancer research.
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1.11 An historical perspective
1.11.1 On the origins of telomeres
It is vital to invoke an evolutionary perspective to understand the role of telomeres in
the evolution of genomes, chromosomes, terminal sequences, genes and proteins.
The current study of telomere biology may be sophisticated, but studies beyond
model organisms are required to give a broader perspective on those features of
telomeres that are organism-specific and those that are conserved. The increasing
interest in telomerase-independent systems might be instrumental in our
understanding of why and how natural selection favoured linear chromosomes over
their circular counterparts in nuclei of eukaryotic cells. One intriguing hypothesis
that has been debated, suggests that the replication strategies of mitochondrial
telomeres represent an evolutionary paradigm for the emergence of linear eukaryotic
chromosomes during a 'pre-telomerase' era. This postulates that a selfish element
replicating via a rolling-circle mechanism could generate terminal arrays of tandem
repeats at chromosomal termini of early eukaryotes (reviewed in Fajkus et ah, 2005,
Nosek et ah, 2006). Why linear chromosomes may have been an adaptation is
unclear. Primordial telomeric structures may then have recruited telomerase, which
provided a more robust method of maintaining chromosomal ends and out-competed
evolutionary ancient mechanisms. The elucidation of the T-loop structure not only at
mammalian chromosomal termini, but that of the ciliate Oxytricha fallax (Murti K. et
ah, 1999) and the flagellate protozoan Trypanosoma brucei (Munoz-Jordan et ah,
2001), raises the tempting suggestion that early eukaryotes could have stabilized
their chromosome ends using the T-loop structure or one similar.
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1.11.2 On the origin of telomerase
The clues to the origins of telomerase come from its structural conservation:
telomerase contains conserved domains with all known reverse transcriptases with
phylogenetic analysis revealing that the major branch in which telomerase resides
contains the eukaryotic retrotransposable elements without long-terminal repeats,
known as the non-LTR retrotransposons (Nakamura T. et ah, 1997 & 1998). As to
which arose first, telomerase or retrotransposons, the debate continues (reviewed in
Eickbush et ah, 1997 and Nakamura T. 1998). Although the origin of telomerase may
thus be traced back to the RNA world (de Lange 2004), this does not necessarily
imply that the enzyme maintained telomeres in ancestral eukaryotes. The
evolutionary success of telomerase in the eukaryotic world might have been due not
only to the efficient synthesis of telomeric arrays but also due to its extracurricular
telomere-independent activities that may have increased cellular viability (section
1.8). A fascinating experiment has been suggested, based on the introduction of
telomerase into natural telomerase-deficient cells, such as D. melanogaster
(representing a lineage in which telomerase was lost) (Nosek J 2006). Would
telomerase out-compete the telomerase-independent mechanisms? Would the
reprogrammed strains differ in their relative fitness? Telomerase is arguably one of
the earliest proteins to have been selected for in the eukaryotic kingdom, probably
due to the array of functions it mediated to ensure cellular viability. Studies of
telomerase in a plethora of extant eukaryotes will further elucidate the exact
historical accounts of both telomerase and telomeres.
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1.12 Current Project
1.12.1 Using sheep to study telomere and telomerase biology
Previous work conducted in our laboratory has demonstrated that sheep fibroblasts
are similar to human fibroblasts in respect to replicative senescence and telomere and
telomerase biology. Sheep fibroblasts have a limited proliferative lifespan which
seems to be controlled by the telomere mitotic clock. In addition, hTERT is
compatible with sheep TR and associated machinery, thus providing an alternative
mammalian model system to study telomere/telomerase biology. Introduction of
hTERT into primary foetal sheep fibroblasts, restores telomerase activity, extends
proliferative lifespan and maintains senescence bypass (Cui et ah, 2002). However,
stabilization of telomere length and karyotypic stability was directly proportional to
the levels of hTERT expression. Unexpectedly this was not reflected in an assay for
telomerase repeat addition activity, with all lines analyzed showing comparable
activtity. Therefore it is not clear whether non-catalytic domains of hTERT have a
telomere maintenance function distinguishable from enzymatic activity, or whether
the hTERT catalytic domain alone is the key rate-limiting factor.
A second study on sheep fibroblasts conducted in our laboratory showed that two
lines derived from the same breed (Black Welsh), differed dramatically in their
proliferative lifespan (Cui et ah, 2003). Both lines showed comparable average
telomere length after derivation and also at replicative senescence; however these
lines differed in their proliferative capacities by ~3-fold. The major limitation in this
analysis was inference based on calculation of average telomere length, taking the
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population as a whole. Recent advances in telomere detection have permitted a
quantitative approach to calculate telomere length based upon signals from
individual telomeres. This method allows analysis of telomere length heterogeneity,
manifest as a result of varying shortening rates with respect to subsets of telomeres.
It was therefore imperative to use this strategy to descriptively address telomere
shortening in these two sheep primary lines, taking into consideration shortening of
individual telomeres, and relate this to the previous observation of differences in
proliferative lifespan.
Further recent advances in the telomere biology field have both permitted analysis of
the G-rich single-strand 3' overhang and implicated this structure as a key factor with
respect to telomere capping. However, it is unclear whether the 3' overhang alters
during cellular proliferation or has a causal or consequential role regarding
replicative senescence. To address these issues, the sheep lines in our laboraotory
again provide a valuable tool; 3' overhang length can be measured during
proliferation of normal sheep fibroblasts to assess alterations to the 3' overhang
length. Furthermore, hTERT-immortalized sheep fibroblasts can be used to address if
there is any direct or indirect relationship between hTERT expression and 3'
overhang length.
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1.12.2 Project objectives
Regulation of telomere length in mammalian cells is a multi-factorial process
involving not only a host of telomere- and telomerase-associated factors, but also the
dynamic physical configuration of chromosomal termini. Hence both extrinsic and
intrinsic factors inter-dependently contribute to maintain telomere metabolic
homeostasis. To gain insight into both avenues:
1) The human telomerase catalytic subunit (hTERT) was studied to determine
whether hTERT reverse transcriptase domain is rate-limiting with respect to telomere
maintenance and senescence bypass, or whether there is evidence for a telomere
maintenance function that can be distinguished from enzymatic activity. Furthermore,
the consequences of long-term culture with hTERT-transfected transgenic lines were
considered.
2) A descriptive study of telomere shortening in primary sheep fibroblasts was
conducted, taking into account individual telomere length heterogeneity. This study
demonstrated the application of using Quantitative-FISH (Q-FISH) in the sheep
model system, thus highlighting the technical advantages over previous methods for
telomere length analysis.
3) The 3' telomeric overhang was analyzed during culture of primary sheep
fibroblasts to determine if the 3' overhang erodes throughout replicative lifespan and
if so, whether a relationship between 3' overhang shortening rate and telomere
shortening rate can be deduced. Furthermore, the 3' overhang was studied in the
context of hTERT-immortalized sheep fibroblasts to infer the relationship between
hTERT expression level and 3' overhang length.
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2.1 General molecular biology materials
Chapter 2 - Materials and Methods
Bacterial Transformation and culture
Luria-Bertani (LB) Medium
1% Bacto-trptone (Difco), 0.5% Bacto-yeast extract (Difco), 125nM sodium chloride
(NaCl).
Luria-Bertani (LB)-Agar
LB medium containing 1.5% agar (Difco).
SOC-medium
2% Bacto-tryptone, 0.5% Bacto-yeast extract, lOmM NaCl, 2.5mM potassium chloride
(KCL), 20mM Mg2+ stock (1M MgCl26H20/ 1M MgSC>47H20), 20mM glucose (Fisons).
Ampicillin selection
Stock solution lOOmg/ml, used at lOOpg/ml concentration.
Agarose gel electrophoresis
lOx TAE Buffer
0.4M Tris-HCl pH 8.0, 0.01M EDTA, 0.2M acetic acid.
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5x DNA Gel Loading Buffer (Sigma)
0.05% Bromophenol blue, 40% sucrose, 0.1 M EDTA Ph 8.0 and 0.5% SDS.
DNA Lysis
TNE DNA lysis Buffer
lOOmM Tris-HCl pH 8.5, 5mM EDTA, 0.2% SDS, 200mM NaCl, lOOpg/ml Proteinase
K, 20pg/ml RNase.
Senescence-associated B-gal staining solution
X-gal
lmg/ml X-gal (Promega), 40mM Na^HPO^citrate pH 6.0, 5mM potassium ferricyanide,




lOmM Tris-HCl pH 7.5, ImM MgCb, ImM EGTA, O.lmM Benzamidine, 5mM |3-
mercaptoethanol, 0.5% CHAPS, 10% glycerol.
1 Ox TRAP Reaction Buffer
200mM Tris-HCl pH 8.3, 15mM MgCl2, 630mM KCL, 0.5% Tween 20, lOmM EGTA.
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5Ox dNTP Mix
2.5mM each of dATP, dTTP, dGTP and dCTP.
PCR Grade Water
Protease, DNase and RNase-free; deionised.
lOx TBE Buffer
0.89M Tris-HCl pH 8.0, 0.89M borate, 0.02M EDTA.
40% Polvacrvlamide Stock Solution
Pre-mixed, 40% liquid acrylamide (19:1 acrylamide:bis-acrylamide ratio) (Electran)
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0.5M Tris-HCl, 3M NaCl pH 7.5.
20x SSC
3M NaCl, 0.3M sodium citrate pH 7.0.
Miscellaneous Reagents
Sterile PBS
0.16M NaCl, 0.003M KC1, 0.008M disodium hydrogen phosphate, 0.001M potassium
dihydrogen phosphate.
TE Buffer
lOmM Tris-HCl pH 8.5, ImM EDTA.
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2.2 Molecular biology methods
2.2.1 Preparation of genomic DNA from cultured cells
Cells were harvested and lysed overnight in 700pl TNE DNA lysis buffer (see 2.1) and
DNA extracted using the Phase-Lock Gel (PLG) method (Eppendorf). 700pl cell lysis
was transferred to a 2ml PLG tube and an equal volume of phenol added. Tubes were
thoroughly inverted to fonn a transiently homogenous suspension, prior to centrifugation
at 13000rpm for 5 minutes. The aqueous phase was transferred to a fresh PLG tube and
an equal volume of chloroform added. Tubes were again thoroughly inverted prior to
centrifugation at 13000rpm for 5 minutes. The aqueous phase was transferred to a fresh
1.5ml tube and an equal volume of cold isopropanol added. DNA was visible upon
inversion of the tube and transferred to a fresh 1.5ml tube. DNA was resuspended in 50-
150ml of TE buffer (see 2.1) dependent on the size of DNA pellet incubated at 4°C to
ensure complete resuspension.
2.2.2 Restriction endonuclease digestion
Digestion of pGEM-T Easy Sub-cloning Vector
lpg of plasmid pGem-T Easy (Promega) DNA was digested with 10 units EcoRl
restriction enzyme in a microcentrifuge tube using the supplied manufacturer's buffer
(Buffer H). The reaction volume was lOpl and incubation was conducted at 37°C for 1
hour, 30 minutes.
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Linearization Digests of t>WGB25 and pWGB23
Prior to transfection with pWGB25 (mutant hTERT plasmid; section 2.9.1) and
pWGB23 (EGFP-mock control plasmid; section 2.9.1), plasmids were linearized by a
single-cut digestion at a non-essential region as follows: 70 units of Pci (New England
Biolabs) was used to digest 66.5pg pWGB25 DNA in a reaction volume of 70pl, using
7pil of the buffer supplied by the manufacturer (lOx NEBuffer 3). 80 units of Bglll
(Roche) was used to digest 54pg of pWGB23 DNA in a lOOpl reaction volume using
lOpl of the buffer supplied by the manufacturer (lOx Buffer M). Samples were incubated
at 37°C for 2-3 hours until complete digestion was observed by agarose gel
electrophoresis.
2.2.3 Agarose gel electrophoresis
Agarose powder was dissolved in IX TAE (0.8-2.0%) by microwave heating and
allowed to cool. Ethidium bromide was added to a final concentration of 0.5pg/ml, prior
to pouring the gel onto a horizontal electrophoresis set-up. DNA samples were mixed
with 5x DNA loading buffer (see 2.1) prior to loading onto gels; at least one lane was
reserved for 5pl of a molecular weight marker (Hyperladder Type I, Roche). An
electrical current between 85 and 100 volts was applied. Following electrophoresis,
DNA was visualized using a UV transilluminator and images captured using Multi-
Analyst software (BioRad).
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2.2.4 Purification ofDNA fragments from agarose gels
DNA fragments electrophoresed through an agarose gel were excised using a clean
sharp scalpel (visualized under long-wavelength UV light) and transferred to a
microcentrifuge tube. The gel slice was processed using a QIAquick column (Qiagen) in
accordance with the manufacturer's instructions. The weight of agarose was determined
and 3 volumes of Buffer QG were added to 1 volume of gel (e.g. 300pl buffer to lOOmg
gel). This mixture was incubated at 50°C for 10 minutes and vortexed at intervals until
the gel slice had dissolved. 1 gel volume of isopropanol was added to the mixture and
the sample transferred to a QIAquick column held within a 2ml collection tube. The
column was microcentrifuged at lOOOOg for one minute to bind the DNA. This step was
repeated a second time to increase DNA yield, after which the flow-through was
discarded. The column was washed with 750pl Buffer PE for 5 minutes to remove any
residual agarose and excess salts, followed by a third 1 minute microcentrifugation.
Flow-through was discarded and the column re-centrifuged to remove any remaining
buffer. The column was placed in a clean 1.5ml centrifuge tube and 40pl of elution
buffer added. The column was allowed to stand for 1 minute prior to a final
centrifugation for 1 minute to elute the DNA.
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2.2.5 DNA quantification
Spectrophotometric measurements were used to determine both the quantity and the
quality ofDNA preparations. Typically a DNA sample was diluted 1:200 with TE buffer
and the absorbance read at 260nm to give the concentration of nucleic acid in the sample.
An optical density (OD) of 1 corresponds to approximately 50pg/ml of double-stranded
DNA. The ratio between readings at 260nm and 280nm provided an estimation of the
purity and hence quality of the DNA preparation. Pure DNA has an OD26o/OD28o ratio of
1.8-2.0. Spectrophotometric measurements were verified by agarose gel electrophoresis
using l-2pl ofDNA.
2.2.6 Preparation of total RNA from cultured cells
Total RNA was extracted using the RNeasy kit (Qiagen) according to the manufacturer's
guidelines. Cells grown on a monolayer were harvested, washed twice with PBS (see 2.1)
and disrupted by addition of 350pl Buffer RLT (Qiagen). Samples were homogenized by
passing a 0.9mm diameter gauge needle through the lysate 5-7 times. 350pl of 70%
ethanol was added to the homogenized lysate and mixed well by pipetting. 700pl of the
sample was applied to an RNeasy mini column placed in a 2ml collection tube and
centrifuged for 15 seconds at 13000rpm and flow-through discarded. At this stage,
samples were DNase treated: lOpl DNase 1 stock solution was added to 70pi Buffer
RDD (Qiagen RNase-free DNase set) and mixed gently by inverting the tube. The
DNase 1 incubation mix (80pl) was added directly onto the RNeasy silica-gel membrane
and placed on the benchtop for 15 minutes. 350pl Buffer RW1 (Qiagen) was added to
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the column and centrifuged for 15 seconds at 13000rpm and flow-through discarded.
The RNeasy column was transferred to a fresh 2ml collection tube and 500pl of Buffer
RPE (Qiagen) was added to the column and centrifuged for 15 seconds at 13000rpm to
wash the column. After discarding flow-through this wash step was repeated with a 2
minute centrifugation. To elute RNA, the RNeasy column was placed in a fresh 1.5ml
tube and 40pl RNase-free water applied directly onto the silica-gel membrane.
2.2.7 RNA quantification
Spectrophotometry measurements were used to determine both the quantity and the
quality of RNA preparations. Typically an RNA sample was diluted 1:200 with TE
buffer and the absorbance read at 260nm to give the concentration of nucleic acid in the
sample. An optical density (OD) of 1 corresponds to approximately 40pg/ml of single-
stranded DNA. The ratio between readings at 260nm and 280nm provided an estimation
of the purity and hence quality of the DNA preparation. Pure RNA has an OD260/OD280
ratio 1.8-2.0. Spectrophotometry measurements were verified by agarose gel
electrophoresis using l-2pl ofRNA.
2.2.8 First-strand cDNA synthesis
The AMV Reverse Transcriptase (RT) (Roche) was used to catalyze the synthesis of
single-stranded cDNA from total isolated RNA. A total reaction volume was prepared
using the following components: 1.5-2.5pg RNA diluted to a final volume of 9pl using
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RNase-free water (diluted RNA incubated at 65°C for 15 minutes), 4pl 5x RT buffer
(Roche), ljil oligo(dT)i5 random primers (Roche), 4pl 5mM dNTP and lp.1 RNase
Inhibitor (Roche). The 20pl reaction was incubated at 30°C for 8 minutes followed by
42°C for 1 hour and 95°C for 5 minutes. Samples were centrifuged briefly and stored at
-20°C.
2.2.9 Reverse-transcription polymerase chain reaction
Each reverse-transcription polymerase chain reaction (RT-PCR) was conducted in a 50pl
reaction volume using the following components: 100ng-200ng of template cDNA
(typically l-2pl) made up to 38.5pl using PCR grade water, 5pi lOx PCR buffer (Roche),
4pl 2.5mM dNTP, lpl forward primer, lpl reverse primer and 0.5pl Taq Polymerase
(Roche). Thermal cycle conditions to amplify total hTERT transgene levels, mutant
hTERT transgene level alone and endogenous sheep GAPDH were set as follows: 94°C
for 45 seconds, 60°C for 30 seconds (annealing) and 72°C for 45 seconds. Thermal cycle
number used was 30 for hTERT and 26 for GAPDH. An annealing temperature of 61°C
was used to detect hTERT 3'UTR in an amplification reaction using 30 cycles, and an
annealing temperature of 54°C used to detect human GAPDH in an amplification
reaction using 26 cycles. lOpl of RT-PCR product was used for agarose gel
electrophoresis to visualize amplified DNA.
To distinguish between the mutant hTERT transgene and endogenous hTERT transcript
in HEK 293-transfected cells, a set of primers were designed whereby the reverse
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primer amplifies from within the SV40 polyadenylation signal in the mutant hTERT
vector (pWGB25, see Appendix 1), generating an amplified product of ~600bp, the
forward primers amplifying from within the mutant hTERT transgene. Thermal cycle
conditions were set as follows: 94°C for 45 seconds, 55°C for 30 seconds (annealing)
and 72°C for 45 seconds, for 26 cycles.
Primer sequences for RT-PCR:
i) Total hTERT transgene (wild-type and mutant)
hTERT-Wl- 5'-AGCGACTACTCCAGCTATG-3' (Forward)
hTERT -W2- 5'-GTTCTTGGCTTTCAGGATGG-3' (Reverse)
Predicted product size - 325bp
ii) Mutant hTERT transgene alone
Mu-hTERT-F 5'-ACGGTGTGCACCAACATCTA-3' (Forward)
Mu-hTERT-R 5'-TGAAATTTGTGATGCTATTGCT-3' (Reverse)
Predicted product size - 598bp
iii) hTERT 3'UTR
Exl5F 5'-CATTCCTGCTCAAGCTGACTCGAC-3' (Forward)
3'UTR R 5'-CCTCAGACTCCCAGCCGTGCG-3' (Reverse)
Predicted product size - 350bp
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iv) Sheep GAPDH
sGAPDH-F- 5'-TGTCCGTTGTGGATCTGACC-3' (Forward)
sGRAPH-R- 5' -CGTACCAGGAAATGAGCTTGAC-3' (Reverse)
Predicted product size - 224bp
v) Human GAPDH
rGAPDHF 5' -TGAGTATGTCGTGGAGTCTAC-3' (Forward)
rGAPDHR 5' -GGCCATGTAGGCCTAGAGGTC-3' (Reverse)
Predicted product size - 750bp
2.2.10 Polymerase chain reaction
Polymerase chain reaction (PCR) was conducted to amplify the GAPDH locus. A 50pl
reaction volume was used incorporating the following components: lOng-lOOng of
template genomic DNA (typically l-2pl) made up to 38.5pl using PCR grade water, 5pl
lOx PCR buffer (Roche), 4pl 2.5mM dNTP, lpl forward primer, lpl reverse primer and
0.5pl Taq Polymerase. Thermal cycle conditions to amplify the endogenous sheep
GAPDH locus were set as follows: 94°C for 45 seconds, 60°C for 30 seconds (annealing)
and 72°C for 45 seconds. GAPDH primers used as described in section 2.2.9.
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2.2.11 Protein lysis (Western Blot)
Protein lysis was carried out on harvested cells using 300|al RIPA Buffer (Chemicon)
containing 50mM NaCl, 25mM Tris pH 8.2, 0.5% Nonidet P40, 0.5% deoxycholate,
0.1% SDS and 0.1% Azide. Upon addition of RIPA lysis buffer, samples were vortexed
for 1-2 minutes and passed through a 0.6mm needle to homogenize. Samples were
centrifuged at 14000rpm at 4°C for 20 minutes and stored at -80°C.
2.2.12 Protein concentration (Western Blot)
A Bovine Serum Albumin (BSA) standard curve was set up to determine protein
concentration of samples. Typically a BSA standard range of 0-5pg/pl was used where
lOpl of each BSA concentration was mixed with 190pl bicinchoninic acid (BCA)
working reagent (Pierce). RIPA buffer was used to dilute BSA standards to the desired
concentration. To 2pl of each protein lysis sample, 8pl ofwater and 190f.il BCA working
reagent were added. All standards and samples were prepared in a 96-well plate and
incubated at 37°C for 30 minutes. A spectrophotometer plate reader was used to read
absorbance at 562nm. All samples were measured in triplicate and average 562nm
absorbance measurement of the blank standards, subtracted from average measurements
of each particular sample. A standard curve was prepared by plotting the average blank-
corrected 562nm measurement for each BSA standard vs. its concentration in pg/ml.
This standard curve was used to determine the protein concentration of each unknown
sample.
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2.2.13 Western Blot analysis
A total of 40pg protein from each sample was used to prepare a boiling mix containing
3x sample loading buffer (62.5mM Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 50mM
DTT and 0.1% bromophenol blue) and water to give a final volume of 20pl. This mix
was boiled at 100°C for 10 minutes prior to separation on a 7.5% vertical
polyacrylamide separating gel (40% acrylamide mix, 10% SDS, 1.5mM Tris pH 8.8 and
water). A 4% polyacrylamide mixture (40% acrylamide mix, 10% SDS, 0.5mM Tris pH
6.8 and water) was used as the stacking gel. All wells were flushed with isopropanol
after adding gel mixtures and flushed with water twice after gels had set. Polyacrylamide
gel electrophoresis (PAGE) was conducted at 150V for approximately 1 hour using lOx
running buffer (0.25M Tris, 1.92M glycine, 1% SDS). 25pl of the Rainbow molecular
weight marker (Amersham) was run on either side of the sample lanes. Protein was
transferred at 4°C overnight onto a nitrocellulose membrane using lOx blotting buffer
(0.25M Tris, 1.92M glycine pH 8.3). Membranes were blocked for 1 hour in PBS
containing 0.1% Tween (PBST) and 10% milk prior to incubation with rabbit
monoclonal anti-hTERT primary antibody Y182 (Abeam) overnight at 4°C using a
1:100 dilution. Membranes were washed twice with PBST/10% milk, followed by
washing twice with PBST alone and twice again with PBST/10% milk, followed by
incubation with goat anti-IgG HRP-conjugated secondary antibody (Dako) at a dilution
of 1:2500 for 30 minutes at room temperature. Proteins were detected using an ECL
chemiluminescence HRP detection substrate (Millipore). Briefly, 3ml luminol and 3ml
peroxide were mixed and poured onto the nitrocellulose membrane prior to 5 minutes
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incubation at room temperature. Blots were drained, covered with acetate and exposed to
autoradiography film for 30 seconds to 20 minutes. Membranes were stripped for 1 hour
using buffer consisting of 62.5M Tris pH 6.8, 2% SDS and lOOmM (3-mercaptoethanol,
and washed twice with PBST followed by blocking in PBST/10% milk for 2 hours.
Blots were re-probed using mouse monoclonal anti-P-actin antibody (Santa-Cruz) at a
1:10000 dilution to detect P-actin, serving as an internal/loading control. Membranes
were washed once with PBST/10% milk, followed by washing once with PBST alone
and once with PBST/10% milk, followed by incubation with goat anti-mouse HRP-
conjugated secondary antibody (Dako) at a 1:2500 dilution. Membranes were exposed to
autoradiography film as described previously.
2.2.14 Protein lysis and concentration (Telomere Repeat Amplification
Protocol Assay)
Harvested cells were lysed using 40pl lx CHAPS buffer (Chemicon) and divided into
1 OjllI aliquots. Cells were snap frozen on dry ice immediately proceeding lysis to ensure
stability of the telomerase protein/RNA complex. A BSA standard was set up similar to
that described in section 2.2.12. A BSA concentration range of 0.125-2pg/pl was used
using lx CHAPS buffer as the diluent. 10pl of each standard was added to 250pl
Coomassie reagent (Pierce). For each protein sample, lpl was added to 9pl IX CHAPS
buffer and 250pl Coomassie reagent. Protein concentration was determined in a 96-well
plate which was incubated for 15 minutes at room temperature with gentle shaking.
Absorbance at 595nm was calculated using a spectrophotometer plate reader and a
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standard curve prepared by plotting the average blank-corrected 595nm measurement for
each BSA standard vs. its concentration in pg/(ll. This standard curve was used to
determine the protein concentration of each unknown sample.
2.2.15 TRAP assay
TRAP assay (Chemicon) was conducted according to procedures previously described
(Kim et al., 1997). Protein lysate was diluted to a concentration of 0.1-0.5pg/pl and lpl
used to set up a reaction mix consisting of 40.6pl of PCR grade water and 8.4pl of
TRAP PCR mix (5pl lOx TRAP buffer, lpl TS primer, lpl Primer mix, lpl 50x dNTP,
0.4pl Taq polymerase), lpl of cell lysate (0.1-0.5pg) was heated in a 0.5ml tube at 85°C
for 10 minutes to heat inactivate telomerase and thus serve as a control for heat
sensitivity. Telomerase extension was achieved by heating samples at 30°C for 30
minutes. Amplification of the telomerase product was subsequently carried out using a
thermal cycle of 94°C for 30 minutes, followed by 59°C for 30 minutes, repeated 30
times. lOpl of 5x DNA loading buffer (Sigma) was added to each PCR product before
telomerase products (25pl per well), including heat inactivation controls, were resolved
on 10% polyacrylamide vertical gels (0.5x TBE, 10% acrylamide mix, 0.1% APS,
0.01% TEMED, adjusted to 50ml with nuclease-free water) using 0.5x TBE as running
buffer. TRAP gels were run at 240V for approximately 2 hours or until the loading dye
had completely run off the bottom of the gel. 20pl of DNA molecular marker VIII
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(Roche) was loaded onto lanes either side of TRAP products. TRAP gels were washed
briefly in lx TE buffer followed by staining for 30 minutes in the dark with SyBR Green
1 (Roche) solution (lOpl SyBR Green 1, 100ml lx TE buffer). TRAP gels were scanned
using an FX phosphoimager and semi-quantitative analysis conducted using Multi-
analyst software.
2.2.16 Competitive inhibition TRAP assay
TRAP assay was conducted as described in section 2.2.14, incorporating two
independent lysate samples. Initially various ratios of the two competing samples were
used but yet ensuring a final protein concentration of lpg/pl; e.g. 0.5pg:0.5pg or
0.25pg:0.75pg. This strategy was modified to compare samples at 5 to 20-fold excess of
protein; e.g. 0.1pg:5pg or 0.1pg:20pg.
2.2.17 Telomere Restriction Fragment length assay
Genomic DNA from cultured cells was isolated as described in section 2.2.1. Telomere
length was determined by telomere restriction fragment (TRF) Southern blot analysis
with a digoxigenin labelled (TTAGGG)3 probe (Roche) as described previously (Harley
et al., 1990) and using the manufacturer's guidelines. A frequent cutter restriction
enzyme mix consisting of 0.75pl (30U) Rsal (Roche), 0.75pl (30U) Hinfl (Roche),
2.5pi Buffer A (Roche) and 0.5pi RNase A, was added to 2-4pg genomic DNA and
made up to a final volume of 2 5pi for each sample tested. After overnight digestion at
37°C, 3pl Xylene Cyanol dye (Mol. Bio. Laboratories) was added to each sample and
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samples electrophoresed on a 0.8% agarose gel, initially at 100V for 20 minutes, prior
to approximately 16 hours overnight at 30V. A digoxygenin-labelled (DIG) high
molecular weight marker (Roche) was freshly prepared for each gel as follows: 4pl DIG
marker, pre-heated at 65°C for 10 minutes, was added to 4pl Xylene Cyanol dye and
12pl nuclease-free water. lOpl of DIG marker was loaded on either side of samples. At
this stage, DNA was visualized under UV light to determine degree of migration on the
gel. Prior to Southern Blot transfer, gels (DNA side up) were depurinated in 0.25M HC1
(10 minutes), rinsed twice with deionised water, denatured using 1.5M NaCl/0.5M
NaOH (2x 15 minute washes), again rinsed twice with deionised water and neutralised
using 0.5M Tris/1.5M NaCl pH 7.5 (2x 15 minute washes). Southern transfer of DNA
fragments was achieved by inverting the gel onto 3M Whatman blotting paper and
placing a positively charged nylon membrane on top of the gel, followed by 3M
Whatman paper and a heavy weight. 20x SSC buffer was used to facilitate the transfer
and blots allowed to transfer overnight. Prior to hybridization, membranes were X-
linked using a UV cross-linker and washed briefly in 2x SSC. Pre-hybridization was
performed using 15ml DIG Easy Hyb solution (Roche) for 1 hour at 42°C, whilst rolling.
Hybridization was performed using 15ml DIG Easy Hyb solution and 3pl telomere-
specific probe (Roche) overnight at 42°C. Membranes were washed prior to DNA
detection using the following regime: 100ml 2x SSC/0.1% SDS (2x 5 minutes at room
temperature with shaking), 50ml 0.2SSC/0.1% SDS (2x 15 minutes at 50°C and rolling),
100ml lx Washing Buffer (Roche) (5 minutes at room temperature with shaking), 100ml
lx Maleic Acid Buffer/lx Blocking serum (Roche) (30 minutes at room temperature
with shaking). After washes, membranes were incubated with Anti-DIG-Alkaline
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Phosphatase solution (Roche; lOpl Anti-DIG-AP and 100ml lx Maleic Acid Buffer/lx
Blocking serum) followed by washing with 100ml lx Washing Buffer ( 2x 15 minutes at
room temperature with shaking). Membranes were finally washed with 100ml lx
Detection Buffer (Roche) (5 minutes at room temperature with shaking) prior to adding
CDP chemiluminescence substrate (Roche) drop-wise onto membranes. Membranes
were wrapped in Saran Wrap and exposed to X-ray film for 30 seconds to 3 minutes.
TRF telomere length was determined using Multi-Analyst 1.1 software.
2.2.18 Telomere-Oligonucleotide Ligation Assay
Telomere-oligonucleotide ligation assay (T-OLA) was adapted from (Cimino-Reale et
ah, 2001). 1.85MBq of 32P radioisotope (Amersham) was used to label lOpmol of
telomere G-rich strand specific oligonucleotide (CCCTAA)4 or mismatch control
oligonucleotide (CCCTTA)4 (MWG Biotech). The end-labelling reaction was catalyzed
using 10U T4 Polynucleotide Kinase (PNK) (Roche) using lx T4 PNK Buffer (Roche)
in a total reaction volume of 25j.il. Samples were incubated at 37°C and reactions
allowed to proceed for 45 minutes, followed by incubation at 68°C for a further 15
minutes. To remove unincorporated labelled nucleotides, samples were first adjusted to
5Op I with 150mM STE Buffer (NaCl/TE) and passed through a G-50 Micro Column
(Amersham) at 2800rpm for 2 minutes. A similar set up was used to label 750ng of
dephosphorylated DNA Molecular Weight Marker VIII (Roche) with 0.925MBq of 32P,
in a reaction volume of lOpl. For hybridization of oligonucleotides to undenatured
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genomic DNA, lpmol G-rich or mismatch-labelled oligonucleotide was added to 10pg
RNase-treated DNA and lx Taq Ligase Buffer (Roche), adjusted to a final volume of
20pi. Hybridization reactions were incubated at 52°C for 16-20 hours. Samples were
briefly centrifuged prior to a ligation reaction using 30U Taq Ligase (Roche) at 52°C for
5 hours. Ligated products were ethanol precipitated by adding 80pl nuclease-free water,
1 lpl 5M NaCl and 250pl 100% ethanol. Samples were incubated at -80°C overnight and
centrifuged at 13000rpm for 50 minutes to precipitate ligated DNA. Products were
washed with 70% ethanol and re-suspended in lOpl nuclease-free water at 52°C for 2-3
hours. DNA was denatured by adding lOpl of formamide based denaturing buffer
(Ambion) and incubated at 100°C for 5 minutes. A vertical denaturing polyacryamide
gel (6M Urea, 5% acrylamide, lxTBE, 0.3% APS, 0.04% TEMED adjusted to 100ml
with deionised water) was used to resolve ligated DNA products, with 5pl of each
sample loaded per lane and 2pl of marker loaded on lanes either side of samples. 0.5x
TBE was used as running buffer and gels run at 2500V for approximately 2-3 hours.
Gels were transferred to Whatman filter paper, dried using a gel drier (80°C for 30
minutes) and exposed to autoradiography film. To ensure equal DNA loading, lOng of
every T-OLA sample was used as a template for genomic PCR reactions to detect the
GAPDH gene. T-OLA images were analysed by Multi-Analyst software.
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2.3 Histological methods
2.3.1 Detection of p-galactosidase activity
Cells grown on monolayers were prepared by washing x2 with PBS, fixed with 3%
formaldehyde and washed again x2 with PBS. Senescence-associated P-gal staining was
detected by adding 5ml fresh X-gal solution (Promega) (see section 2.1) and incubating
cells for approximately 16 hours at 37°C.
2.4 Bioinformatics methods
2.4.1 BLAST and Multiple Sequence Alignment analysis
A BLASTN nucleotide search was conducted using the NCBI search engine, with the
sequence of ligated inserts (approximately 250bp) as a query sequence. Databases of all
mammalian species available were compared to identify percentage homology with the
prospective sheep gene sequence of interest. A ligated insert of known sequence
(hTERT fragment from the HEK293 line) was also sent to DNASeq for validation and
the nucleotide sequence (~300bp) used to BLAST all eukaryotic databases to determine
percentage of TERT sequence homology across species.
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2.5 Quantitative methods
2.5.1 Quantitative-Fluorescence In-Situ Hybridization (Q-FISH)
analysis
Q-FISH analysis was conducted on metaphase images (section 2.10.2) using TFL-
Telomere TeloQuant Analysis software (Peter Lansdorp laboratory, Vancouver, Canada).
The Open Lab 2D microscope image processing software was used to capture FISH
images using an exposure time of 0.99 seconds. Images of DAPI-stained chromosomes
and Cy3-stained telomere repeats were captured independently. Approximately 350-400
chromosomes were accounted for with respect to each cell line, representing 7-10
metaphase spreads. This permitted valid statistical analyses. A minimum telomere
threshold value of 2 (arbitrary numerical value) was set for TeloQuant analysis. Due to
the denatured appearance of sheep metaphase chromosomes, a paint tool (Photoshop)
was used to define borders of individual chromosomes and thus allow the software to
distinguish chromosomes for telomere quantification. An arbitrary value is assigned to
each telomere end - Telomere Fluorescence Units (TFU) - with TFU being directly
proportional to the size of the individual telomere repeat length. (NB: Zero TFU is not
necessarily regarded as a telomere signal free end (SFE), but rather reflects a telomere
signal below the threshold of this software). TFU values were categorized into 'bins' at
intervals of 50 using Microsoft Excel Software and a 'frequency' command used to
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represent number of telomeres with TFU values within a given category.The data was
plotted either directly or as a percentage of telomere ends per category.
2.5.2 Densitometric analysis (RT-PCR)
For the GRN clones, RNA expression levels were quantified by densitometry using
Multi-Analyst software and normalized to GAPDH. Relative stoichiometry was inferred
by assigning a value of 1 to the GRN23(C1) mock vector control and calculating total
hTERT expression as relative.
To calculate relative inhibition of endogenous hTERT in HEK 293 cells transfected with
a mutant hTERT transgene, endogenous hTERT RNA levels were normalized to
GAPDH and relative inhibition calculated relative to the untransfected control.
2.5.3 Densitometric analysis (TRAP)
Telomerase activity in GRN clones was quantified using Multi-Analyst software, as the
ratio of the intensity of the telomere repeat ladder over the intensity of the 36bp internal
control band. Relative TRAP activity was calculated relative to the GRN23(C1) mock
vector control.
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2.5.4 Densitometric analysis (TRF)
Mean TRF telomere length was calculated using Multi-Analyst software according to
the following formula:
TRF = E(ODi)/ £(ODi/L)
where OD, is the chemiluminescent signal and Lj is the length of the TRF fragment at
position i. The calculation takes into account the higher signal intensity from larger TRF
fragments due to multiple hybridization of the telomere-specific hybridization probe. A
power regression standard using the DIG molecular weight marker is used to determine
the actual telomere length, and average background subtracted for each sample.
2.5.5 T-OLA G-rich size distribution analyses
T-OLA images were analysed by Multi-Analyst 1.1 software. The relative frequency of
overhangs of different length was obtained by normalizing the intensity of each single
band to the sum of intensity of all the bands of the ladder. This densitometric analysis
was performed for at least three different experiments for each cell line to calculate
standard deviations of the mean relative frequencies.
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2.6 Cell culture materials
Basic sheep fibroblast medium
Glasgow minimal essential medium (GMEM; Invitrogen) supplemented with 10% foetal
calf serum (FCS; Globepharm), 2mM L-glutamine, ImM sodium pyruvate and lx non¬
essential amino acids (all Gibco).
Basic human fibroblast and HEK 293 medium
Dulbecco's modified eagles medium (DMEM; Invitrogen) supplemented with 10%
foetal calf serum (FCS; Glopepharm), 2mM L-glutamine, ImM sodium pyruvate and lx
non-essential amino acids (all Gibco).
Sterile PBS
As described in section 2.1
Trypsin/EDTA solution (Sigma")
0.5g/l porcine trypsin and 0.2g/l EDTA in Hanks' Balanced Salt solution with phenol
red.
1 x Freeze mix
90% GMEM and 10% dimethyl sulfoxide (DMSO; Sigma).
G418 (Geneticin)
50mg/ml stock solution (Invitrogen) diluted to working concentration of 400-750pg/ml.
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2.7 Cell culture methods
2.7.1 Maintenance of primary cell lines
Sheep fibroblasts, BW6F2 and BWF1, were isolated from a day 35 Black Welsh
eviscerated foetus as described previously (Wilmut et al., 1997). Cells were cultured in
Glasgow minimal essential medium (Sigma), supplemented with 2mM L-glutamine,
ImM sodium pyruvate, lx non-essential amino acids and 10% foetal calf serum
(GlobePharm) in a humidified incubator at 37°C, 5% CO2 and 21% O2 using a 25 or
75cm3 plastic tissue culture flask. Human BJ-hTERT foreskin fibroblasts and HEK 293
cells were cultured in a similar fashion but using DMEM (Invitrogen). Cells were
supplemented with fresh medium every two days and serial passage performed upon
90% confluency as follows: culture media was aspirated and cells washed with PBS to
remove traces of serum. Cells were then incubated with l-3ml of Trypsin-EDTA (Sigma)
for 2-3 minutes at 37°C and further encouraged to detach by gently tapping the side of
the flask. Immediately after detachment, serum-containing medium was added to
inactivate trypsin and cells harvested by centrifugation at lOOOrpm for 4 minutes.
Supernatant was discarded and cells resuspended in fresh serum-containing medium
before transfer to a new flask at the desired ratio, typically 1:6. For an accurate
estimation of cell number, harvested cells were resuspended in 5-10ml of medium,
mixed thoroughly and counted using a haemocytometer. A total of 64 squares were
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counted (4 grids, 16 squares each), averaged and cell number determined using the
following formula:
Cells/ml =
I [(Grid A 1-16) + (Grid B 1-16) + (Grid C 1-16) + (Grid E 1 -16)/4] * 104,
Culture of Black Welsh sheep fibroblasts in hypoxic conditions was achieved using a
specialized air-tight chamber supplemented with 2% O2 regularly.
2.7.2 Freezing and resuscitating cells
Subconfluent monolayer cultures were harvested as previously described (section 2.8.1)
and pellets resuspended in lx freezing mix (section 2.7). 1ml aliquots were frozen
overnight at -80°C before being transferred to N2O) for long-term storage. Cells
recovered from long-term storage were thawed rapidly at 37°C and resuspended in
appropriate basic culture medium. Cells were then pelleted at lOOOrpm for 4 minutes to
remove traces of DMSO, plated on complete growth medium and refreshed after 24
hours.
2.7.3 Growing cells under a selection regime
For GRN sheep fibroblasts clones, cell monolayers were passaged 1:6, 24 hours prior to
adding selection. Cells were cultured with basic culture medium (section 2.7),
supplemented with 400tig/ml Geneticin (Invitrogen) or lpg/ml Puromycin (Invitrogen),
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to select for G418- and puromycin-resistant cells that express mutant (and EGFP mock
control) and wild-type hTERT transgenes respectively. Cells were cultured for 10-14
days, serially passaged when required and supplemented with fresh selection medium.
To isolate E1EK 293 cells transfected with mutant hTERT or mock EGFP vector (section
2.9.1), cells were cultured with basic culture medium (section 2.7) and supplemented
with 400-750pg/ml Geneticin (Invitrogen). After four days culture, cells from each
experimental set-up were pooled and expanded as one population, grown for
approximately four weeks under a selection regime, and protein lysate and RNA
collected at intervals.
2.7.4 Population doubling (PD) rate calculation
Each GRN sheep fibroblast clone was expanded to confluency in a T75 tissue culture
flask, from which 3 x 105 cells were plated into a T25 culture flask and growth curves
commenced at this point. Cells were sub-cultured twice weekly and maintained at log
phase growth. Population doubling rate was calculated according to the following
formula:
PD = log E/S / log 2,
where E = end count and S= start count.
84
Chapter 2 - Materials and Methods
2.8 Transgene introduction - methods of transfection
2.8.1 Electroporation
The GRN(25), GRN(23) and BW6F2(25) sheep fibroblast lines were generated
previously in our laboratory by Ling Mo. To generate bi-transgenic lines that express
both wild-type and mutant hTERT transgenes, the GRN1-1 line was transfected with
pWGB25. GRN1-1 represents a hTERT-immortalized line that exhibits low levels of
wild-type hTERT and pWGB25 (7.3kb, see Appendix 1; constructed by Dr. Wei Cui)
contains mutant hTERT cDNA driven by the phosphoglycerate kinase (PGK) promoter
and mutated at three bases in three distinct reverse transcriptase (RT) motifs, thus
rendering the hTERT transgene catalytically dysfunctional. RT-domain mutations were
as follows: Arginine was substituted at amino acid position 631 with Alanine (R631A),
Aspartic acid at position 712 with Alanine (D712A) and Aspartic acid at position 868
with Alanine (D868A). (Plasmid GRN380, containing mutant hTERT cDNA was kindly
provided by Geron Corp.) To generate an EGFP mock vector control line, GRN1-1 was
transfected with pWGB23 (4.7kb, see Appendix 1; constructed by Dr. Wei Cui).
pWGB23 contains an EGFP cDNA driven by the phosphoglycerate kinase (PGK)
promoter. To generate a cell line control, the parental sheep fibroblast line, BW6F2, was
transfected with pWGB25 to generate a transgenic line that exhibits mutant hTERT
expression alone. All transfections were conducted using lOpg of plasmid DNA and via
the electroporation method under a condition of 400V, 250uF. The GRN1-1 line was
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transfected at passage 27 and BW6F2 transfected at passage 8. All transfected cells were
placed under a G418 selection regime using 400pg/ml Geneticin and stable clones
showing good morphology were picked and expanded in a T25 flask. Clones were
denoted passage 1 (post-transfection) at this stage.
2.8.2 Lipofectamine 2000-mediated transfection
Lipofectamine 2000 (Invitrogen) was used to transfect HEK 293 cells with either the
pWGB25 mutant hTERT plasmid or pWGB23 EGFP mock vector control.
Lipofectamine 2000 is a cationic lipid formulation that may be used to efficiently
transfect cells on a monolayer or in suspension. All transfections were carried out in a 6-
well format with cells seeded at a density of 5 x 104, 1 x 10s or 2 x 105. DNA to
lipofectamine ratio used was either 1:2.5 (4pg DNA: lOpl lipofectamine) or 1:3 (4pg
DNA: 12pl lipofectamine). The transfection procedure was as follows: 4pg DNA was
diluted in 240pl Opti-MEM 1 reduced serum medium w/o serum (Invitrogen) and mixed
gently. An appropriate volume of Lipofectamine 2000 (10 or 12pl) was diluted in 240pl
Opti-MEM 1 and incubated for 5 minutes at room temperature. Diluted DNA and
Lipofectamine 2000 was combined by gentle pipetting and incubated for 20 minutes at
room temperature. Complexes (500pl) were added carefully in a drop-wise fashion to
each well and mixed gently by rocking the plate. Cells were incubated at 37°C for 5
hours whence fresh medium was applied. 400pg/ml Geneticin was supplemented to
fresh medium 24 hours post-transfection. A Lipofectamine 2000-only transfection was
used as a negative control. Cells were passaged upon confluency and split into 3 x T75
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flasks for each transfection set-up. After 7 days, all HEK 293-mutant hTERT and HEK
293-EGFP- transfected populations were pooled and expanded. Transfection efficiency
was judged by viewing EGFP-transfected clones under UV light. At day 14 post-
transfection, Geneticin concentration was increased to 750pg/ml and cell populations
expanded. RNA and protein was collected at 1 week intervals for a period of 4 weeks.
2.9 Fluorescence-in situ hybridization (FISH)
2.9.1 Preparation of cells in fixative
Cells were cultured to 100% confluency prior to splitting to ensure synchronous release
from contact inhibition. Fixative was applied 26 hours post-transfection, during log-
phase growth. Typically, cells were washed with PBS, trypsinized and harvested by
centrifugation at 1500rpm for 5 minutes. Medium was removed and cells resuspended in
fresh 10ml 0.6% tri-sodium citrate (hypotonic solution), added drop-wise whilst
vortexing. Tubes were incubated for 15 minutes at room temperature to allow cells to
swell. Cells were again centrifuged at 1500rpm for 5 minutes and supernatant discarded.
6ml fresh fixative (3:1 methanol: acetic acid) was added drop-wise whilst vortexing and
tubes centrifuged at 1500rpm for 5 minutes. This fixation step was repeated twice. Cells
were resuspended in 500pi fixative, whereby the suspension appears milky, and stored at
-20°C.
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2.9.2 Preparation of metaphase spreads
Microscopic slides were immersed in 50ml 100% ethanol/lml concentrated HCL, kept
in 50ml Glass Hellendahl jars. Prior to use, slides were immersed in distilled and then
deionised water and then incubated at 37°C for 5 minutes. The surface of slides was
made moist by breathing and 2-3 drops of cell fixative suspension gently dropped onto
slides at a 45°C angle. Slides were moved to a vertical position immediately after drops
had landed to remove excess solution. Slides were allowed to dry at room temperature
for 15 minutes after which metaphase quality and quantity was viewed under a
microscope using a lOx and 20x phase light objective
2.9.3 FISH
Detection of telomeres in metaphase chromosomes was carried out using the Telomere
PNA FISH/Cy3 kit (Dako). This procedure uses a 24-mer Cy3-conjugated peptide
nucleic acid probe (PNA) (a synthetic DNA/RNA analogue) specific to TTAGGG
telomere repeat sequences. (Pre-treatment and all treatment stages were carried out in
50ml glass Hellendahl jars). A pencil was used to mark an area of approximately 20 x
20mm length on metaphase slides, where high quality of spreads was evident. Pre-
treatment was conducted as follows: slides were immersed in TBS (Dako) for 2 minutes
followed by immersion in 3.7% formaldehyde (diluted with TBS) for 2 minutes and
again immersed in TBS (2x 5 minutes). Slides were then immersed in pre-treatment
solution (Dako) for 10 minutes (diluted 1:2000 with TBS) and washed in TBS (2x 5
minutes). Slides were finally immersed in a cold ethanol series (70%, 85% and 100%
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ethanol; 3x 2 minutes) and left to dry vertically at room temperature for 5 minutes.
Denaturation and hybridization were conducted as follows: lOpl Telomere PNA/Cy3-
conjugated probe was applied to the marked area on slides and covered with a plastic
coverslip. Slides were placed in a pre-heated incubator (adjusted to 80°C) for 3 minutes
and placed in a dark box at room temperature for 30 minutes to allow hybridization.
Slides were washed in 50ml Rinse Solution (Dako) for 1 minute to remove coverslips
prior to immersion in 50ml Wash Solution (Dako) at 65°C for 5 minutes. Slides were
washed in a cold ethanol series as before and left to dry vertically at room temperature
for 5 minutes. For mounting and counterstaining, 2x 10pl of O.lpg/ml DAPI
(Vectashield) was applied onto each slide and a glass coverslip placed on top. Slides
were left for 15 minutes to allow counterstain colour to develop before performing
fluorescence microscopy using a lOOx oil objective with a propidium iodide filter
(similar wavelength to a Cy3 filter).
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2.10 Statistical methods
Standard deviation
Standard deviation of the mean was calculated where appropriate using the following
formula:
o = y/L(.x-yf/N
where x = individual scores, y = mean of individual score andN is the total number of
scores.
Q-FISH statistics
The Chi Squared test was used to determine whether or not the two sheep fibroblast lines
used for study (BWF1 and BW6F2) significantly differed with respect to telomere
length - Telomere Fluorescence Units (TFU) - as determined by Q-FISH. In addition,
Chi Squared was performed for telomere length values within each line to show that
telomere shortening significantly differs from early to late passage. The basic formula
used for statistical analysis was as follows:
2
_ v (Observed frequency - Expected frequency)2X — z.
Expected frequency
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TFU values were placed into categories with intervals of 50 TFU (e.g. - 50, 100,
150....900) and percentage of telomere ends per category plotted. However this resulted
in the number of categories exceeding the upper limit of that required for an acceptable
degree of freedom for the Chi Squared analysis. Therefore the TFU categories were
grouped as follows: 50-200; 201-400; 401-600; 601-900. The 50-200 TFU category
represents the shortest telomeres and the 601-900 TFU represents the longest telomeres
in this setting. With this reduced number of grouped categories, Chi Squared was
performed to test significance of telomere lengths within and between the cell lines.
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CHAPTER 3: ANALYSIS OF
CATALYTICALLY DYSFUNCTIONAL HTERT
IN PRIMARY OVINE FIBROBLASTS AND
HEK 293 TUMOUR CELLS
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3.1 Introduction
As previously discussed in section 1.4, TERT has been implicated as a key factor
limiting telomerase activity in human somatic cells, because the RNA subunit is
constitutively expressed at a low basal level in cells (Feng et al., 1995). This hypothesis
is supported by the observation that ectopic expression of human TERT (hTERT) in
primary human fibroblasts restored telomerase activity, extended telomeres and
indefinitely prolonged cellular lifespan (Bodnar et al., 1998, Counter et al., 1998). It has
been accepted generally that telomere length in mammals is regulated by a homeostatic
mechanism that is governed in part by telomerase and a telomere-specific protein
complex recently termed 'Shelterin', which consists of TRF1, TRF2, TIN2, Rapl, TPP1
and POT1 (de Lange 2005). However, telomere length is not always maintained in cells
with reconstituted telomerase, indicating that telomerase activity does not necessarily
imply telomere maintenance (Ouelette et al., 1999, Cui et al., 2002). Similarly the
telomeres ofmany tumour cell lines are shorter than those of corresponding normal cells,
despite the fact that the tumour cells have high levels of telomerase activity (Hastie et al.,
1990, Counter et al., 1994). Telomerase-mediated telomere maintenance rather than
telomerase expressionper se, may be one key normal cellular lifespan-limiting factor. In
the last decade, murine models have been instrumental in demonstrating the impact of
telomerase function in the context of a whole organism. Mice with inactivated TR or
TERT exhibit gradual telomere attrition and long-term viability of the strain is
compromised due to infertility (Blasco et al., 1997, Erdmann et al., 2004). Conversely
mice with ectopic TERT show telomere extension, increased cell proliferation and a
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higher incidence of tumour formation (Oh et ah, 2001, Artandi et ah, 2002). However,
telomerase-deficient mice do not recapitulate the whole spectrum of human pathologies.
For example mTR knockout mice only show a phenotype after 6 or 7 generations,
whereas by contrast, hTR haploinsufficiency in humans is lethal at foetal stage
(Vulliamy et ah, 2001). These discrepancies may be explained by the fact that
laboratory mouse (Mils muscuius) telomeres are long (30kb to more than 200kb) and
hypervariable (Prowse et al., 1995, Starling et al, 1990) compared to human telomeres
(5-15Kb) (Kipling et al., 1990). Moreover in most human tissues, telomerase is not
readily detectable (Kim N-H et al., 1994), whereas telomerase activity is found in most
mouse tissues (Greenberg et al., 1998). Therefore, another animal model other than
mouse is necessarily required. Previous work in our laboratory has shown that sheep
(Ovis dries) fibroblasts share a lot of similarities with human in respect to telomere and
telomerase biology. Sheep fibroblasts have a defined in vitro lifespan, their telomeres
shorten at rates comparable to that reported in humans, and ectopic expression of
hTERT effectively immortalizes the cells (Cui et al., 2002 & 2003, Clark et al., 2003).
The hTERT-immortalised sheep fibroblasts showed that at higher levels of hTERT
expression, full length telomeres are maintained and karyotypic stability is preserved. By
contrast, at lower levels, telomere erosion and genomic instability occur to an extent that
is directly attributable to the level of hTERT expression - however, telomerase activity
was comparable between these lines (Cui et al., 2002). This further highlights the
complex relationship between telomerase function and telomere maintenance. One
question arising is whether non-catalytic domains in hTERT have any function(s) with
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respect to telomere maintenance, be it direct (e.g. proper telomerase assembly; substrate
binding) or indirect (e.g. recruitment of telomerase-associated factors), independent of
reverse transcriptase-mediated telomere maintenance; however it is conceivable that
hTERT catalytic domain expression level solely is rate determining for telomere repeat
processivity. An alternative hypothesis regarding telomerase-mediated telomere
maintenance follows from the postulation of a dimeric model of TERT in order for
proper telomerase function (Prescott & Blackburn 1997). This model of a dimeric
telomerase complex predicts that telomerase function and telomere maintenance may be
compromised if the complex is disrupted, where both TERT molecules may function
inter-dependently.
In order to address both these issues, a catalytically dysfunctional hTERT transgene was
expressed in an hTERT-immortalized primary sheep foetal fibroblast line in which
telomeres stabilize at an average length much shorter than the untransfected parental line.
This system provides an opportunity to study effects of over-expression of hTERT non-
catalytic domains on telomerase activity and telomere maintenance. This strategy
thereby presents a window in which telomere maintenance function may be attributed to
hTERT that can be distinguished from enzymatic activity. Conversely the presence of a
catalytically dysfunctional hTERT should further understanding of whether proper
hTERT function requires an inter-dependent hTERT dimer with two intact reverse
transcriptase motifs. In this regard both mutant/wild-type telomerase heterodimers and
mutant/mutant telomerase homodimers may compete with and compromise wild-
type/wild-type telomerase homodimeric function.
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Additionally, catalytically dysfunctional hTERT was transfected into a telomerase
positive primary human tumour line, in order to assess the effects of mutant hTERT on
endogenous hTERT function. This strategy underlines the anti-telomerase dominant
negative strategies proposed to target telomerase in a tumour setting.
3.1.1 Hypothesis
1) hTERT reverse transcriptase activity is rate-limiting with respect to hTERT-
mediated telomere maintenance.
2) Introduction of mutant hTERT in tumour cells inhibits endogenous telomerase
activity through dominant-negative and/or competitive interactions.
3.1.2 Chapter aims
1) To familiarize with techniques to measure telomere length and telomerase
activity.
2) To determine whether mutant hTERT has the capacity to restore telomerase
activity and affect proliferative lifespan.
3) To determine whether hTERT non-catalytic domains have a role in telomere
maintenance that can be distinguished from enzymatic activity in telomerase
positive cells.
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4) To gain insight into proper telomerase function with respect to hTERT
interacting monomers.
5) To analyze the effects of introducing catalytically dysfunctional hTERT into a
telomerase positive human tumour cell line.
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3.2 Results
3.2.1 Generation of stably transfected clonal lines
A hTERT-immortalized BW6F2 sheep fibroblast clonal line (GRN1-1) and its parental
cells, BW6F2, were transfected with a mutant hTERT construct or a mock vector
construct containing GFP (section 2.9.1). To select for and generate stable clones, the
constructs also contain a neomycin cassette (transfections and generation of lines
conducted by Fing Mo, previously in our laboratory). A 7.3 kb mutant hTERT construct
was used for the study, containing three in vitro induced amino acid substitutions
(R631A, D712A and D868A) and driven by the PGK promoter. For mock controls, a
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Figure. 3.1: Schematic of pWGB transgenic constructs. (Top) pWGB25 mutant
hTERT (7.3Kb) with amino acid substitutions indicated. (Bottom) pWGB23 EGFP
mock vector (4.6Kb). The PGK promoter, SV40 polyadenylation signal and neomycin
selection cassette are indicated for both constructs.
After selection, multiple clones were picked up from transfected GRN1 -1 cells both with
pWGB25 and 23 constructs. However, a lower number of clones were formed from
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parental BW6F2 cells. Only two clones BW6F2 (25)-7 and -8 were able to be expanded
from pWGB25 transfection, for further analysis.
3.2.2 Mutant hTERT cannot restore telomerase function
To address whether mutant hTERT alone can reconstitute telomerase activity, the effect
of mutant hTERT expression on telomerase activity was first addressed in the parental
sheep fibroblast line, BW6F2, using the Telomere Repeat Amplification Protocol
(TRAP) assay (section 2.215). Telomerase activity is not induced by catalytically
inactive mutant hTERT expression in primary sheep fibroblasts even though mutant






Figure 3.2: Telomerase activity in primary sheep fibroblasts transfected with
mutant hTERT. (A) Expression of mutant hTERT in primary sheep fibroblasts. The
BW6F2 parental sheep fibroblast line was transfected with a catalytically dysfunctional
mutant hTERT alone. Two clones, BW6F2(25)-7 and BW6F2(25)-8, showed high levels
of mutant hTERT expression. No DNA contamination was detected in RNA samples
lacking reverse transcriptase. PCR reactions were conducted at 30 cycles. (B) No
telomerase activity is detectable in the parental sheep fibroblast line transfected with the
pWGB25 mutant hTERT transgene alone. 0.2|lg of BW6F2(25).8 total protein extract
was used for TRAP. Heat inactivated and internal standard control is shown.
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This proved that telomerase activity is totally abolished by mutating three amino acids in
three distinct reverse transcriptase motifs of the hTERT catalytic domain and that a
functional hTERT catalytic domain is required for telomerase activity. In addition, the
transfected cells did not proliferate vigorously and senesced after several passages (Fig.
3.7A) similar to EGFP transfected clones. These results confirmed that the three point
mutations in distinct reverse transcriptase motifs of hTERT had abolished its catalytic
function and that the mutant hTERT does not have the ability to reconstitute telomerase
activity.
3.2.3 RNA expression analysis in transfected GRN1-1 clones
The effect of mutant hTERT expression on telomerase activity was next addressed in
hTERT-immortalised sheep fibroblasts using the Telomere Repeat Amplification
Protocol (TRAP) assay (section 2.215). Variable levels of the catalytically dysfunctional
hTERT transgene expression were evident in the pWGB25 stably transfected clones of
the hTERT-immortalized foetal sheep fibroblast line, GRN1-1. Due to only three base
pairs differing between wild-and mutant- hTERT, we were unable to differentiate
between their expression levels with current available techniques. Thus, expression of
total hTERT mRNA was analysed by semi-quantitative Reverse Transcriptase-PCR
(section 2.2.8 and 2.2.9). As all lines were derived from a clonal cell line GRN1-1 and
have similar levels of wild-type hTERT, the excess of TERT above that of the controls
was mainly attributed to mutant hTERT levels.
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The results showed that five clones (GRN25-1, GRN25-5, GRN25-6, GRN25-7 and
GRN25-9) expressed high levels of mutant hTERT expression (Fig.3.3, lanes 1-5)
relative to the wild-type hTERT expression level of mock vector controls, GRN23-C1
and GRN23-C4 (Fig.3.3 lanes 7-8). In the GRN25-10 line, steady-state mRNA level of
hTERT was too low to be detected under these conditions.
1 2. 3--4--J5 .6 7. 8
Figure 3.3: Analysis of mutant hTERT mRNA expression levels. (B) Expression of
mutant hTERT in hTERT-immortalized (GRN) sheep fibroblasts. Five mutant hTERT-
transfected clones show high levels of mutant hTERT mRNA with GRN25-6 and
GRN25-7 exhibiting the highest levels. All PCR reactions were conducted at 30 cycles
and GAPDH serves as the loading control. No DNA contamination was detected in
RNA samples lacking reverse transcriptase. Passage number post-transfection is
indicated.
Relative stoichiometry ofmutant to wild-type hTERT was inferred by calculating band
intensity using Multi-Analyst software with a relative value of 1 assigned to the
normalized mean intensity of the mock controls. On this basis, we grouped the GRN
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clones into two classes according to the level of total TERT expression: medium (7.7,
9.0 and 9.4 fold excess in lines GRN25-1, GRN25-5 and GRN25-9 respectively) and
high (12.6 and 14.1 fold excess in lines GRN25-6 and GRN25-7 respectively). Relative
expression of the GRN25-10 was below the mock control level (0.6).
In summary, by transfecting a 7.3kb mutant hTERT construct, we generated GRN(25)
lines that over-express hTERT relative to immortalized BW6F2 sheep fibroblasts.
Crucially these lines over-express intact non-catalytic domains but express a catalytic
domain mutated at three distinct reverse transcriptase motifs. These lines provide an
opportunity to investigate a putative role for hTERT non-catalytic domains with respect
to telomere maintenance, distinguishable from enzymatic activity.
3.2.4 Protein expression analysis
Western Blot analysis was conducted as described in section 2.2.13. Protein expression
levels revealed a more complex pattern. GRN23-C1 exhibits wild-type hTERT
expression alone, whereas GRN25 lines show total hTERT expression (wild-type and
mutant). GRN25-1, GRN25-6 and GRN25-9 have the highest levels of total hTERT
expression (3.3-fold higher than mock control). GRN25-5 and GRN25-7 had lower
levels of total hTERT expression (2.6-fold and 2.0-fold higher then control) (Fig 3.4).
Clones GRN25-1 and GRN25-9 show higher protein levels relative to the other clones
than would be predicted by RNA expression analysis. Conversely GRN25-7 has much
lower levels ofprotein than expected.
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Figure 3.4: Protein expression analysis in GRN clones. Western blot showing hTERT
protein expression. Protein (40ug) was separated on 7.5% SDS-PAGE and blotted onto
nitrocellulose membrane. The blot was incubated with anti-hTERT antibody Y182
(Abeam) followed by incubation with HRP-conjugated secondary antibody. The signals
were visualized using an ECL detection kit. The hTERT protein is shown as 122kDa.
Relative expression to GRN23-C1 mock control is shown in panel below. Beta-actin is
shown as an internal control to verify equal amounts of protein loaded.
Superficially, this may appear to reflect differences in translation efficiency, but the
effect of mutant hTERT is likely to be a factor. If mutant hTERT compromises cellular
proliferation and senescence bypass status, then the existence of a heterogeneous
population rather than the presumed clonogenic population may result in subsets of cells
with low or no levels ofmutant hTERT, having a growth advantage. This scenario will
be discussed in section 3.2.3 and Chapter 4.
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3.2.5 Telomere Repeat Amplification Protocol (TRAP) analysis on
hTERT-immortalized lines
Telomere Repeat Amplification Protocol (TRAP) assay was next carried out on the
mutant hTERT stable-transfected GRN clonogenic lines. The analysis showed that the
four lines (GRN25-1, GRN25-5, GRN25-9 and GRN25-10) which exhibited low to
medium levels of mutant hTERT expression, showed comparable telomerase activity to
the GRN23-C1 mock vector control (Fig. 3.5, lanes 1-2 and 5-6). By contrast, in the
lines exhibiting higher levels of mutant hTERT, (GRN25-6 and GRN25-7), telomerase
activity was almost undetectable (Fig.3.5, lanes 3-4).These results indicate that the
catalytically dysfunctional mutant hTERT may function to inhibit telomerase activity.
This abrogation of telomerase catalytic activity appears a direct function of mutant
hTERT expression levels, with only the two lines with highest levels of the mutant
transgene expression, showing compromised telomerase activity.
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Figure 3.5: Telomerase activity in hTERT-immortalized sheep fibroblasts. (A)
Reconstituted telomerase activity in hTERT-immortalized GRN25 clones. Telomerase
activity was measured by TRAP assay with 0.1 pg of total protein of each cell extract.
Telomerase activity in four lines (GRN25-1, GRN25-5, GRN25-9 and GRN25-10) is
comparable to that of the mock control (GRN23-C1). Telomerase activity is inhibited in
the GRN25-6 and GRN25-7 lines, which have the highest levels of mutant hTERT
expression relative to the other clones. Heat inactivated and internal standard controls
are indicated. (B) TRAP activity relative to the G23-C1 mock vector control.
Densitometric analysis was used to compare relative levels of TRAP activity based on
the intensity and length of the TRAP product, nonnalized to the internal control. TRAP
activity is completely inhibited in the GRN25-6 and GRN25-7 clones, whereas relative
activity is 50 - 100% in all other clones. (NB: TRAP was conducted at the same passage
number as for RT-PCR analysis; Fig.3.3).
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Low levels of telomerase activity was however detected in the GRN25-6 and GRN25-7
lines when total protein extract was increased 5-fold from 0.1 |lg to 0.5|lg (Fig. 3.6).
Nevertheless, telomerase inhibition through dominant-negative and/or competitive
inhibition effects, are still noticeable; the 36-bp internal standard is present in these
samples whereas they are absent in all other GRN clones, including the GRN23 mock
controls, except GRN25-1. This indicates sufficiently high levels of telomerase activity
in the majority ofGRN clones, to out-compete the shared forward primer used in TRAP
to amplify both the TRAP product and the internal standard. Of note is the telomerase
inhibition evident in GRN25-1, not detected in the previous TRAP (Fig. 3.5). The
discrepancy may be accounted for by this initial TRAP assay being conducted ~6PDs
prior to TRAP assay conducted using 0.1 |ig. This hints at high levels of mutant hTERT
post-transfection in the GRN25-1 line, resulting in early telomerase inhibition, followed
by restoration of telomerase activity to levels comparable to mock controls in a short
period of serial culturing.
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Figure 3.6: TRAP analysis on hTERT-immortalized clones using a 5-fold increase
(0.5|lg) of protein lysate. Trace telomerase activity is evident in GRN25-1, GRN25-6
and GRN25-7, whereas very high levels of activity are present in all other GRN clones.
This is inferred by the TRAP product and also the presence/absence of the 36-bp internal
standard. The HI human ES line and HEK293 tumour line are included as positive
controls for the assay. Heat inactivated controls are indicated.
This indicates the complexity of telomere and telomerase dynamics per population
doubling and highlights a caveat of studying this dynamic interplay via molecular
snapshots of time.
3.2.6 Analysis of extensive culture period
3.2.6.1 Calculation ofproliferation rate
Since the TRAP assay results showed that telomerase activity in the mutant clones was
inhibited, the effects of mutant hTERT on cell growth and proliferation was next
examined by recording their growth curves. The BW6F2(25)-7 and BW6F2(25-8 sheep
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fibroblast clones, transfected with mutant hTERT alone did not proliferate vigorously
and senesced after several passages at around day 50-60 of the culture regime (Fig. 3.7a).
All GRN clones, except GRN25-7, grew uncompromised with a steady rate of
proliferation during the 160 days of the growth curve recording period, with about one
population doubling every 19 hours. There is no significant difference to the overall
proliferation profile between these clones and control GRN23 clones which only
expressed wild-type hTERT (Fig. 3.7a). The reconstituted telomerase activities were
sufficient to bypass senescence in all clones in spite of the GRN25-6 and GRN25-7
clones exhibiting telomerase inhibition. This indicates that trace telomerase expression
may be sufficient to maintain a senescence bypass status, presumably due to telomerase
maintaining telomere length in the subset of shortest telomeres, thus avoiding activation
of a p53-mediated growth arrest.
3.2.6.2 Senescence-associated p-galactosidase staining
In the GRN25-7 clone however, a period of slower proliferation was evident at around 3
weeks of continuous culture, in which population doubling rate slowed to over 40 hours
(Fig. 3.7b).Concurrent with this, a subset of cells within the population adopted a
morphology of bigger and flat appearance with clearly visible microtubules, a
characteristic of the senescent phenotype. This subset of cells represented around 30% of
the total population. To further confirm that these cells were senescent, the senescence-
associated P-galactosidase (SA-|3-gal) staining assay was applied to the GRN25-7 cells
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and the results indicated positive staining as expected (Fig. 3.7c). Approximately 50% of
cells within the population showing a senescent-like phenotype, stained positive for SA-
p-gal, i.e. half the population. This may reflect the fact that only senescent cells stain
positive, whereas pre-senescent cells, although displaying a similar phenotype, did not
express the particular stress marker(s) to result in a positive histochemical stain. This
raises the question of whether (3-galactosidase is a truly accurate marker for cellular
replicative senescence?
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Figure 3.7: Effects of mutant hTERT expression on cellular proliferation and
senescence. (A) General proliferation profile of GRN clones. GRN25 and GRN23
clones maintained a steady population doubling rate throughout the 160-day culture
period and accumulated 138-160 population doublings. The overall profile of the growth
curves does not differ significantly. All clones underwent 150-160 population doublings
except GRN25-7, for which the total population doubling was 138. The BW6F2(25)-7
and BW6F2(25)-8 control clones express mutant hTERT alone and accumulated 28 and
12 population doublings respectively. Both lines ceased proliferating by -50-60 days
post-commencement of the growth curve. (B) GRN25-7 lag phase. Proliferation rate of
GRN25-7 slowed dramatically during a 14-day period during which the cell population
doubled only five times. Arrows denote lag phase. (C) SA-(3-Gal staining in the GRN25-
7 clone. Senescent morphology was evident during early stages (7 population doublings)
of extended culture (.A-B). Incubation with fresh senescence-associated (3-Gal (SA-(3-Gal)
resulted in positive histochemical staining at pH 6.0 (C-D) Photos were taken 16 hours
post-incubation. Arrows indicate senescent cells. As a negative control GRN25-5 from a
late stage of culture (140 population doublings) was also incubated with SA-(3-Gal, (E-
F). Magnifications: A, B and D, xlO; C, E and F x4. Scale bar for A, B and D denotes
100 pM and 500pM for C, E and F. (Growth profiles of the BW6F2(25) clones were
generated by Ling Mo).
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3.2.7 Telomere Restriction Fragment (TRF) length analysis
The most obvious function of active telomerase is to add telomeric repeats to telomere
ends to prevent telomere attrition each time a cell divides. However, it is unclear if it is
exclusively the catalytic domain of hTERT that is rate-limiting in this aspect or whether
non-catalytic motifs may play functional roles, be it directly or indirectly, in repeat
addition processivity. Previous studies have indicated that forced expression of hTERT,
although extending proliferative lifespan, did not maintain telomere length (Zhu J. et ah,
1999, Ouelette et ah, 2000). In particular, a prior study in sheep primary fibroblasts
showed that stabilization of telomere length and karyotypic stability are directly
correlated with the level of hTERT gene expression, even though telomerase activity
was comparable within these lines (Cui et ah, 2002). This led to the hypothesis that
hTERT non-catalytic motifs may play a role in telomere maintenance that may be
distinguished from enzymatic activity.
To assess the effect of over-expressing non-catalytic hTERT domains on telomere
maintenance, we cultured mutant TERT-transfected immortalized GRN clones for an
extensive period of-160 days. Telomere length was measured by Southern Blot (section
2.2.16) with a (TTAGGG)3 probe, and the mean TRF was calculated at multiple time
points (0, 70 & 130 days) during long term culture for each cell line. The results showed
that after -70 days in culture, telomere lengths shortened in all cell lines (Fig.3.8A and
Table 3.1). However, GRN25-1 and GRN25-7 exhibited significantly shorter mean
telomere length (6.7 kb and 7.7 kb, respectively) in comparison with GRN23 control
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cells (9.2kb and 10.1 kb, p=0.02). The remaining GRN25 clones (GRN25-5, 9.5kb;
GRN25-6, 10.6kb; GRN25-9, 9.1kb and GRN25-10, 9.2kb) showed similar telomere
shortening as the GRN23 controls (p = 0.95). This pattern of telomere shortening
persisted throughout the culture period and mean TRF lengths in all GRN clones were
stabilized after approximately 100 population doublings post-transfection. Stabilized
mean TRF length in clones GRN25-5, GRN25-6 and GRN25-9 were within the range of
6.6-7. lkb, and did not differ significantly to the 7.0 and 7.2kb of GRN23 mock controls
(p = 0.29), whereas the mean TRF lengths in GRN25-1 and GRN25-7 were eventually
stable at 5.2 kb and 6.3kb, significantly shorter than that in the mock controls (p =
0.0002) (Fig. 3.8B and Table 3.1).
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Figure 3.8: Telomere restriction fragment length in mutant hTERT-expressing
clones after period of extensive culture. Telomere length was measured using
Telomere Restriction Fragment (TRF) Southern Blot analysis with a TTAGGG3 probe.
Samples were analysed at intervals throughout a 160-day culture period. (A) TRF
analysis from early and middle passage. No significant enhanced telomere maintenance
is evident at this stage with GRN25-5 (9.5Kb), GRN25-6 (10.6kb), GRN25-9 (9.1kb)
and GRN25-10 (9.2kb) showing comparable mean TRF length to GRN23-C1 (9.2kb)
and GRN23-C4 (10.1 kb) mock vector controls. Aggravated telomere attrition is evident
in the GRN25-1 (6.7kb) and GRN25-7 (7.7Kb) clones. (B) TRF analysis from late
passage. Mean TRF length in all GRN clones are maintained at a stabilized length after
approximately 100 population doublings. GRN25-1 and GRN25-7 show significantly
shorter stabilized mean telomere lengths (5.2 kb and 6.3kb respectively) compared to the
GRN23-C1 (7.0kb) and GRN23-C4 (7.2kb) mock transfected controls, whereas GRN25-
5 (7.1kb), GRN25-6 (6.9kb), GRN25-9 (6.6kb) and GRN25-10 (7.1kb) show
comparable mean stabilized lengths. Calculated mean telomere lengths are depicted by
white lines and are stated in Table 1. PD, Population Doublings.
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G&VCelt Line Population Doubling Dayi in Qilture Mean TRf
(PD) (Kbp)
025-1 2 4 11.0
67 79 6.7
130 133 5.2 &
G25-5 0 0 14.0
70 81 95
127 135 7.1 *
025-6 0 0 135
64 79 10.6
125 134 6 9a
G25-7 0 0 11.6
50 81 7.7
no 135 6.3 a
G25-9 0 0 9.2
74 81 9.1
131 133 6.6 a
G25-10 0 0 13.7
70 81 9.2
128 134 7.1 a
G23-C1 0 0 12.2
74 81 92
131 134 7.2 a
G23C4 0 0 11.0
76 81 10.1
132 133 7.0 a
Table 3.1: Summary of mean TRF length in hTERT-immortalized sheep
fibroblasts. a Represents mean TRF length at which telomeres stabilize.
From the analysis of telomere length after long term culture of hTERT-immortalized
clones with varying levels of catalytically dysfunctional mutant hTERT expression, no
enhanced telomere maintenance function is evident. For the majority of lines, there is no
significant difference in mean telomere restriction fragment length after culture, when
compared to mock controls. Thus we do not find evidence to support the notion that
hTERT non-catalytic motifs have a role in telomere maintenance that can be readily
distinguishable from hTERT enzymatic activity.
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These results indicate that high levels ofmutant hTERT expression might accelerate the
telomere shortening in GRN25-1 and GRN25-7 cells probably as a consequence of
inhibited telomerase activity. Aggravated telomere attrition in GRN25-1 reveals a more
complex pattern whereby telomerase inhibition was evident at PD 0 but relieved at PD 6.
The possibility of transgene silencing and selection upon a heterogeneous population
will be discussed in Chapter 4. Furthermore, the other high expressing mutant hTERT
clone GRN25-6, did not appear to have accelerated telomere shortening in spite of the
clear inhibition of telomerase activity. These results indicate that telomere length
regulation is more complicated and consideration has to be given to the multiple
extrinsic and intrinsic factors involved.
3.2.8 Competitive inhibition TRAP
To address the molar stochiometry of mutant hTERT and wild-type hTERT in this
context, a TRAP assay was designed (section 2.2.15) to analyze the particular threshold
upon which the mutant hTERT exerts an inhibition effect on the hTERT-immortalized
line chosen for study here. This assay was referred to as a 'competitive inhibition TRAP'
although the term will be used to include inhibition and/or dominant-negative effects. As
the GRN25 clones express both wild-type and mutant hTERT, the GRN23-C1 line was
chosen to monitor hTERT inhibition as this line exhibits wild-type hTERT expression
alone. The BW6F2(25)-8 line was used as the source of high level mutant hTERT, as
this line does not express wild-type hTERT which would confound results. A
presumption in this approach states that the expression level of mutant hTERT in the
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BW6F2(25)-8 line is similar to that of the GRN25-6 and GRN25-7 line in which the
dominant-negative/competitive inhibition effect was evident. Although this may not be
the case, the rationale for the competitive inhibition TRAP was to obtain an approximate
threshold at which mutant hTERT excess conferred an inhibitory effect on wild-type
hTERT expression levels and hence on wild-type hTERT function.
Initially, the assay was conducted using a maximum 5-fold excess of mutant hTERT to
wild-type hTERT protein lysate, thereby constituting the upper limit of recommended
total protein lysate amount for the TRAP assay (0.5pg). As no inhibition was evident
within this molar ratio imbalance (Fig 3.9a), mutant hTERT to wild-type molar ratio was
increased up to 200-fold. Although complete inhibition was evident when mutant
hTERT was in excess by between 150-200-fold (Fig. 3.9b), the internal control standard
was not amplified in the PCR reaction indicating saturating levels of mutant hTERT
levels in the total lysate. Although mutant hTERT levels at such an excess would be
expected to promote an inhibitory effect, the competitive inhibition TRAP does not give
an accurate level of the mutant hTERT:wild-type hTERT relative stoichiometry due to
the absence of the internal control.
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Figure 3.9: Competitive inhibition TRAP assay. A 5-fold Excess of mutant hTERT
does not result in inhibition of wild-type hTERT telomerase activity (A). A molar ratio
of between 150-200-fold excess results in complete inhibition of telomerase activity (B),
but with the failure of the 36-bp internal standard to be amplified.
3.2.9 Transfection ofmutant hTERT into HEK 293 cells
Due to the observed effect of a catalytically dysfunctional mutant hTERT exerting a
dominant-negative/competitive inhibition effect on wild-type hTERT, thus
compromising telomerase activity and function, the natural progression was to try and
abrogate telomerase activity in a tumour setting. The HEK 293 tumour line was chosen
for this study as this line exhibits high levels of telomerase activity (Fig. 3.6). The
working hypothesis states that introduction of the mutant hTERT transgene will inhibit
endogenous hTERT protein monomers from acting at the telomere substrate through a
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dominant-negative/competitive inhibition mechanism. If endogenous telomerase activity
is inhibited, HEK 293 cells may be forced into replicative senescence or to an apoptotic
fate, plausibly due to lack of telomere maintenance in the subset of the shortest
telomeres in the population. This would support the many documented strategies to
inhibit telomerase in a tumour setting using a dominant-negative approach.
3.2.9.1 Selection of293 transfected cells
HEK 293 cells were transfected with the pWGB25 vector containing mutant hTERT
cDNA and the PWGB23 EGFP-containing mock vector and selected for as described in
section 2.9.2. Upon 7 days of selection, populations were pooled and expanded as one
mixed population. Transfection efficiency was judged by monitoring EGFP expression
in the mock controls. (NB: This is an approximation of transfection efficiency regarding
the mutant hTERT construct as the vector size is much larger compared to the mock
EGFP construct). At this stage, heterogeneous EGFP expression was evident in the
mock controls with EGFP expression absent in many cells. Approximately 40% of cells
were EGFP positive. A similar number of cell death/survival was evident in the mutant
hTERT-transfected cells. At 14 days post-transfection the pooled populations were
placed under a more stringent selection regime (section 2.9.2) and expanded for four
weeks with RNA expression analyzed throughout this period (see section 3.2.7.2).
During this stage, EGFP positive cells represented -75% of the total population in the
mock-transfected line and analysis at this stage clearly showed that even in the 75%
GFP positive cells the levels of GFP expression were variable (Fig. 3.9 A-C). Cell
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survival rate under this selection regime was comparable for the mutant hTERT-
transfected lines (Fig. 3.10 D-E).
Figure 3.10: HEK 293 cells transfected with mutant hTERT or EGFP mock control.
Images were taken 21 days post-transfection and represent pooled populations under a
stringent selection regime. (A-C) HEK 293 cells transfected with EGFP: A, phase-light;
B, EGFP; C, merged. (D-E) HEK 293 cells transfected with mutant hTERT. Scale bar
represents 100pM.
3.2.9.2 RNA expression and telomerase activity analysis of transfected HEK
293 cells
RT-PCR analysis was conducted as described in section 2.2.9. Primers to detect the
mutant hTERT transgene were designed whereby a portion of the SV40 polyadenylation
signal was amplified in addition to a portion of the mutant hTERT transgene. As the
SV40 polyadenylation signal is not present endogenously, this strategy allowed the
mutant hTERT transgene to be distinguished from the endogenous hTERT in 293-
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transfected cells. RNA was collected at the beginning of the stringent selection regime
and each week for a period of four weeks thereafter. The primers chosen to conduct
analysis on endogenous hTERT were located in the hTERT 3'UTR region, therefore
allowing the endogenous hTERT to be distinguished form the transgenic hTERT. A
clear reduction in the endogenous hTERT expression levels in HEK 293 cells
transfected with the mutant hTERT construct, is evident after 7 days and persists
through to the 14-day stage (Fig. 3.11a). This is concurrent with high levels of mutant
hTERT transgene levels evident at the 7 day-stage (Fig. 3.11c). However by day 28,
endogenous hTERT levels are restored to that of the untransfected HEK 293 cells (Fig.
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Figure 3.11: Endogenous and mutant hTERT RNA expression levels in HEK 293
cells transfected with a mutant hTERT transgene. (A) Endogenous hTERT gene
expression. mRNA expression is considerably reduced by day 7 of a stringent selection
regime, with levels being restored to that comparable to the untransfected control by day
28. (B) GAPDH RNA expression levels. GAPDH levels at the same stage showing equal
loading for RT-PCR analysis. (C) mutant hTERT RNA expression levels. Consistent
with the endogenous hTERT RNA expression profde, mutant hTERT RNA expression
levels are high after day 7, followed by a considerable reduction by day 14 that persists
throughout the remaining period monitored.
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As endogenous hTERT levels were not completely abrogated, telomerase activity is not
compromised in the mutant hTERT transfected lines. Telomerase activity is comparable
to the untransfected HEK 293 cells at all stages analyzed (Fig. 3.12). This is consistent
with the data presented in section 3.2.5.
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Figure 3.12: Telomerase activity in 293 cells transfected with mutant hTERT.
Telomerase activity was measured at various stages during a 35 day period after
expanding populations that survived the selection regimes. No difference between
telomerase activity in the untransfected 293 cells and those transfected with mutant
hTERT is evident. Mock transfected EGFP populations are shown. TRAP was
conducted using 0.1 pg.
These results reflect the heterogeneous nature of these transfected populations similar to
the GFP tranfectants. Although endogenous hTERT levels are reduced after introduction
of the mutant hTERT transgene, a subset cells within the population may have mutant
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hTERT levels that are insufficient to confer a dominant-negative effect upon translation
of the mutant protein. Therefore these cells may have a growth advantage over a subset
of cells which suffer a dominant-negative effect, presuming that this effect results in
cells proliferating more slowly relatively. This notion is supported by the observation
that there was almost no cell death during this culture period under stringent selection,
indicating that cells that exhibited high levels of mutant hTERT expression did not die
but rather may have been selected against during serial passaging.
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3.3 Discussion
The relationship between telomerase enzymatic activity and telomere maintenance has
been poorly understood in the field of telomere biology. It has consistently been reported
that telomerase activity per se does not lead to the maintenance of telomeres, both in
normal and abnormal cellular contexts (Ouelette et ah, 1999, Hastie et ah, 1990, Counter
et ah, 1994). Our laboratory have previously used primary sheep (Ovis aries) fibroblasts
to study hTERT function with respect to telomere maintenance, in order to provide an
alternative mammalian model to the laboratory mouse. In this setting, stabilization of
telomere length and karyotypic stability are directly correlated to the level of hTERT
gene expression. However this was not reflected in telomerase activity as detected by the
in vitro-based TRAP assay (Cui et ah, 2002). This led to the speculation as to whether
the hTERT reverse transcriptase catalytic domain was the key rate-determining subunit
within the telomerase complex with respect to telomere maintenance, or whether non-
catalytic hTERT domains play a role in telomere maintenance that can be distinguished
from enzymatic activity. To address these questions, a strategy was devised to
ectopically express a catalytically dysfunctional hTERT transcript in a primary sheep
fibroblast line that exhibits low levels of hTERT expression, insufficient to prevent
telomere erosion and the onset of karyotypic instability. This provides a system in which
to descriptively study both the dimeric function of hTERT and the effects of hTERT
non-catalytic domain over-expression.
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RNA expression analysis showed that two clones exhibited high levels of mutant
hTERT and three clones exhibited moderate levels. This was readily translated to the
analysis of TRAP activity as lines with moderate levels of mutant hTERT showed
comparable levels of telomerase activity to the mock control, whereas lines with high
levels ofmutant hTERT showed inhibition of telomerase activity likely due to possible
dominant-negative and/or competitive inhibition effects between the wild-type and
mutant hTERT protein. Thus mutant hTERT expression compromised wild-type
telomerase activity in a manner directly attributable to mutant hTERT expression level.
When TRAP assay was conducted using a 5-fold increase in protein lysate however, low
levels of telomerase activity was evident in lines with high levels of mutant hTERT
transcript, thus highlighting a critical caveat when considering dominant-negative
strategies to target hTERT in tumours. It was striking to note that when TRAP analysis,
conducted at stages that differed by ~6 PDs was compared, one line (GRN25-1) showed
a dominant-negative affect at the earlier time-point but which was not evident 6PDs later.
This indicates that wild-type telomerase activity was inhibited in a subset of cells within
this population but due to a heterogeneous population, this subset was rapidly selected
against, whereby a subset(s) with levels of mutant hTERT insufficient to confer
inhibitory effects were selected for. This observation is consistent with the idea that high
levels of mutant hTERT may have adverse effects on cellular proliferation and may
indeed inhibit cell growth.
An extensive culture period of 160 days allowed the effects of mutant hTERT
expression to be studied in a cellular context. No significant change in the general
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proliferation profile was evident between mutant hTERT-transfected and mock-
transfected clones. Proliferation rate throughout culture was similar for all clones and
calculated to be on average one population doubling per 19 hours, except GRN25-7
which exhibited a period of slower proliferation between days 14-28 of the culture
period. Population doubling rate during this period slowed dramatically in this clone, to
one population doubling per 3-4 days. This was concurrent with a senescent morphology
within a subset of cells (30%) within the population. Approximately half of this
population stained positively for the senescence-associated histochemical marker (3-
galactosidase. This data indicates that sufficiently high expression of catalytically
dysfunctional hTERT inhibits proper telomerase function, presumably due to restriction
of functional homodimers at the telomere substrate. However, this was only reflected in
a subset of cells within the GRN25-7 population, with the bulk of the population
exhibiting a selective advantage thereafter, resulting in a comparable proliferation rate to
all other clones. Only in this context is it possible to attempt to reconcile protein
expression data. Protein levels of mutant hTERT within the GRN25-7 line were much
lower than expected from the RNA expression analysis and TRAP activity. However as
protein analysis was conducted ~9 PDs later than RNA and TRAP analysis, the lower
levels of mutant hTERT protein may reflect selection within this 'mixed' population,
with a subset of cells exhibiting high levels of mutant hTERT initially, being selected
against.
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It has been reported that stochastic variation of this nature may account for
heterogeneous populations in vitro that are inaccurately termed 'clonal' (Martin-ruiz et
ah, 2004). In this context, a subpopulation of cells with compromised telomerase
function would be selected against during long-term culture. It has been documented that
TERT may regulate cellular survival and proliferation independent of enzymatic activity
in tumour cells (Cao Y. et ah, 2002). This data however, indicates that in primary
fibroblasts, pro-survival functions of hTERT are a direct function of catalytic activity.
Consistent with this, the parental sheep fibroblast line used for this study, transfected
with catalytically dysfunctional hTERT alone, ceased to proliferate and entered
replicative senescence after ~50 days culture.
Mean TRF length calculation at mid point and late stage of the extended culture period
revealed comparable mean telomere length during culture and also comparable
stabilized mean telomere length between the majority of clones and mock controls.
Maintenance at a stabilized mean telomere length and the persistent check on entry to
replicative senescence, is therefore most likely due to wild type expression level in these
clones, as in mock controls. Significant telomere attrition however, was evident in two
of three clones with high levels of mutant hTERT expression (GRN25-1 & GRN25-7).
Telomeres in these clones eventually reached mean stabilized lengths much shorter than
those in mock controls. These results seem to be directly attributable to mutant hTERT
expression. Mutant hTERT/mutant hTERT and mutant hTERT/wild-type hTERT
dimeric complexes are likely to be in much greater abundance than wild-type/wild-type
dimers within these lines (Fig. 3.13). Inhibition of telomerase activity and increased
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telomere attrition are therefore likely to be due to the compromising of wild-type
homodimeric function at the telomere substrate due to the molar ratio imbalance of
hTERT complexes. This is consistent with the notion that hTERT homodimers are
necessary to form a functional telomerase complex at the telomere substrate, where
catalytic domains of both hTERT molecules may function inter-dependently. On this
basis, the GRN25-1 clone which showed telomerase inhibition at the beginning of the
growth curve but restoration of telomerase levels after ~6 PDs, may have experienced
aggravated telomere attrition at an early stage. However, there is no evidence for any
lengthening of telomeres (with respect to average telomere length) after restoration of
telomerase activity. Surprisingly one clone with high mutant hTERT expression level
and subsequent abrogation of telomerase activity, showed comparable stabilized mean
telomere length to mock controls. This highlights the limitation of in vitro based
telomerase activity assays to assess proper telomerase function; as telomere length is not
controlled by telomerase (TERT and TR) alone but requires other telomerase associated
proteins and telomere binding proteins, such as POT1, TRF1 and TRF2, differences in
expression level of these factors may account for this discrepancy. For example, TRF1 is
known to negatively regulate telomere length (Ohki et al., 2004) and therefore
differences in expression level of TRF1 may be one factor that accounts for this
discrepancy. Generally the heterogeneous nature of the lines used in this study may
exhibit varied expression levels of telomere-associated proteins that contribute to
telomere homeostasis.
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Figure 3.13: Functional dimerization model of hTERT. hTERT-mediated interactions
in the GRN sheep fibroblast clones favour the homodimeric model of hTERT first
postulated by Prescott, J. and Blackburn, E. in 1997. On this premise, only wild-type
hTERT homodimeric interactions can contribute to a functional telomerase complex
(left). Catalytically defective mutant hTERT homodimers (middle) and wild-type/mutant
hTERT heterodimers (right) result in a non-functional telomerase complex with respect
to telomere repeat addition processivity, suggesting that the hTERT catalytic domain is
the rate-limiting factor. Blue, hTERT non-catalytic domains; Brown, wild-type reverse
transcriptase domain; Red, mutant reverse transcriptase domain; Green box, sheep TR.
Collectively there is no evidence to indicate that non-catalytic hTERT domains
contribute to telomere maintenance in a manner distinguishable from catalytic domain
mediated telomerase activity. Rather, these data support the notion that telomere
maintenance requires a functional telomerase complex with hTERT monomers likely
interacting in an inter-dependent manner. Furthermore the result demonstrates that
although hTERT non-catalytic domains may be necessary for telomerase assembly and
processivity at the telomere substrate, they are not rate-determining. The catalytic
domain of hTERT appears to be a crucial rate-determining factor regarding processivity
(Rahman et al., 2006); however a more thorough understanding of telomerase- and
telomere-associated factors will be required to understand fully the interplay that
governs telomere homeostasis in vitro and in vivo. Consistent with the work from other
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laboratories, these results also show a potential interest of using dominant-negative
mediated anti-telomerase gene therapy to treat cancer but consideration has to be taken
on how to ensure sufficiently high levels of mutant hTERT expression in a tumour line,
that is also persistent throughout treatment. Data presented here show that even trace
telomerase activity may be sufficient to maintain a check on replicative senescence
and/or apoptotic pathways. Furthermore, the heterogeneous nature ofpopulations ex vivo
will have to be realized during conceptual models of anti-telomerase therapy.
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4.1 Introduction
Data presented in Chapter 3 suggest that 'clonogenic' sheep fibroblast lines used for
this analysis, are not exactly homogenous regarding transgene expression, as was
initially regarded, particularly after long-term culture. These cells became
heterogeneous in nature within the particular population. This is a theme that is
recurrent within studies of clonally-derived cell lines as an in vitro tool. Many
authors have stated reservations regarding in vitro artifacts that are hoped will reflect
in vivo settings. The difficulties in recreating a proper biochemical and physiological
niche in vitro is a severe obstacle at present and we cannot profess to be culturing
cells in an accurate tissue and cellular microenvironment.
Transgenic technology in vitro presents an additional caveat whereby the monitoring
of long-term consequences of transgene expression is vital, especially with respect to
the potential of gene therapy. Can we presume that transgene expression levels are
sustained throughout a long culture period incorporating over lOOPDs? Can we
presume that transgene expression is constant in every cell in the population?
Therefore as the GRN sheep fibroblasts used for this analyses were cultured for ~160
days, the natural follow-up was to analyze the functional consequences of transgene
expression during long-term culture. This not only provides an opportunity to gain
further insight into this concept from a technical point of view but also presents
additional information regarding alterations to total hTERT transgene expression and
to telomerase activity, furthering understanding of the effects of mutant hTERT in
hTERT-immortalized sheep fibroblasts.
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A distinct limitation in studying the sheep as a mammalian model for telomerase and
telomere biology and function is the absence of the gene sequences for sheep TERT
as well as telomere binding proteins. Therefore it is difficult at present to provide
direct evidence for possible activation or up-regulation of the endogenous sheep
TERT transcript. Rather the convergence of various lines of data relating to the
consequences of long-term culture may be used to provide indirect evidence of the
functional presence or absence of sheep TERT. As the transgenic constructs used for
this study were transfected into the GRN1-1 line, previously shown to express levels
of hTERT insufficient to maintain full-length telomeres and prevent the onset of
karyotypic instability (Cui et ah, 2002), it is plausible to hypothesize that endogenous
TERT may be switched on during long-term culture of the GRN25 fibroblasts. In this
regard, sheep TERT activation may be concurrent with the functional
immortalization of these lines and may facilitate the maintenance of a senescence-
bypass status. This concept does not necessarily imply that these lines are
transformed; it is accepted that telomerase itself does not cause growth deregulation,
unlike classical oncogenes, therefore additional alterations in the genome are
required to transform a cell that is telomerase positive (reviewed in Harley et ah,
2002).
132
Chapter 4 - Consequences of long-term culture
4.1.1 Hypothesis
1) GRN sheep fibroblast lines consist of a heterogeneous population upon
which selection pressures bias a particular subset(s) upon serial culture. Cells with
compromised telomerase activity therefore would be selected against.
2) Endogenous sheep TERT is activated as a consequence of long-term
culture, reflected by an increase in telomerase activity.
4.1.2 Aims
1) To gain a thorough understanding of the consequences of mutant and
wild-type hTERT transgene expression levels during an extensive culture period;
verify whether transgene expression persists, varies or is lost.
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4.2 Results
4.2.1 RNA expression analysis after long-term culture
Semi-quantitative RT-PCR analysis was carried out on GRN clones at -day100 to
determine total hTERT transgene expression levels at this stage (section 2.2.8 and
2.2.9). The null hypothesis states that there is no difference in total hTERT transgene
levels at this stage when compared to the initial stage of RNA analysis, prior to
commencement of the extensive culture period. Surprisingly, RT-PCR analysis
revealed almost complete absence of any hTERT transcript, indicating that the
mutant hTERT transcript is completely silenced by this stage (Fig. 4.1). Trace
hTERT message was detectable in three clones, including one of the mock controls.
It is unclear whether this reflects the wild-type hTERT or mutant hTERT transgene
(or both).
Figure 4.1: hTERT RNA expression analysis in hTERT-immortalized
fibroblasts after -100 days culture. RT-PCR analysis showing total hTERT
expression levels in GRN hTERT-immortalized sheep fibroblasts. Total hTERT
transcript is completely absent in the majority of lines, with trace expression evident
in GRN25-7, GRN25-9 and the GRN23-C1 mock control. GRN1-1 represents the
hTERT-immortalized parental line, into which either mutant hTERT or EGFP was
transfected. GAPDH internal controls and no reverse transcriptase controls are
shown. PCR was conducted at 30 cycles.
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As this analysis was conducted at the -100 day stage, in comparison to day 0
previously (Fig. 3.1), it is unclear as to how early or late the mutant hTERT
transgene has been silenced. Therefore RNA collected from an earlier stage (-day
80) was retrospectively analyzed for hTERT RNA expression levels. At this stage,
the GRN clones exhibited readily detectable levels of total hTERT message, but
which was much lower than that evident at the initial stage of analysis (Fig. 4.2).
Levels of total hTERT were comparable across all the GRN lines, although the
GRN23-C4 mock control showed slightly higher expression.
hTERT 325bi>
sGAPDH 224bp
Figure 4.2: hTERT RNA expression analysis in hTERT-immortalized
fibroblasts after - 80 days culture. RT-PCR analysis showing total hTERT
expression levels in GRN hTERT-immortalized sheep fibroblasts. Total hTERT
expression levels are comparable across all the GRN25 clones, but slightly higher in
the GRN23-C4 mock control. GAPDH internal controls and no reverse transcriptase
controls are shown. PCR was conducted at 30 cycles.
This observation suggests that the mutant hTERT transgene may be silenced by this
stage in a proportion of cells within each population, but that mutant hTERT
expression persists in another subset(s) of cells within the same population. Of note
is the level of hTERT expression in the GRN23 mock controls relative to the GRN25
lines. GRN23-C1 shows comparable hTERT expression to the GRN25 lines, whereas
GRN23-C4 shows a slightly higher level. This difference may be accounted for by
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differences in cDNA loading as GAPDH levels appear higher in the mock controls.
Therefore total hTERT levels may in fact be comparable across all lines. As the
mock controls express wild-type hTERT alone, the comparable hTERT levels across
the GRN25 lines, may thus reflect wild-type hTERT levels, suggesting that mutant
hTERT may have been already lost by this stage of the culture period. To better
illustrate hTERT transgene silencing, semi-quantitative analysis was conducted by
calculating densitometry of normalized hTERT expression bands. Analysis from day
80 and day 100 of the culture period were compared to the initial expression levels at
day 0 (section 3.2.1.2), prior to the start of long-term culture. Densitometric analysis
illustrates complete hTERT silencing by day 100. At day 80 most lines show a clear
reduction in hTERT expression most probably due to silencing in a subset of cells.
Unexpectedly, wild-type hTERT expression in the mock controls appears to increase
at the day 80 stage, prior to complete silencing by day 100 (Fig. 4.3).
^ 160.00
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GRN25-1 GRN25-5 GRN25-6 GRM25-7 GRN25-9 GRN25-10 GRN23-C1 GRN23-C4
Figure 4.3: Semi-quantitative analysis of hTERT expression. At day 0, the vast
majority of hTERT expression is due to mutant hTERT in the GRN25 clones. By day
80, mutant hTERT transgene silencing is evident in a proportion of cells in each line.
By day 100 complete transgene silencing ofmutant hTERT is evident in all GRN25
clones. Wild-type hTERT expression appears to increase by day 80 in the GRN23
mock controls prior to complete silencing in day 100.
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4.2.2 Selection regime for mutant hTERT transcript
To infer whether the mutant hTERT transcript was completely absent, representative
GRN clones at late passage were placed under a neomycin selection regime (as
described in section 2.8.3), set at the initial concentration (400pg/ml) at which these
clones were selected post-transfection. The presumption here states that the if the
neomycin selection cassette is silent/absent, then due to the close proximity of the
mutant hTERT transgene, it too will be silenced/absent. No cell death was evident
until cells were passaged 48 hours after applying Geneticin selection. By -day 6 of
the selection regime, all lines exhibited widespread cell death with no cells surviving
by -day 14 in the GRN25-1 line and the GRN 1-1 and GRN23-C1 controls (Fig.
4.4a). GRN1-1 serves as a negative control for the selection regime as this line has
no neomycin transgene. A minority of cells survived selection in the GRN25-6 and
GRN25-7 lines and this selected subset repopulated the population, with confluency
reached by -day 13 (Fig. 4.4b).
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Figure 4.4: GRN culture under neomycin selection. Late passage hTERT-
immortalized GRN clones were cultured under a 400pg/ml neomycin selection
regime for ~2 weeks. No cells survived neomycin selection by day 14 in the GRN25-
1 line and GRN1-1 and GRN23-C1 controls (Top panel). After an initial period of
gross cell death in the GRN25-6 and GRN25-7 lines, a subset of cells were selected
for and repopulated the population to confluence by -day 13 (Bottom panel). Scale
bar represents 500pM.
This observation suggests that the neomycin cassette has been silenced during long-
term culture, with cells where this phenomenon has occurred being selected for. The
obvious inference is that mutant hTERT and EGFP transgenes have therefore also
been silenced in the GRN25-1 and GRN23-C1 clones respectively. This suggests that
in GRN25-1 cells in which silencing of the neomycin (and hence mutant hTERT)
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transgene has occurred, this has thus resulted in a growth advantage in that particular
subset of cells. The resistance in a minority of cells within the GRN25-6 and
GRN25-7 populations, indicate that a subset of cells expressed sufficient levels of
neomycin to confer resistance and most probably low levels ofmutant hTERT.
RT-PCR analysis was conducted on the neomycin-selected GRN25-6 and GRN25-7
lines and compared to an earlier stage where mutant hTERT silencing was evident, to
determine ifmutant hTERT had been selected for. RNA expression of hTERT shows
a slight increase in mutant hTERT transcript in the neomycin-selected lines (Fig.
4.5). The neomycin cassette was only detected in the GRN25-6 line at this stage,
indicating that only trace neomycin is sufficient to confer the resistance in GRN25-7
as no transcript was detected in the GRN25-7 line.
sGAPDH
Figure 4.5: Total hTERT RNA expression analysis on neomycin-selected lines.
Total hTERT levels are slightly higher in the neomycin-selected lines compared to
an earlier passage where no transcript is evident. The GRN25-7 line at the beginning
of the extensive culture period is shown as a positive control.
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4.2.3 Monitoring of EGFP expression in mock-transfected clones
The GRN23 EGFP mock-transfected controls were monitored for EGFP expression
under UV light. The GRN23-C1 control line, exhibited no EGFP expression after the
extended culture period. This line was shown previously to exhibit EGFP expression
prior to long-term culture (Fig. 4.6b). In contrast, the GRN23-C4 control line,
exhibited a mosaic pattern of EGFP expression, ranging from high levels in some
cells, to complete absence in others (Fig. 4.6a). However, silencing of the EGFP
transgene in the GRN23-C1 line is not expected to have conferred a growth
advantage upon those cells as such, as EGFP is expected to exert a negligible effect
on cellular viability and proliferation. Rather it is likely that silencing has occurred in
all cells within the population. The EGFP cassette is still present in the GRN23-C4
line, although expression is mosaic. Excluding variation in these lines due to a
stochastic manner, the key variable is the site of integration of the EGFP and
neomycin-resistant transgenic loci. This observation, taken together with those of
section 4.2.2, is consistent with the notion that the GRN lines are heterogeneous in
nature, rather than homogenous/truly clonal.
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Figure 4.6: EGFP expression in GRN23 mock-transfected clones after extensive
culture period. (A) EGFP expression is completely absent in the GRN23-C1 clone
at this stage, whereas a mosaic pattern of EGFP expression is present in the GRN23-
C4 clone, ranging from high expression to no expression in subsets of cells within
the population. The GRN25-5 line at a similar stage of the culture period is shown as
a negative control. Scale bar represents 500pM. (B) EGFP expression evident in the
GRN23-C1 clone prior to the extensive culture period. (EGFP image for (B) taken by
Ling Mo).
4.2.4 Selection regime for wild-type hTERT transcript
As a puromycin-resistant cassette was present in the transgenic loci containing wild-
type hTERT, a puromycin selection regime using the same concentration used to
initially select for the hTERT-immortalized GRN1-1 clone (0.75pg/ml), was used to
determine indirectly if the wild-type hTERT transcript was still present after long-
term culture. By day 5, no cells survived this regime in any of the representative lines
analyzed, indicating that the puromycin cassette and through inference, the wild-type
hTERT transcript, had been silenced in a subset(s) of cells (Fig. 4.7).
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Figure 4.7: GRN culture under puromycin selection. Late passage hTERT-
immortalized GRN clones were cultured under a 0.75pg/ml puromycin selection
regime. No cells survived the selection regime after a period of 5 days. Scale bar
represents 500pM.
Although wild-type hTERT is lost through serial culturing by this stage, the GRN
lines still maintain a consistent proliferation profile and thus maintain a senescence
bypass status. Furthermore, telomerase is active and telomeres are stabilized and
maintained at this stage. This would not be expected if hTERT was not expressed
and telomerase did not function to maintain telomeres, at least at the subset of the
shortest telomeric substrates, unless endogenous sheep TERT is activated. This data
indirectly implicates endogenous sheep TERT as being activated and functioning as a
pro-survival factor, acting at the telomere termini to maintain telomere length and to
keep senescence checkpoint pathways at check.
4.2.5 TRAP analysis after long-term culture
To investigate whether telomerase activity altered during this period of extensive
culture, TRAP analysis was conducted on the GRN clones at late-passage using the
same concentration of protein lysate (0.1pg/pl) used for the initial TRAP analyses
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prior to the culture period. This ensures a direct comparison of TRAP activity at the
different stages of analysis.
TRAP analysis at -day 100 shows that telomerase activity has considerably
increased by this stage. This is indicated by the loss of the 36-bp internal standard in
the reaction due to primer competition; i.e. high levels of telomerase results in a
telomeric substrate product that utilizes, most if not all, of the forward primer (Fig.
4.8a). Of note is the high level of telomerase activity detected in lines GRN25-6 and
GRN25-7, previously shown to be effected by a dominant-negative/competitive
inhibition interaction. This is consistent with the data indicating silencing of the
mutant hTERT transgene. However as the previous data also indicated that the wild-
type hTERT transgene has been silenced, telomerase activity would not be expected
in this context, at least not telomerase activity due to hTERT. This result therefore
indirectly supports the notion that endogenous sheep TERT is activated in the GRN
lines by this stage, and is therefore the source of TRAP activity in the assay. (NB:
Due to the conservation of the telomeric repeat sequence in mammalia, TERT from
any mammal would be expected to elongate the telomeric substrate used for TRAP
assay).
However, to confirm that telomerase activity had indeed increased after the period of
long-term culture, a systemic TRAP assay was conducted by preparing protein lysate
and measuring concentration of samples systemically from both the early and late
stage. On the basis of this analysis it is difficult to state whether telomerase activity
has increased at the later stage, as telomerase activity and the internal standard are
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comparable across the lines. The analysis confirms the alleviation of telomerase
inhibition conferred by mutant hTERT in the GRN25-6 and GRN25-7 lines (Fig.
4.8b). Taken together, TRAP analysis demonstrates that telomerase activity is high in
all GRN lines after ~ 100 days in culture, suggesting that the source of this activity
may be the endogenous TERT protein, rather than the hTERT transgenic protein.
<25).9 (25).10 (2J).C1 (fJ).C4
Early Passage Late Passage
— — i« ^5
Cell Line § S | S g 3 j § § §
«««»££ i t 2
COOUUU 13 O SJ 45
r. 1
o -r










Figure 4.8: TRAP assay on GRN lines after period of extensive culture. (A)
TRAP analysis on GRN lines at -day 100 of the extensive culture period and using
O.lpg/pl. Telomerase activity is high and comparable in all lines, adjudged by the
TRAP product ladder and the loss of the 36-bp internal standard. Heat inactivated
controls are shown. (B) Systemic TRAP analysis. Protein measurement and TRAP
analysis was conducted in a systemic fashion using lysate from an early stage of
culture and after -100 days. Telomerase activity is comparable in all GRN lines at
late passage and this activity level is similar to the majority of lines at the early stage.
Release of telomerase inhibition in the GRN25-6 and GRN25-7 lines is evident.
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The lack of the sheep TERT sequence hampers any study attempting to identify its
activation and subsequent biological role. The data presented here indirectly
implicates endogenous sheep TERT as being activated after a sustained period of
culture.
4.3 Discussion
The heterogenic nature of the hTERT-immortalized lines (GRN) used for this study
was presented in Chapter 3, with particular regard to the GRN25-7 line which
exhibited the highest levels of mutant hTERT at the particular molecular snapshot
analyzed. The obvious implication was that mutant hTERT compromised active
hTERT in this line through competitive binding to the wild-type hTERT or the
telomere substrate. This would then have lead to an adverse affect on cellular
proliferation as observed with a subset of cells within the population entering a
senescence-induced growth arrest. However the majority of cells within the
population maintained a normal fibroblastic morphology and maintained an
uncompromised growth rate, thus eventually being selected for due to the growth
advantage conferred. This led to speculation as to whether heterogeneity evident in
GRN25-7 is initially directly attributable to the effects ofmutant hTERT expression,
followed by selection upon serial passage as a consequence of long-term culture, in
excess of lOOPDs.
Initially, total hTERT transgene expression was monitored, with the null hypothesis
stating that hTERT transgene expression will be comparable to levels evident prior to
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the extended culture period. Strikingly by day -100, almost no hTERT message is
evident in any of the GRN lines, including mock controls. Expression analysis at
-day 80 showed comparable levels of hTERT expression across all lines, although
this was much lower than levels detected in the five lines adjudged to express
medium to high mutant hTERT expression prior to the extensive culture period
(section 3.2.1). This hints at the heterogeneous nature of these lines, whereby mutant
hTERT may have been silenced in a subset of cells within a population, a subset unto
which a growth advantage is conferred thereafter. Mutant hTERT expression may
then still be evident by day -80 as a subset of cells within the population still retains
mutant hTERT expression; however, by day -100, it appears the subset with
'silenced' mutant hTERT has overwhelmed the population. That the mutant hTERT
transgene was indeed silenced, was indirectly confirmed by culturing GRN cells at
this late stage under a neomycin selection regime, as the mutant hTERT cDNA will
be in close proximity to the neomycin resistant cassette upon integration. Only cells
from the GRN25-6 and GRN25-7 populations survived this regime - nevertheless
only a very sparse subset of cells survived selection and eventually repopulated the
population. Therefore even in these lines, it appears the mutant hTERT transgene is
silenced in the majority of cells. The subset conferring neomycin resistance may
truly reflect a subset of cells where mutant hTERT is still active, although the caveat
of only a few neomycin molecules conferring resistance to Geneticin, must be
considered.
Surprisingly, when the mock controls were monitored at this stage for expression of
the EGFP transgene, one clone showed a mosaic pattern of expression (GRN23-C4)
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whilst the other clone showed complete abrogation of expression (GRN23-C1). This
indicates complete silencing of the transgene in GRN23-C1 as high EGFP expression
was evident prior to the extensive culture period. This silencing phenomenon appears
to be an inherent consequence of serial passaging during an extensive period, as
EGFP expression per se would not be expected to have any compromising effects on
cellular growth and viability, regardless of whether expression was heterogeneous
within a given population. Therefore this implicates that although mutant hTERT
may have adverse affects on cellular growth, this is confounded by the possibility
that transgene silencing may have occurred in these lines purely as a result of culture
and selection bias as a result. If this were the case then the wild-type hTERT
transgene would also be expected to be silenced in the GRN lines. When grown
under a puromycin selection regime to infer presence of wild-type hTERT, no cells
from any representative line survived. Thus wild-type hTERT is also silenced in
these lines. However, senescence bypass has been shown to be uncompromised in
these lines during this stage (section 3.2.4), raising the question of whether the
endogenous sheep TERT is activated and functioning to check senescence pathways
and maintain telomere length in the subset of shortest telomeres. Indirect evidence
for this is presented through TRAP analysis after the extensive culture period;
telomerase activity is high and comparable across all the GRN lines, with restoration
of telomerase activity in GRN25-6 and GRN25-7 after the initial period of
telomerase inhibition. If the wild-type hTERT transgene were indeed silenced in
these lines, telomerase activity would be expected to be absent. Therefore activation
of endogenous sheep TERT is implicated here, as the sheep telomerase complex
would be expected to elongate the telomeric substrate used in the TRAP assay. Any
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study attempting to address this issue is hampered by the lack of the sheep TERT
coding sequence.
In light of evidence presented here that demonstrates silencing of the hTERT
transgenes, results discussed in chapter 3 may be viewed within this context. In
particular, telomerase inhibition in GRN25-1 at the earliest stage TRAP (section
3.2.3), followed by restoration of activity to levels similar to mock controls after ~6
PDs, may be explained due to transgene silencing. It is likely that mutant hTERT
expression levels were sufficiently high (most likely comparable to levels in GRN25-
6 and GRN25-7) so as to exert a dominant-negative/competitive inhibition effect at
the early stage. However due to silencing ofmutant hTERT in a subset of cells (or at
least reduced expression levels), these cells were endowed with a growth advantage
within the population. This may then explain the restoration of telomerase activity
due to uncompromised function ofwild-type hTERT, albeit after only ~6 PDs.
This study highlights the precarious nature of a sustained period of in vitro culture
using transgenic lines and underlines the importance of maintaining stringent
selection throughout the extensive culture period as well as frequent monitoring of
whether transgene expression is persistent.
148
Chapter 5 - O-FISH analysis: Descriptive study of telomere heterogeneity
CHAPTER 5
QUANTITATIVE-FISH (Q-FISH) ANALYSIS
TO DETERMINE TELOMERE LENGTH
HETEROGENEITY IN NORMAL OVINE
FIBROBLASTS
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5.1 Introduction
Telomere length regulation is controlled by a complex homeostatic mechanism that
invokes both extrinsic factors such as telomerase and other telomere-associated
factors, but also key intrinsic manifestations based on telomeric configuration
structure and telomere length heterogeneity. Classical telomere length measurement
has relied on a calculation of average telomere length based upon telomere restriction
fragments (see section 2.2.16). Such analysis reflects the span of telomere lengths
from a population as a whole; however our current understanding of telomere
dynamics reveals a considerable degree of telomere length heterogeneity within any
given karyotype, which importantly is of functional significance (see section 1.6.1).
To address this technical issue, Peter Lansdorp and co-workers refined the
fluorescence in situ hybridization (FISH) technique and established a method to
robustly quantify individual telomere lengths on chromosome arms, providing a
powerful tool to resolve telomere length at the individual chromosomal level
(Lansdorp 1996). The method utilizes a fluorescence-tagged telomere repeat probe
that is administered to metaphase spreads and fluorescence units from individual
telomeres measured by dedicated software.
A descriptive study conducted in our laboratory previously reported considerable
differences in proliferative lifespan of two normal sheep fibroblast lines -BWF1 and
BW6F2- (Clark et ah, 2003). Both these foetal fibroblast lines were independently
isolated from the same genetic breed, Black Welsh (sheep breeds are essentially
outbred and exhibit less than 1% co-ancestry within a breed). Both derived lines
exhibited similar mean telomere restriction fragment lengths after isolation (BWF1,
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18kb; BW6F2, 20kb) and at replicative senescence (BWF1, llkb; BW6F2, llkb).
Intriguingly proliferative lifespan differed 3-fold between these two lines, with
BW6F2 entering replicative senescence at ~112PD, whereas senescence in BWF1
was reached after ~34PD. This is directly correlated to the average telomere
shortening rate in these lines, with BWF1 exhibiting an average shortening rate of
301bp/PD, whereas BW6F2 exhibited a shortening rate of 91bp/PD (Clark et ah,
2003). What are the intrinsic factors that account for such a significant difference in
average telomere shortening rate? Is this causal or consequential of proliferative
lifespan? These issues are difficult to address mechanistically at present, reflected by
the lack of reports documenting intrinsic or extrinsic determinants of telomere
shortening rate. However with advances in the methods to quantitatively measure
individual telomere lengths, descriptive studies may be undertaken to help begin to
understand this process further. The key limitation of the previous study in our
laboratory was that true telomere length heterogeneity was not accounted for and
therefore only average shortening rate had been calculated. It is likely that average
telomere shortening rate only indirectly indicates the functional consequence of
telomere attrition. For example, telomere shortening rate within only a subset of
telomeres may be directly correlated to the onset of replicative senescence rather
than average telomere length in the karyotype per se. Therefore it was of interest to
optimize Q-FISH methodology in the sheep system to attain a description of
telomere shortening in the Black Welsh fibroblasts that takes into account true
telomere heterogeneity and to calculate telomere shortening rate on this basis.
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5.2.1 Hypothesis
1) Telomere shortening rates differ considerably between the BWF1 and BW6F2
lines; within each line telomere shortening rates are constant throughout (null
hypothesis).
2) A subset of telomeres in both the BWF1 and BW6F2 lines exhibit a
significantly faster telomere shortening rate than all other telomeres, but there are a
greater proportion of telomeres representing this category ('short' telomeres) in the
BWF1 line compared to the BW6F2. Thus it follows, that entry into replicative
senescence is earlier in the BWF1 line due to the rapid shortening of telomeres
within this subset
5.2.2 Chapter aims
1) To present the first demonstration ofQ-FISFI methodology in ovine cells
2) To provide descriptive analysis of telomere length heterogeneity within two
primary ovine fibroblast lines derived from the same genetic background.
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5.2 Results
5.2.1 Fluorescence In-Situ Hybridization (FISH)
FISH was conducted on metaphase spreads as described in section 2.10 and
constitutes a key rate-determining step regarding Q-FISH analysis. Sheep
chromosomes by their very nature are not as compact/condensed as mouse and
human chromosomes and appear somewhat denatured in their appearance. Telomere-
FISH can only serve to approximately judge individual telomere lengths by
estimating the brightness of signals, for example a long telomere length showing
brighter signal than a short one. It is evident that telomere FISH clearly shows
telomere shortening in the BW6F2 and BWF1 sheep fibroblasts during in vitro
culture from early through to late, pre-senescent passage (Fig. 5.1a and b).
Fluorescent intensity is high and comparable between the lines at the early passage
stage as expected. However, telomere FISH signals in BWF1 became invisible by
passage 18 (PD29). In contrast, the signals in BW6F2 were still detectable until
passage 37 (PD103). Therefore, the differences in telomere shortening rate become
evident between the two lines. This is consistent with the results reported previously
documenting differing proliferative capacities regarding these two lines (Clark et al.,
2003).
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Figure 5.1: Telomere Fluorescence In-Situ Hybridization on metaphase spreads
from BW6F2 and BWF1 ovine fibroblasts. Telomeric fluorescent signals
progressively diminish in both the BW6F2 and BWF1 lines during culture, with the
earliest passage generating the strongest telomere fluorescent signal. However,
telomere length below the minimum length required to generate a signal under the
conditions for image capture used here is reached by passage 37 (PD103) in BW6F2
(A), whereas a similar minimal telomere length is reached by passage 18 (PD29) in
BWF1 (B), thus reflecting the intrinsic difference in telomere shortening rate
between the two lines.
Observation ofmetaphase also provided scope to determine if the Black Welsh lines
displayed a normal karyotype throughout culture. Sheep have 26 autosomes and two
sex chromosomes (diploid chromosome number of 54), including six distinct large
metrocentric chromosomes. Diploid chromosome number was -54 (give or take 1-2
chromosomes that can be attributed to the preparation of the spread) in each
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metaphase analyzed and neither variation in metrocentric chromosome number nor
obvious abnormal chromosomes (such as dicentric), were evident within any
metaphase. Therefore there are no gross abnormal chromosomal changes evident
within the BW6F2 and BWF1 lines to confound analysis.
5.2.2 Metaphase manipulation using TFL-TELO software
It is difficult to distinguish between subtle differences in telomere length and more
accurately quantify them with FISH alone. To allow for an accurate comparison on
telomere length within each line and between lines, dedicated software called TFL-
TELO Q-FISH, was applied. However, due to the rather 'puffy' denatured
morphology of sheep chromosomes, Q-FISH software currently available cannot
distinguish individual chromosomes from one another and therefore, upon the
superimposing ofDAPI stained chromosomes and Cy3-conjugated telomeres, cannot
assign numerical values to fluorescent-tagged telomere repeat sequences (Fig. 5.2a).
This problem can be overcome by 'drawing' around the edges of each chromosome
using an appropriate drawing tool in Photoshop. This allows each chromosome edge
to be defined, enabling the software to recognize individual chromosomes within
each metaphase spread (Fig. 5.1b). It is difficult practically to obtain fluorescent
values for every telomere end, particularly the very weak signals, but using this
modified approach, it is possible to record values for the vast majority of ends.
Therefore, if a sufficient number of chromosomes from a number of metaphase
spreads are counted, then Q-FISH analysis using this approach can be valid. Thus, it
is possible to quantitatively analyze telomere-FISH fluorescent signal intensities
using ovine metaphase spreads.
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Figure 5.2: Manipulation of ovine metaphase spreads. Due to the denatured
morphology, characteristic of sheep chromosomes (A, left), current Q-FISH software
cannot distinguish between individual chromosomes (B, left). Therefore each
chromosome image must be defined using an appropriate drawing tool, (A, right,
indicated by arrows). Q-FISH software can then be used to analyze the manipulated
metaphase spread and calculate telomere length based on arbitrary fluorescence units
(B, right). Chromosome number assignment denoted is also arbitrary. Coloured
circles represent individual telomeres on each chromosomal arm; fluorescent signal
intensities (proportional to telomere length) that are above the minimum detection
level, are categorized into five subgroups (high to low) and assigned one of five
different coloured circles.
5.2.3 Quantitative-FISH analysis
Approximately 8-10 metaphase spreads were analyzed for every cell line/passage
studied. The latest passage for both the BWF1 and BW6F2 cell line, provided the
fewest high quality spreads suitable for Q-FISH analysis, owing to the low signal
intensities due to very short telomeres at this stage. The number of chromosomes
counted for each line analyzed is shown in Table 5.1. As the number of quality
metaphase spreads with sufficient signal intensities was low for the BW6F2 p37 line,
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only 95 chromosomes could be counted. Therefore this line will be excluded for the
overall Q-FISH profile analysis (see Appendix 3 for profile that includes this line).
Cell line Number of chromosomes counted
BW6F2 P4 (PD8) 329
BW6F2 P7 (PD15) 323
BW6F2P20 (PD52) 321
BW6F2P37 (PD 103) 95
BWF1 P5(PD4) 380
BWF1 P13 (PD 19) 337
BWF1 P18 (PD29) 286
Table 5.1: Number of chromosomes analyzed by Q-FISH for each cell line.
Due to the quality of sheep metaphase spreads, a number of telomere end signals are
not detected due to overlapping arms, therefore accounting for all signal free ends
(SFE) would result in an overestimation as many of these telomeres would be
expected to have signal intensities detected by the Q-FISH software. Therefore the
category of SFE will be excluded for the general descriptive analysis of the Q-FISH
profile, (see Appendix 4 for profiles including the SFE category). Furthermore,
rather than directly plot crude signal intensities, a better representation will be
deployed here, one which plots the percentage of telomere ends per category.
Category here refers to the Telomere Fluorescence Units (TFU) that is arbitrarily
assigned by the software, which is directly proportional to telomere length. (The
absolute values ofTFU recorded, are presented in the Appendix 2 section).
The general pattern of telomere shortening as determined by the Q-FISH method is
comparable between the two Black Welsh lines (Fig. 5.3). However the specific
profiles differ in a manner that may be interpreted to give a descriptive account of the
rate of shortening and the percentage of telomere ends at particular lengths at each
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molecular snapshot. At the early stage of analysis, BW6F2 (p4; PD8) (Fig. 5.3a and
c) shows a wider and hence more heterogeneous distribution than BWF1 (p5; PD4)
(Fig. 5.3b and d). BWF1 has a higher percentage of telomere ends at the low
intensity categories than BW6F2. This pattern persists as cells from these lines
proliferate, with BW6F2 maintaining a more heterogeneous distribution of telomere
length than BWF1. This analysis also shows that telomere shortening rate is more
pronounced at an early stage in BW6F2 as shortening rate between p4 (PD8) and p7
(PD15) was more dramatic than the rate between p7 (PD15) to p20 (PD52).
Although telomere length profiles are similar between these two stages, results are
confounded somewhat by the lack of 'true' SFE data. Nevertheless, using SFE data
generated from this analysis, BW6F2 p20 shows a much greater degree of telomere
ends at the <50 TFU category, approximately 2-fold higher (see Appendix 3). This is
suggestive of a subset of telomeres shortening at a faster rate than the rest of the
telomeres in a given cell at this stage. Conversely, the data suggests that telomere
shortening rate in BWF1 is more homogenous, which is reflected by only a slight
increase in the proportion of SFE detected at each stage (see Appendix 4).
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Figure 5.3: Q-FISH profiles of Black Welsh sheep fibroblasts. Histograms and
line graphs showing percentage of telomere ends per category, with category
reflecting arbitrary telomere fluorescence units as measured by the Telo-TFL Q-
FISH quantitative software. A more heterogeneous telomere length profile is evident
in BW6F2 (A and C), compared to a relatively more homogenous distribution in the
BWF1 line (B and D). A greater proportion of telomeres correspond to low telomere
fluorescent unit categories in BWF1 throughout the culture period.
5.2.4 Gated Q-FISH analysis
To better present telomere length determined by Q-FISH analysis, categories were
gated to show percentage of telomere ends per gated category (Table 5.2). This
approach shows clearly that BWF1 has a greater percentage of telomere ends of the
shortest telomere length category (category 50-200) and conversely a much lower
percentage of telomere ends of the longest telomere length categories (category 450-
600 and 650-900). Interestingly, both the BWF1 and BW6F2 lines show a
comparable percentage of telomere ends representing the 250-400 TFU categories, a
category that reflects the highest proportion of telomere ends at the early passage.
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50 1.3 4.4 26.0
100 4.6 12.5 13.7 34.9
150 7.4 11.7 12.7 21.3 !
200 10.4 9.6 12.4 10.1 |
250 12.7 10.4 13.2 4.7
300 12.1 9.6 9.5 1.2
350 112 7.8 8.0 0.6
400 11.3 7.3 7.1 0.6
450 8.0 6.6 5.3 0.0
500 6.5 5.3 4.5 0.6
550 5.0 3.7 3.1 0.0
600 2.9 2.3 1.5 0.0
650 2.3 3.1 1.8 0.0
700 1.4 1.8 1.3 0.0
750 0.9 1.4 0.6 0.0
800 0.7 0.7 0.6 0.0
850 0.4 I.I 0.2 0.0
900 0.7 0.6 0.0 0.0
% Telomere Ends per category
Gate I (Category 50-200)
Gate 2 (Category 250-400)
Gate 3 (Category 450-600)
Gate 4 (Category 650-000)
B
50 6.7 5.6 III
100 15.9 14.6 22.8
150 18.7 16.1 21.4
200 14.5 16.5 19.8
250 12.3 13.7 11.9
300 9.6 9.9 6.9
350 5.3 9.1 3.4
400 4.4 5.9 1.8
450 3.4 3.8 0.6
500 2.3 2.7 0.2
550 1.9 1.0 0.0
600 1.6 0.5 0.0
650 1.3 0.3 0.0
700 0.8 0.1 0.0
750 0.5 0.0 0.0
800 0.1 0.0 0.0
850 0.1 0.0 0.0
900 0.4 0.0 0.0
% Telomere Ends per category
Gate I (Category 50-200)
Gate 2 (Category 250-400)
Gate 3 (Category 450-600)
Gate 4 (Category 650-900)
Ciltegui r Cafc-guiy CalegoM Category CZHOTH
50*200 250-400 450-600 650-000 50-400)
BW6F2 p4 23./ 47.3 22.4 | 6.4 71.0 [ 28.8
BW6F2 p7 38.2 35.1 17.0 8.7 73.3 j 26.6
BW6F2p20 42.8 37.8 14.4 | 4.5 80.6 | !M
BW6F2p37 92.3 L 7.1 0.6 1 0.0 1 99.4 0.6
mm
BWFIp5 41.3 46.1 9.2 3.2 87.4 12.4 ]
BWFlpl3 52.8 38.6 8.0 0.4 91.4 8.4 1
BWFIpIS 75.1 24.0 0.8 0.0 I 99.1 0.8
% Telomere Ends per gated category
% Telomere Ends per gated category
Table 5.2: Percentage of telomere ends per gated category. BW6F2 exhibits a
greater proportion of telomere ends at the 450-600 and 650-900 TFU categories.
Conversely, BWF1 exhibits a greater proportion of telomere ends at the 50-200 TFU
category throughout the culture period analyzed. Both lines have a comparable
proportion of telomere ends representing the 250-400 TFU categories.
The heterogenic dynamics of telomere shortening rate can be inferred on the basis of
this analysis. Whereas a comparable proportion of telomeres at early passage
(BW6F2 p4, 47%; BWF1 p5, 46%) are of lengths calculated as 250-400 TFU,
telomere shortening is more pronounced in a subset of telomeres in BWF1 and
BW6F2. This accounts for telomeres that correspond to 50-200 TFU even at this
early passage. But crucially, there is approximately twice the percentage of telomere
ends at this 'short' telomere category in BWF1 (-41%) compared to BW6F2
(-24%). This suggests that although both lines consist of a subset of telomeres within
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the population that have a more pronounced telomere shortening rate relative to the
rest of the population, the proportion of telomeres exhibiting such a rate is
substantially higher in BWF1 compared to BW6F2.
The initial descriptive gated categories reveal a subset of telomeres within the BWF1
line that exhibited more pronounced telomere shortening If only two TFU categories
are regarded, representing simply 'long' and 'short' telomeres (category 50-400 TFU
and category 450-900 TFU respectively), the comparative distribution of telomere
length heterogeneity can be more readily appreciated. (NB: This categorization is
simply the two categories either side of the median TFU calculated for these lines.)
Although 'long' and 'short' telomeres are a subjective measure in this context, the
relative distribution is what matters. This analysis shows that at an early stage,
similar for both lines (BWF1 p5; BW6F2 p4), -87% of telomeric ends are 'short'
within the BWF1 line, whereas -71% of telomeric ends fall within this category for
BW6F2. This conversely results in more than twice the number of 'long' telomere
ends within the BW6F2 (-29%) line compared to BWF1 (-13%). This pattern
persists throughout the proliferative lifespan of these lines, with -99% of telomeric
ends exhibiting 'short' telomeres in the BWF1 pi 8 line, whereas -81% of telomeres
are 'short' in the BW6F2 p20 line (Table. 5.3).
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Category 50-400 TFU Category 450 900 TFU
BWFlpS 87.4% 12.6%
BWFlpl3 91.4% 8.6%
BWF p 18 99.1% 0.9%
BW6F2 p 4 71.0% 29.0%
EW6F2 p7 73.3% 26.7%
BW6F2 p20 80 6% 19 4%
Table 5.3: Percentage of telomere ends within gated categories representing
'short' and 'long' telomeres. A greater proportion of telomere ends represent the
'short' telomere category in the BWF1 line compared to BW6F2 at the initial stage
of analysis. This pattern of distribution persists throughout the culture period
analyzed.
To confirm that the differences in telomere length within passages of each line and
between the two lines are significant, a Chi Squared test (see section 2.11) was
conducted on the values representing the percentage of telomere ends per TFU
category. For the telomere length distribution within the BWF1 line, a Chi Squared
value of 20.1 was calculated using 6 degrees of freedom. This reflects a p value of
less than or equal to 0.01 (99% confidence level), hence the telomere lengths are
significantly different. Similarly for the BW6F2 line, a Chi Squared value of 54.5
was obtained (p value less than or equal to 0.001; 99.9% confidence level). When
comparing telomere lengths between the two lines, a Chi Squared value of 65.1 was
obtained ((p value less than or equal to 0.001; 99.9% confidence level). Therefore
telomere lengths within each line measured from early to pre-senescent passage, are
significantly different, as is telomere length distribution between the two lines.
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5.2.5 Calculation of telomere shortening rate
To accurately determine telomere shortening rate, absolute TFU and population
doublings incurred has to be considered. This allows for a calculation of overall
mean telomere shortening rate (Total TFU/PD) as well as shortening rate between
each particular stage of analysis (e.g. early to middle passage). It must be stated that
calculation of telomere shortening rate deployed here, excludes the category of SFE
due to the limitations previously noted. Due to the low sample size of the BW6F2
p37 pre-senescent passage, that line will be omitted from this calculation. Regardless
of these limitations, calculation of telomere shortening rate based on a quantitative
assessment of telomere signals, can further our understanding of intrinsic telomere
dynamics when comparing the BW6F2 and BWF1 lines. An objective description of
telomere shortening rate, regarding individual telomere ends is a more robust method
of analysis than a rather subjective calculation of mean telomere length within a
population across particular snapshots in time. To determine mean TFU for each
passage based on the Q-FISH output, the total number of telomere ends (frequency
of events) for each TFU value (category) was calculated to give the weighted
frequencies for each telomere end. The sum of weighted frequencies divided by the
sum of frequencies gave the mean TFU for each passage. The total PDs were taken
from a previous report from our laboratory (Clark 2003).
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PD)
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TFU = Arbitrary Telomere Fluorescence Units
NB: Data excludes SFE category and also omits the BW6F2 p37 line (low sample size)
Mean shortening rate BWF1 3.3
= - 2.5-fold difference
Mean shortening rate BW6F2 1.3
Table 5.4: Calculation of mean telomere shortening rate based upon TFU.
Mean telomere shortening rate based upon TFU shortening, is approximately 2.5-
fold greater in the BWF1 line. However, there is a wide distribution of telomere
shortening rate from the overall mean shortening rate, when different stages of the
culture period are considered. BWF1 incurs a shortening rate of 1.3TFU/PD between
p5 and pi3 and increases dramatically to 6.3TFU/PD between pi3 and pi 8.
Conversely, mean shortening rate for BW6F2 is 2.9TFU/PD between p4 and p7 and
slows to 1.1TFU/PD between p7 and p20.
The analysis shows that telomere length, based upon mean TFU, is substantially
higher in the BW6F2 line; e.g.- mean TFU is 351 for BW6F2 p4, whereas mean TFU
is 255 for BWF1 p5 (Table 5.4). Total telomere shortening (TFU shortening or more
accurately, signal decrease of telomere fluorescence units) is greater in BWF1 than
BW6F2 (TFU shortening of 82 and 59 respectively) over the culture period analyzed
(Table 5.4). Taking into account the PDs accumulated within each line, telomere
shortening rate based upon TFU shortening rate can be calculated between each stage
(early, middle and late passage). The result shows that the two Black Welsh lines
differ not only regarding overall telomere shortening rate, but also at which stage
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telomere shortening rate is more pronounced or less pronounced relatively. BWF1
incurs a mean telomere shortening rate of 3.3 TFU/PD, whereas BW6F2 incurs 1.3
TFU/PD (Table 5.4). This amounts to a ~2.5fold difference in overall mean telomere
shortening rate. This is close to the ~3-fold difference in mean telomere shortening
rate reported previously, based on telomere restriction fragment length analysis
(~91bp/PD for BW6F2; ~300bp/PD for BWF1) (Clark 2003). However the mean
telomere shortening rate within these lines is not homogenous throughout the culture
period; rather shortening rate dramatically alters at different stages, depending on the
line in question. Between p5 (PD4) and pi3 (PD19), BWF1 exhibits a mean telomere
shortening rate of 1.3TFU/PD, whereas between pi3 and pi8 (PD29), mean telomere
shortening rate is substantially more pronounced - 6.3TFU/PD (Table 5.4).
Surprisingly, although there is a clear alteration in rate of telomere shortening in the
BW6F2 line, the shortening rate is more pronounced at an early stage. Between p4
(PD8) and p7 (PD15), BW6F2 exhibits a shortening rate of 2.9 TFU/PD, whereas
this rate decreases to 1.1 TFU/PD at p20 (52PD) (Table 5.4) Thus TFU calculations
based upon Q-FISH profiles, suggest heterogeneous telomere shortening rates within
the Black Welsh lines, with a more pronounced shortening rate being incurred much
later in BWF1 than BW6F2. It is interesting to observe the degree by which telomere
shortening rate alters within the BWF1 line. Telomere attrition is more pronounced
by approximately ~5-fold between the two stages analyzed, (1.3TFU/PD to 6.3
TFU/PD). Conversely, telomere attrition rate slows by ~3-fold between the two
stages analyzed within the BW6F2 line.
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5.3 Discussion
This analysis is the first demonstration of the Q-FISH technique in ovine metaphase
spreads and shows how individual telomere repeats may be quantitatively assessed.
Thus it is possible to present a highly specific description of telomere shortening
dynamics using the Q-FISH method. This study, regards alterations in overall
telomere length profiles and ofmean telomere shortening rate dynamics, taking into
account quantitative values form individual telomeres. It may be more informative to
directly monitor telomere shortening rate within individual telomere ends, but to do
so would require labeling sheep chromosomes in a manner that allows them to be
distinct from one another. This would include the ability to identify sheep
chromosomes by eye prior to overlaying images using the Q-FISH software, thus
accounting for telomere shortening in say sheep chromosome 6 during proliferative
lifespan.
There are however a number of limitations using the TFL-TELO Q-FISH software.
Firstly, sheep chromosomes cannot be treated with colcemid, which is the
conventional method for treating mouse and human cells prior to metaphase
preparation. Treatment with colcemid on sheep cells results in chromosomes
fragmenting, the reason being unclear. Instead, sheep cells are released from contact
inhibition due to 100% confluency, 24 hours prior to metaphase preparation. As
colcemid acts to inhibit spindle formation, the absence of colcemid possibly results
in many sheep cells not at the metaphase stage when cells are prepared for FISH
analysis. This reduces the number of quality spreads. Secondly, sheep chromosomes
are required to be manipulated prior to overlaying chromosome and telomere repeat
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images. And finally, the minimum threshold for the software to detect telomere
signals is set too high - this results in a read-out of SFE that do not necessarily
reflect telomeres with no signal. The subsequent problem regarding this issue is that
it is difficult to consider chromosome termini with very short telomeres, as they will
all be categorized under SFE in combination with chromosomes that genuinely have
no signal. Therefore at present, it is difficult to assess telomere lengths of the
'shortest' telomeres at replicative senescence. Nevertheless, a descriptive study of
telomere length heterogeneity, within the permissible threshold of the software, is
still informative, quantitative and gives a greater degree of resolution than TRF
analysis on an entire population.
Generally, the Q-FISH profiles when plotted as the percentage of telomere ends per
TFU category, shows BW6F2 to display a more heterogeneous profile than BWF1.
Both lines show a reasonably normal distribution of telomere lengths; i.e. - a
minority subset of telomeres with very long or very short telomeres, with the
majority of telomeres representing an intermediate length. Therefore we can infer
that average telomere length does not differ dramatically between these lines.
However, the skew of this distribution is more biased towards shorter telomeres in
BWF1, relative to BW6F2. Thus, BWF1 exhibits a Q-FISH profile that is relatively
more homogenous than BW6F2. This distribution is better represented by gating
TFU categories. Comparison of telomere ends per TFU category at the initial stage
of analysis is revealing. Both BWF1 and BW6F2 have a comparable percentage of
telomere ends at category 200-400 (46.1% and 47.3% respectively), a category that
represents a relatively intermediate telomere length in this study. However, BWF1 at
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this early stage exhibits 41.3% of telomeres in the 'shortest' TFU category (50-150
TFU), whereas only 23.7% of BW6F2 telomeric ends represent this category at a
similar stage of analysis. This is a recurring pattern at each stage analyzed - BWF1
exhibits a greater proportion of 'short' telomeres. Therefore although the proportion
of telomeres with average telomere length is inferred to be comparable, BWF1
exhibits a greater proportion of very short telomeres. This suggests rather
superficially, that although replicative senescence may be triggered at a comparable
'mean' telomere length, the telomere shortening rate in a subset of telomeres within
the BWF1 population may be a key determinant of the much earlier onset of
senescence activation in this line. This pattern is descriptive evidence of intrinsic
differences of telomere shortening rate between individual telomere ends within the
BWF1 and BW6F2 lines, thereby rendering a rejection of the null hypothesis.
Taking into consideration the previously reported PD rate for these lines (Clark
2003), a more accurate description of telomere shortening rate can be deduced. As
expected, this reveals that BWF1 exhibits a more aggravated mean telomere
shortening rate (based upon TFU shortening) relative to BW6F2. Mean telomere
shortening rate is approximately 2.5-fold more pronounced in BWF1. However, the
rate of BWF1 telomere shortening (6.3TFU/PD) is dramatically more pronounced at
a later stage of culture (pl3 to pi8) than at an early stage (1.3TFU/PD; p5 to pi3).
The pattern is reversed in BW6F2 with telomere shortening rate more pronounced at
an earlier stage (2.9TFU/PD; p4 to p7) than at a later stage (1.1TFU/PD; p7 to p20).
It is important to note that even this more pronounced telomere shortening rate in
BW6F2, is still only half the attrition rate of BWF1 at the later stage of culture.
Interestingly, if absolute TFU is taken into consideration for each line, there are more
168
Chapter 5 - O-FISH analysis: Descriptive study of telomere heterogeneity
telomeres (relatively) with a high TFU (600 TFU or more) for BW6F2 than for
BWF1, notably at the earliest stage analyzed (see Appendix 2 for absolute TFU
values). This was not shown in previous methods to analyze telomere length based
on TRF studies (Clark et ah, 2003). This may reflect a limitation in using TRF
analysis to measure telomere length compared to the quantitative approach as
provided by Q-FISH.
These results hint at the functional consequence of BWF1 exhibiting a greater
proportion of 'short' telomeres at similar stages of culture (i.e. - passage number).
There is a suggestion that aggravated telomere attrition within the BWF1 line is
directly attributable to the earlier onset of senescence and hence the reduced
proliferative lifespan evident in this line. However using a descriptive approach such
as this makes it difficult to infer a conclusion of causal or consequential
relationships. Is the more pronounced telomere shortening rate in BWF1 a key
determinant of a shorter proliferative lifespan relative to BW6F2? Or is telomere
shortening rate in this context, consequential of alternative intrinsic and extrinsic
factors that determine proliferative lifespan? Both these lines are derived from the
same breed and therefore constitute similar genetic backgrounds. This probably
accounts for the comparable average telomere lengths after derivation of the lines
and upon onset of replicative senescence. However the intrinsic differences in
telomere shortening rate may be due to more subtle differences in genetic profiles of
these lines, such as gene expression levels and timing of expression. Although the
very nature of in vitro culture systems confers various sources of stress upon cellular
populations, these lines repeatedly show this intrinsic difference in telomere
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shortening rate, implying that the cause of this difference is likely due to the inherent
genetic make-up of the lines, rather than due to a stochastic variable.
Overall, Q-FISH provides a robust, reproducible and quantitative method to analyze
individual telomere length to a high resolution. Moreover, it is likely that telomeres
that are detected as 'short', i.e.- corresponding to -50 TFU, may not have been
readily detected by the TRF assays deployed previously, and so obscured results.
Factors regulating telomere shortening rate remain one of the most elusive avenues
in telomere biology research. One of the key limitations is that analysis is usually
conducted at molecular snapshots in time rather than as a smooth temporal
continuum. It will be important to determine telomere shortening at each round of
cell division and for each telomere. Q-FISH profiles of telomere dynamics have
showed that heterogeneity is apparent within telomere ends as proliferation
progresses, therefore although average telomere shortening rate at any given point
can be informative, individual telomere shortening rates will be crucial to our
understanding of issues such as proliferative lifespan capacity and onset of
replicative senescence.
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CHAPTER 6
TELOMERE-OLIGONUCLEOTIDE
LIGATION ASSAYAND LOW OXYGEN
CULTURE IN OVINE FIBROBLASTS
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6.1 Introduction
Two main mechanisms have been postulated to restrict lifespan of primary mammalian
cells. The first suggests that cultured cells suffer from extrinsic physiologic stress and
cumulative damage that ultimately trigger senescence (von Zglinicki et ah, 2001 &
2003). The second proposes that an intrinsic counting mechanism triggers senescence
after a predetermined number of cell generations (Hayflick 1961) that may be cell-type
and species-specific. The 'telomere-length as a mitotic clock' hypothesis is based on the
latter model whereby progressive telomere shortening induces senescence once one or
more telomeres erode to a critical length (Harley et al., 1990, Zou Y. et al., 2004).
Consistent with this hypothesis, expression of telomerase, which halts telomere erosion,
prevents senescence (Bodnar et ah, 1998). Critically, some important findings are not
easily explained by the telomere length hypothesis; many normal cells enter senescence
with relatively long telomeres and there are many examples of cells that have much
shorter telomeres than those found in senescent cells, yet retain the ability to divide
(Allsopp et ah, 1995, Blackburn 2000). Thus, short telomeres per se are not
incompatible with continued cellular division. In human chromosomes, the long terminal
protrusions of single-stranded G-rich sequence have been reported to vary from 50nt to
more than 500nt (Makarov et ah, 1997, Stewart et ah, 2003). It has been suggested that
long TTAGGG single-strand protrusions, besides being an effective substrate for
telomerase, may form several non-canonical structures. Seminal work involving electron
microscope observation revealed that up to 42% of telomere ends form a large loop in a
reaction that depends on the presence of a 3'-overhang (3'-OH) on the G-rich strand and
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the telomeric double-stranded binding protein TRF2 (Van Steensel et al., 1998, Griffith
et al., 1999). The free 3'end was shown to invade the duplex telomere array at the loop
junction. This terminal structure, termed the T-loop, may explain how the extreme
termini of chromosomes are distinguished from a DNA break, preventing an appropriate
DNA damage response and avoiding G-rich strand degradation or end-to-end fusions of
chromosomes. The elucidation of the T-loop poses several key questions: how does
telomerase access the hidden chromosomal ends and what is the relationship between
telomerase expression and 3'-OH length; is the t-loop structure altered at replicative
senescence and if so, is this event a trigger of senescence or consequential? Regarding
the latter hypothesis, it has been reported in normal human fibroblasts that the 3'-OH is
eroded at replicative senescence and that this may be a molecular trigger of senescence
(Stewart et al., 2003). However others have shown, using the same cell type, that 3'-OH
is eroded only at crisis and therefore represents a consequential event to upstream
senescence activation (Chai et al., 2005).
An intriguing hypothesis was furhter postulated by Jerry Shay and Woodring Wright,
which states that telomere shortening rate is directly determined by 3'-OH length. In
this respect, telomere erosion would be predicted to be directly proportional to 3'-OH
loss after each round of cell division. The potential ability to manipulate this rate of
shortening has profound implications both for slowing the rate of replicative ageing in
normal cells and accelerating the rate of telomere loss in cancer cells in combination
with anti-telomerase therapies. Further independent studies using a variety of human cell
types and those from different mammalian species, will be required to fully understand
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the molecular alteration of the 3'-OH during culture and to determine whether telomere
shortening rate is detemined by the 3'-OH length.
The study presented here utilizes an alternative mammalian model, the sheep (Ovis
aries), to study the relationship between G-rich 3'OH length and population doubling
and also of the relationship of 3'-OH to telomere length and hTERT gene expression. As
discussed in Chapter 5, the sheep breed studied here, exhibits similar in vitro telomere
lengths after isolation of foetal fibroblast cell lines (~18kb and ~21kb), to that reported
for somatic human cells (~5-15kb) (Kipling 1990). Moreover previous experiments in
our laboratory have shown that ectopic expression of hTERT in sheep fibroblasts
reconstitutes telomerase activity, extends lifespan and maintains senescence bypass (Cui
et al., 2002). This study will use the Telomere-Oligonucleotide Ligation Assay (T-OLA)
to investigate whether the G-rich 3'-OH alters during in vitro culture of normal sheep
fibroblasts and if so, whether this is a direct correlate to telomere shortening rate. In
addition, T-OLA will be conducted on hTERT-immortalized sheep fibroblasts to
determine if there exists a relationship between 3'-OH length and hTERT gene
expression level. A possible relationship between oxidative stress response capacity and
telomere and 3'-OH shortening rate will also be addressed.
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6.1.1 Hypothesis
1) Telomere shortening rate is determined by 3'-OH length in primary sheep
fibroblasts.
2) 3'-OH length correlates to both hTERT expression level and to telomere length;
lines with high levels of hTERT expression maintain longer telomeres and longer 3 '-OH
than lines with lower levels of hTERT expression.
3) Telomere shortening rate can be slowed when sheep fibroblast lines are grown
under low oxygen (2%) conditions due to decreased oxidative stress.
6.1.2 Chapter aims
1) To provide the first demonstration of the T-OLA technique in primary ovine
cells.
2) To investigate the relationship between 3'-OH length and telomere length in
primary ovine cells. If telomere shortening rate is determined by 3'-OH
length, the BWF1 line would be predicted to have longer 3'-OH.
3) To investigate the relationship between 3'-OH length and hTERT
expression level.
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6.2 Results
6.2.1 T-OLA Optimisation
To assess the length of the telomeric overhang, the T-OLA assay was conducted as
described in section 2.2.17 (Cimino-Reale et al., 2001). Specifically, radiolabeled
oligonucleotides complementary to the telomeric overhang are annealed to genomic
DNA, ligated and then electrophoretically separated. The length of ligation products and
their signal intensity then reflect the length of overhangs in the sample. Firstly, T-OLA
conditions were optimized in our laboratory using the BJ-hTERT immortalized primary
human fibroblast line, previously reported by others. In our laboratory settings, the
optimised amount of genomic DNA used for T-OLA was lOpg rather than 5pg
previously documented. In addition, annealing temperature for hybridization of
radiolabeled oligonucleotide to telomeric overhang was set at 52°C, rather than the
previously documented 50°C. For ligation of hybridized products, 30U of Taq ligase
was required for efficient ligation, rather than the 20U documented by others. A
maximal 3'-OH signal of 324nt was detected for the BJhTERT line (Fig. 6.1), shorter
than a previous recent report with respect to this line (Stewart et al., 2003). This may
reflect intrinsic differences in these clonal lines across laboratory settings.
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Figure 6.1: T-OLA optimization. T-OLA analysis of genomic DNA from human BJ
fibroblasts immortalized with hTERT using radioactively labeled oligonucleotide of the
sequence (CCCTAA)4or mismatch control (CCCTTA)4 A maximal product of 324nt is
detected.
6.2.2 T-OLA analysis of primary sheep fibroblasts
We sought to address whether the G-rich 3' telomeric overhang is altered during in vitro
culture and whether this correlates to telomere shortening rate, in an alternative higher
order mammalian species, the sheep (Ovis aries). Our laboratory previously reported
two sheep fibroblast lines (BWF1 and BW6F2) which showed comparable telomere
lengths after isolation and at replicative senescence, but which differed dramatically in
replicative lifespan, due to intrinsic differences in telomere shortening rate (BWF1
exhibited a 3-fold shorter replicative lifespan) (Clark et al., 2003). T-OLA analysis was
conducted to measure whether the 3' telomeric overhang is altered during in vitro
culture of BWF1 and BW6F2 normal primary sheep fibroblasts and the experiment
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repeated twice. Both lines showed progressive 3'-OH shortening of 72nt, from a
maximal T-OLA signal of 456nt at early passage to 384nt at late pre-senescent passage,
(Fig. 6.2a, and Table 6.1). However, this lower value of overhang length was detected
after 48 population doublings (PD) in BWF1 and 103 PD in BW6F2 (Fig 6.2b).
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Figure 6.2: G-rich 3'-OH analysis of DNA from Black Welsh sheep fibroblasts
(BWF1 and BW6F2). (A) T-OLA analysis of DNA at increasing PDs up till pre-
senescence. A maximal T-OLA signal of 456nt at early passage and 384nt at late
passage, is detected for each line. Genomic PCR of the GAPDH locus using lOng
template conducted on each sample is displayed on the lower panel. (B) However, 3'-
OH shortening is more pronounced in BWF1 with the lower 3'-OH value of 384nt
reached after 48PD in this line compared to 103PD in theBW6F2 line.
In order to determine the length distribution of the G-rich 3'-OH, repeated experiments
were performed on BWF1 and BW6F2 fibroblasts. For BWF1, 27 % of the G-rich tail
was in the class ranging from 240nt to 456nt at an early culture stage (PD7), falling to
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22% at PD28 and 16% at PD48 (Fig. 6.3b). Comparably for BW6F2, 32% of the G-rich
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Figure 6.3: Distribution of G-rich 3' overhangs in cultured primary sheep
fibroblasts. The band intensity of ligated products was calculated using Multi-Analyst
1.1 software. The frequency of overhangs of different length for (A) BW6F2 and (B)
BWF1, was obtained by normalizing the intensity of each single band to the sum of
intensity of all bands in the ladder at the PDs indicated. On the x-axis the numbers of
oligonucleotides ligated by the T-OLA are reported.
Thus the data supports the conclusion that 3'-OFI shortens during in vitro culture of
normal sheep fibroblasts.
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6.2.3 TRF analysis of normal sheep fibroblasts
To establish whether 3'-OH shortening correlates to telomere length, telomere restriction
fragment length analysis was conducted on Black Welsh lines at the same stages as that
of T-OLA analysis and directly compared. Telomeric overhang shortening paralleled
mean telomere length shortening in both lines (Fig. 6.4a) and was found to be a
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Figure 6.4: 3'-OH length correlates to telomere length in primary sheep fibroblasts.
(A) Denaturing TRF Southern-blot analysis of genomic DNA from Black Welsh lines at
the indicated PDs. (B) Direct correlation between 3'-OH length and mean TRF length.
The rate of 3'-OH shortening was next calculated and compared to the rate of telomere
shortening. Mean telomere shortening rate was calculated as 51.1bp/PD for BW6F2 and
128.0bp/PD for BWF1, approximately a 2.5-fold difference. This is similar to the
shortening rate reported previously (Clark et al., 2003). Comparably, mean 3'-OH
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shortening rate was calculated as 0.8nt/PD for BWF6F2 and 2.88nt/PD for BWF1- a
3.5-fold difference. Of the total 72nt of 3'-OH eroded during the culture period analyzed,
1.11% on average is lost per PD in BWF6F2, whereas 4.0% is lost per PD in BWF1
(Table 6.1). Strikingly, of the total 4.5kb telomere erosion in BW6F2 during this culture
period, 1.13% is lost on average per PD, and of the 3.2Kb telomere erosion incurred in
BWF1, 4.0% is lost per PD. Although the percentage loss of mean telomere length and
telomeric overhang length is identical, it is difficult to determine if this is coincidental or
of functional importance. However, the findings indicate that mean telomere shortening
rate is related to mean telomeric overhang shortening rate in primary sheep fibroblasts in
this context. The data supports the conclusion that 3'-OH shortens during in vitro culture
of normal sheep fibroblasts and that 3'-OH shortening parallels telomere shortening.
However there is no evidence that this is a direct correlate; telomere shortening per PD
is significantly more pronounced than 3'-OH shortening per PD, thus the data does not
provide evidence for telomere shortening rate being directly proportional to the size of
the 3'-OH. It is important to state that maximal 3'-OH length reported here simply
reflects the maximal T-OLA signal obtained from the assay under these settings and
does not exclude the possibility of true 3'-OH length being longer.
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BW6F2 15 18.1 456
64 15.8 408
103 13.6 384 51.1 0.8 1.13 1.11
BWF1 4 16.1 456
14 - 408
29 12.9 384 128.0 2.88 4.0 4.0
''Population doubling rate calculated from growth curve reported in (Clark 2003).
Table 6.1: Summary of TRF and T-OLA analysis on sheep fibroblast clones.
6.2.4 Culture of sheep fibroblasts under low oxidative stress
It has been suggested that telomeres measure stress and damage accumulation more
readily than simple mitotic time and that telomere shortening may be stress-dependent
due to a telomere-specific damage repair deficiency (von Zglinicki et al., 2002 & 2003).
Previously a laboratory in Newcastle, UK, (von Zglinicki lab) have investigated whether
response to oxidative stress may be a determinant of differences in telomere shortening
and 3'-OH shortening rate evident in the BWF1 and BW6F2 normal sheep fibroblasts.
Anti-oxidative defence capabilities was investigated in these lines by measuring
peroxide levels under normal and hyperoxic culture conditions. Actual units of peroxide
levels were similar for BWF1 and BW6F2 under normoxic conditions. However, under
hyperoxic culture shock conditions, although peroxide levels rose significantly for both
lines, levels were 3-fold more pronounced in BWF1 than for BW6F2 (see Appendix 5).
This suggests that stochastic variations ofmild oxidative stress may be one factor for the
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shorter proliferative lifespan of BWF1. Therefore it was of interest to investigate
whether culture in 2% low oxygen rather than 21% oxygen may overcome a possible
stress-induced premature senescence in BWF1. BWF1 cells at PD20 were cultured in
each oxygenated setting and PD calculated. Although proliferation rate of cells in 2%
oxygen increased moderately after -28PD, cells reached replicative senescence at the
same proliferative age (-35PD) under both conditions (Fig 6.5). The outcome was
similar for BW6F2, where cells under both oxygenated conditions reached senescence at
-100PD (data not shown). Therefore, culture in 2% oxygen failed to reduce the rate of
telomere shortening in this setting.
Figure 6.5: Culture in low percentage oxygen in BWF1 primary sheep fibroblasts.
Senescent morphology was evident after -35 PD for BWF1 cells cultured in 21% and
2% oxygen from -20PD.
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6.2.5 T-OLA analysis of hTERT-immortalized sheep fibroblasts
A recent reported has documented how the 3'-OH is found to be significantly shorter in
samples derived from endometrial cancers compared to those derived from normal
endometria (Hashimoto et ah, 2005). This was the first report examining the 3'-OH of
telomeric repeats in clinical cancer samples. Unexpectedly perhaps, this study failed to
observe any correlation between the levels of telomerase activity and 3'-OH or telomere
length. Furthermore it remains elusive as to whether there is a correlation between
telomerase activity and 3'-OH in a normal cellular context. Previously our laboratory
reported the generation and characterization of hTERT-immortalized primary sheep
fibroblasts (GRN). In this scenario, telomere length stabilization and karyotypic stability
were directly correlated to levels of hTERT expression as measured by absolute real
time qRT-PCR (Cui et al., 2002, Table 6.2). To investigate the relationship between
hTERT gene expression and telomeric overhang length, T-OLA analysis was conducted
to measure the 3'-OH length in GRN hTERT-immortalized fibroblasts that had incurred
in excess of 400PD; at this stage, telomeres were shown to be stabilized and lines with
low levels of hTERT displayed 90-100% karyotypic abnormalities (Table 6.2). T-OLA
indicates a strong relationship between hTERT expression and 3'-OH length: lines with
>300 copies of hTERT mRNA per cell (GRN2-1 and GRN2-7) exhibited the longest
maximal 3'-OH length at 504nt; lines with 0.5-87.5 copies of hTERT per cell (GRN2-5
and GRN2-8) had a shorter 3'-OH length of 432nt and lines with <0.5 copies of hTERT
per cell (GRN1-1 and GRN2-13) exhibited the shortest 3'-OH length at 312nt (Fig.6.6a
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and b; Table 6.2). In support of this, we found a significant correlation (r = 0.70)
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Figure 6.6 : Telomeric 3'-OH analysis from hTERT-immortalized sheep fibroblasts.
(A) T-OLA analysis on GRN hTERT-immortalized sheep fibroblasts at culture stage in
excess of 400PDs. GRN2-1 and GRN2-7 exhibited the longest maximal T-OLA signal
(504nt). GRN 1-1 and GRN2-13 exhibited the shortest signal (312nt).Genomic PCR of
the GAPDH locus using lOng template conducted on each sample is displayed on the
lower panel.
GRN 1-1 and GRN2-13 had considerably shorter stabilized telomere lengths (6.5 and
6.0kb) than all other lines investigated and correspondingly showed the shortest
telomeric overhang length (312nt). Conversely, GRN2-1 and GRN2-7 showed the
longest stabilized mean telomere lengths (17.2 and 18.0kb) and longest 3'-OH (504nt).
GRN2-5 and GRN2-8 had telomere lengths (17.0 and 15.8kb) and 3'-OH lengths (432nt)
at an intermediate length between these two classes (Fig. 6.7a and Table 6.2).
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Furthermore, 3'-OH length correlated significantly (r = 0.92) to calculated stabilized




















5 10 15 20
Telomere (TRF) length (nt)
Figure 6.7: TRF analysis from GRN hTERT-immortalized sheep fibroblast lines.
All telomere restriction fragments shown represent stabilized telomere lengths with the
mean telomere length indicated. GRN1-1 and GRN2-13 have substantially shorter
telomere lengths (6.5 and 6.0kb respectively) than all other GRN clones, which exhibit a
mean telomere length range of ~16-18kb.
The frequency distribution of G-rich tails was calculated for the GRN clonal lines.
GRN2-1 and GRN2-7 exhibited 32% and 36% G-rich tails respectively for the overhang
class ranging from 312 to 504nt; conversely, GRN1-1 and GRN2-13 exhibited 4% and
6% of G-rich tails respectively within this range with GRN-5 and GRN2-8 exhibiting a
frequency between these two groups (24% and 25% respectively) (Fig 6.8).
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Figure 6.8: Frequency distribution of G-rich tails in hTERT-immortalized
fibroblasts. Maximal T-OLA product at PDs indicated for each line is denoted by an
asterisk. GRN2-1 and GRN2-7 exhibit the longest maximal telomeric overhang length
and approximately one third of overhangs are within a size of 312-504nt. Conversely,
GRN1-1 and GRN2-13 have the shortest maximal telomeric overhang length and
approximately 5% of overhangs are within a size range of 312-504nt. GRN2-5 and
GRN2-8 exhibit a maximal overhang length intermediate to these outliers.
Thus the data provide strong evidence for a relationship between hTERT expression
level and 3'-OH length. However, whether this is a direct causal relationship or
indirectly as a result of hTERT-dependent stabilized telomere length is unclear.
6.2.6 Relationship between 3'-OH and karyotypic stability
3' telomeric overhang length was further shown to be related to abnormal karyotype
levels previously reported (Cui et al., 2002). GRN1-1 and GRN2-13 which showed the
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shortest 3'-OH length, also displayed the highest degree of karyotypic instability at the
PDs indicated - 93% and 100% abnormal karyotype respectively. GRN2-1 and GRN2-7,
with the longest 3'-OH length, showed a more stable genome at similar PDs - 0% and
3% karyotypic abnormalities respectively. GRN2-5 and GRN2-8, with 3'-OH in
between these two groups, showed 3% and 50% of abnormal karyotypes at similar PDs.
This is a strong indication that 3'-OH length and not telomere length per se may
contribute to chromosomal instability. In support of this notion, dicentric chromosomes,
characteristic of end-to-end telomere fusions, were only apparent in GRN1-1 and
GRN2-13, lines which had significantly the shortest 3'-OH length (Table 6.2) (Cui et al.,
2002). The data suggests that a minimal length of 3'-OH may be necessary to confer
genomic stability, likely due to the formation of a proper telomere end-capping structure
such as the T-loop. In this regard, 3'-OH length below this threshold may be a
determinant of the onset of karyotypic instability.
Cell line PD* Mean 3'-OH Relative hTERT %




GRN1-1 427 6.5 312 2.6 0.34 93
GRN2-1 408 17.2 504 5873.5 375.08 0
GRN2-5 416 17.0 432 1278.3 87.24 3
GRIV2-7 421 18.0 504 5752.6 345.14 3
GRN2-8 408 15.8 432 8.1 0.58 50
GRN2-13 413 6.0 312 1.0 0.08 100
Table 6.2: Summary of TRF and T-OLA analysis on hTERT-immortalized sheep
fibroblast clones; (c>dande taken from Cui W. et al 2002).
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6.3 Discussion
6.3.1 Analysis of primary sheep fibroblasts
This is the first report of 3' telomeric overhang analysis in primary sheep fibroblast lines
and thus represents an alternative mammalian model in which to study function of the
3'-OH and its interplay with telomere-related factors. These observations demonstrate
that 3'-OH length erodes during in vitro culture of normal primary sheep fibroblasts and
that 3'-OH length correlates significantly (r = 0.798) to telomere (TRF) length. Previous
reports using cultured human fibroblasts have argued for 3'-OH being eroded only at
replicative senescence (Stewart et al., 2003) or at crisis (Chai et al., 2005). The gradual
shortening of 3'-OH in sheep fibroblasts may reflect intrinsic cross-species differences.
Both the BWF1 and BW6F2 sheep fibroblast lines studied here exhibit similar 3'-OH
length at an early stage of culture (456nt) and at a pre-senescent stage (384nt). Therefore
the telomere shortening does not seem to corrrelate directly with the size of 3'-OH.
However, the rate of 3'-OH loss is more pronounced in BWF1 compared to BW6F2.
This parallels telomere shortening rate and relates to a 2.5-fold shorter replicative
lifespan in BWF1 compared to BW6F2. We further compared percentage of mean 3'-
OH loss per PD between the two lines and show that 4.0% of total overhang erosion
occurs per PD in BWF1 whereas the figure is 1.1% for BW6F2- approximately a 4-fold
difference. Similarly, regarding percentage ofmean telomere shortening per PD, 4.0% of
total telomere loss, occurs per PD in BWF1 and 1.1% per PD in BW6F2 - again
approximately a 4-fold difference. Thus, mean 3'-OH shortening rate per PD directly
parallels mean telomere shortening rate in this setting. Although we find a correlation
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between relative 3'-OH shortening and relative telomere shortening, there is a
substantial discrepancy between actual mean telomere and 3'-OH shortening rate. Mean
telomere shortening rate in BWF1 is ~128bp/PD, whereas mean 3'-OH shortening rate is
~2.9nt/PD. Similarly, the respective values are ~51bp/PD and 0.8nt/PD for BW6F2.
Therefore although the 3'-OH and telomere duplex array both shorten during in vitro
culture, the data shows that telomere shortening rate is not directly determined by 3'-OH
erosion. One explanation of this apparent discrepancy is that 3'-OH shortening may
reflect the end-replication problem, whereas overall telomere shortening better reflects
other nucleolytic processing events as well as a function of (external) oxidative stress
and (internal) anti-oxidant defence. In support of the latter argument, BW6F2 showed a
substantially better response to hyperoxic culture conditions than BWF1. Therefore anti-
oxidative capacity may be a key determinant of replicative lifespan and may transpire to
overall telomere shortening rate. The dramatically shorter lifespan and more pronounced
telomere shortening rate in BWF1 may hence be related to response to mild-stress in
culture. On this basis it was reasoned that culture in low oxygen may slow BWF1
telomere shortening rate to levels comparable with BW6F2. However culture in a 2%
low oxygen chamber, failed to increase replicative lifespan of BWF1 and BW6F2
fibroblasts. This may reflect the fact that these lines have adapted, genetically and
epigenetically, to culture conditions of 21% oxygen and thus gene expression profiles
may not be readily reversible. A definitive experiment would require culture in low
oxygen directly after derivation of primary cells. It is also imortant to note that Black
Welsh fibroblasts used in this study were isolated from the foetal carcass which is
composed mainly of skin fibroblasts and was reported to be less sensitive to room
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temperature oxygen levels. This may explain why there is no difference in anti-oxidative
response between BWF1 and BW6F2 under normoxic conditions (see Appendix 5) and
subsequently why there was no difference in proliferative lifespan observed under low
oxygen conditions. Therefore it may not be surprising that both lines show reduced anti-
oxidative capabilites under hyperoxic conditions (although BW6F2 fared better under
hyperoxin conditions, peroxide levels still rose substantially).
6.3.2 Analysis of hTERT-immortalized sheep fibroblasts
The relationship between hTERT gene expression and 3'-OH length was next addressed.
A recent previous report failed to find any significant correlation between levels of
telomerase activity and 3'-OH in a tumour setting (Hashimoto et al., 2005), but no report
has been documented regarding any relationship in hTERT-immortalized cells both in
vitro and in vivo. Our laboratory previously analyzed Black Welsh sheep fibroblasts
immortalized with ectopic hTERT and reported that telomere maintenance and
karyotypic stability are directly correlated to levels of hTERT expression (Cui et ah,
2002). The current analysis of 3'-OH in this setting revealed a significant correlation (r
= 0.702) between maximal 3'-OH length and copies of hTERT mRNA per cell. The
longest 3'-OH length, concurrent with near maximal mean telomere length and stable
karyotype, was evident in lines exhibiting >300 copies of hTERT mRNA per cell.
Conversely, shortest 3'-OH length, concurrent with shortest mean telomere length and
grossly abnormal karyotype, was evident in lines exhibiting <0.5 copies of hTERT
mRNA per cell. This is in accordance of RT-PCR data from others which indicate that
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most cancer cells contain only a very few (<2 copies per cell) molecules of hTERT full-
length mRNA (Yi X. et ah, 2001). Thus, 3'-OH length in cells with low levels of forced
hTERT mRNA expression may mimic the biological situation in most tumours.
Stabilized mean telomere (TRF) length also showed a strong correlation (r = 0.924) to
3'-OH length in these cell lines. Thereby lines with high levels of hTERT expression
exhibited near full length mean telomere length, more or less normal karyotype (0%
abnormal in GRN2-1 and 3% abnormal in GRN2-7) and a maximal T-OLA product of
504nt after -400PD. Conversely, lines with low levels of hTERT exhibited a mean
stabilized telomere length shorter than the senescent length of the parental lines, grossly
abnormal karyotype (93% in GRN1-1 and 100% in GRN2-13) and correspondingly a
maximal T-OLA product of 312nt. Therefore telomeric overhang length appears to be
related to the stability of the genome and attributable to levels of hTERT expression.
Whether this is a direct relationship or indirectly as a function of hTERT-mediated
telomere duplex repeat maintenance is unclear. The data presented here regarding 3'-OH
shortening in normal sheep fibroblasts suggests that 3'-OEl length in hTERT-
immortalized fibroblasts is an indirect function of hTERT expression level and is
determined by telomerase-mediated telomere maintenance.
Viewed together, the data indicates that the telomeric 3'-OH length of 504nt in
fibroblasts immortalized with high levels of hTERT, may represent full length maximal
3'-OHs in Black Welsh fibroblasts in vitro. The 3'-OH length of 456nt at early stage
BWF1 and BW6F2 fibroblasts presumably reflects 3'-OH erosion with PDs incurred up
to that stage. Conversely, the 3'-OH length of 384nt evident at late pre-senescent stage
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BWF1 and BW6F2 fibroblasts, may reflect a length close to a minimal length of 3'-OH
required to maintain a T-loop structure and hence chromosomal stability and cell
viability. In support of this, the GRN1-1 and GRN2-13 hTERT-immortalized lines, with
a 3'-OH length of 312nt show a hugely abnormal karyotype. 3'-OH in these lines may
have been permitted to shorten beyond the minimal 3'-OH length necessary for genomic
stability, due to the forced expression of hTERT, ensuring bypass of replicative
senescence activation pathways. It is plausible that 3'-OH length in these lines may be
insufficient to allow the G-rich strand overhang to invade the duplex array to form a T-
loop or any other non-canonical structure. In support of this, previous experiments in our
laboratory showed these lines to exhibit a high degree of dicentric chromosomes (Cui et
al., 2002), not apparent in any of the other lines, which indicates telomere end-to-end
fusions, the likelihood of which may be increased by loss of a 3' telomere capping
structure (Fig. 6.9). This scenario may represent a tumourigenic setting where 3'-OH
length (and stabilized mean telomere length) is shorter than the corresponding wild-type
tissue, thus resulting in loss of end-protection and facilitating chromosomal dysfunction
that augments the tumour cells.
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Figure 6.9: Relative 3-OH length in normal and hTERT-immortalized sheep
fibroblasts. Maximal telomeric overhang is presented relative to the GRN2-1 and
GRN2-7 lines (denoted by an asterisk), which showed the longest T-OLA product
(504nt). G-rich strand shortening in normal fibroblasts is shown on the right of chart,
denoted by arrows. 3'-OH length was calculated as 384nt for both BWF1 and BW6F2 at
a pre-senescent stage. The shortest 3'-OH length was calculated for GRN1-1 and GRN2-
13 (312nt) and is denoted by a cross and may represent 3'-OH lengths insufficient to
permit a telomere end-capping structure such as the T-loop.
In summary, the data presented shows that 3'-OH length in primary sheep fibroblasts,
rather than be maintained during culture, gradually erodes and that maximal 3'-OH
length correlates to mean telomere length. More informatively, the relative rate of 3'-OH
loss was found to directly correlate to the relative rate of overall telomere loss. In
addition, the correlation of 3'-OH length to telomere length is a function of hTERT
gene expression in hTERT-immortalized sheep fibroblasts. A high degree of karyotypic
instability is prevalent in hTERT-immortalized cell lines with a 3'-OH length below that
of late stage normal fibroblasts, thus implying that the 3'-OH-governed telomere end-
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protection structure is required for maintenance of genomic stability. This raises the
interesting question of whether telomerase mediated telomere repeat addition results in
3'-OH length, sufficient to form a T-loop structure in any cells at all within the context
of a tumour? And if not, how does the pro-survival role of telomerase override the
seemingly compromised state of cell viability, conferred due to loss of telomere end-
protection and consequent karyotypic abnormalities?
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CHAPTER 7
DISCUSSION
Regulation of telomere length in mammalian cells is a complex multi-factorial process
involving not only a dynamic interplay of telomere- and telomerase-associated factors,
but also the physical configuration of telomeric structure at chromosomal termini. Hence
both extrinsic and intrinsic factors inter-dependently contribute to maintain telomere
metabolic homeostasis. The project presented here has used an alternative mammalian
model, the sheep (Ovis aries), to gain valuable insight into telomere length regulation,
with respect to aspects of both extrinsic and intrinsic factors regulating mammalian
telomere length. The justification of this model was provided by previous research in our
laboratory which showed that sheep fibroblasts have a defined in vitro lifespan, sheep
telomeres have been reported to shorten at rates comparable to that reported in humans,
and ectopic expression of hTERT effectively reconstitutes telomerase activity and
immortalizes the cells (Cui et al., 2002 & 2003, Clark et al., 2003). This presents some
considerable advantages of using the sheep system, when compared to the classical
model, mouse. In general telomere and telomerase biology may be more reflective of
human in the sheep.
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7.1 Extrinsic regulation of telomere length
A previous study in our laboratory monitoring sheep fibroblasts immortalized with
ectopic hTERT, showed that telomere erosion and genomic instability occur to an extent
that is directly attributable to the level of hTERT expression; at higher levels of hTERT
expression, full length telomeres are maintained and karyotypic stability is preserved. By
contrast, at lower levels of hTERT expression, telomeres erode and karyotypic
abnormalities manifest. Surprisingly, telomerase activity was comparable between these
lines (Cui et al., 2002). This highlights the complex relationship between telomerase
function and telomere maintenance. Based on this evidence, two general hypotheses
were formulated: i) do non-catalytic motifs of hTERT mediate regulation of telomere
length in a manner that can be distinguished from hTERT catalytic activity? ii) or is the
hTERT catalytic domain solely rate-determining with respect to telomerase-mediated
telomere maintenance? In order to address both these issues, a catalytically
dysfunctional hTERT transgene was expressed in an hTERT-immortalized primary
sheep foetal fibroblast line in which telomeres stabilize at an average length much
shorter than the untransfected parental line. This strategy thereby permitted both a
window in which telomere maintenance function may be attributed to hTERT that can
be distinguished from enzymatic activity, but also a system to test the effects of
catalytically inactive hTERT on active telomerase activity.
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The data presented showed that clones exhibiting high levels of mutant hTERT
expression inhibited telomerase activity, whereas clones exhibiting lower levels did not.
These results indicated that the inhibition effect of mutant hTERT has a threshold and
that this is likely due to a dominant-negative and/or competitive inhibition effect
between the wild-type and mutant hTERT proteins. Thus mutant hTERT expression
compromised wild-type telomerase activity in a manner directly attributable to mutant
hTERT expression level. When mutant hTERT expression is sufficiently higher than the
wild-type, it competitively inhibits the binding of wild-type hTERT to telomerase RNA
or the formation of TERT homodimers, hence inhibition of telomerase activity.
However, when TRAP assay was conducted using 0.5pg rather than 0.1 pg protein
lysate, low levels of telomerase activity was detectable in cells with high expressing
mutant hTERT. This low level of telomerase activity could be due to a small number of
cells in which mutant hTERT was silenced or expressed at low levels and highlights a
caveat of considering dominant-negative anti-telomerase intervention in tumour cells.
Furthermore, sufficiently high levels of mutant hTERT expression were found not only
to inhibit telomerase activity but also to affect cellular proliferation and telomere length,
which may be a consequence of telomerase inhibition. Although the general
proliferation rate throughout culture was similar for all clones, one clone, shown to
exhibit the highest relative levels of mutant hTERT, exhibited a period of slower
proliferation after only a short period in culture, concurrent with a senescent morphology
and positive senescence-associated [Tgalactosidase staining within a subset of cells
within the population. However, the remaining cells in the population where telomerase
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inhibition was presumably not effected, thereafter incurred a growth advantage and were
thus selected for. This highlights the difficulty in regarding lines derived from a single
colony as truly 'clonal'. Stochastic variation of this nature may account for
heterogeneous populations in vitro that are inaccurately termed 'clonal' (Martin-ruiz et
al., 2004).
Significant telomere attrition was evident in two of three clones with high levels of
mutant hTERT expression. Telomeres in these clones eventually reached mean
stabilized lengths much shorter than those in mock controls. These results seem to be
directly attributable to mutant hTERT expression. Mutant hTERT/mutant hTERT and
mutant hTERT/wild-type hTERT dimeric complexes are likely to be in much greater
abundance than wild-type/wild-type dimers within these lines. Inhibition of telomerase
activity and increased telomere attrition are therefore likely to be due to the
compromising of wild-type homodimeric function at the telomere substrate due to the
molar ratio imbalance of hTERT complexes. This is consistent with the notion that
hTERT homodimers are necessary to form a functional telomerase complex at the
telomere substrate (Prescott & Blackburn 1997) where catalytic domains of both hTERT
molecules may function inter-dependently.
The long-term monitoring of these hTERT-immortalized lines revealed a critical caveat
regarding the precarious nature of a sustained period of in vitro culture using transgenic
lines. After ~ 3 months of continuous propagation, almost no hTERT message (wild-
type and mutant) was evident in any of the lines, including mock controls. This hints at
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the heterogeneous nature of these lines, whereby mutant hTERT may have been silenced
in a subset of cells within a population, a subset unto which a growth advantage is
conferred thereafter. As proliferation rates were nevertheless maintained
uncompromised at the same rate throughout this period and as telomerase activity was
high in all lines at late passage, the indirect inference was that endogenous sheep TERT
may be activated in these lines. This event may plausibly occur as a consequence of a
transformation event in these lines during long-term culture. It is interesting to note that
in spite of the loss of mutant hTERT expression in the late passage of those two clones
which exhibited relatively aggravated telomere attrition, the telomere length in these two
clones did not recover to the length comparable to the mock controls after long-term
culture, rather they stabilized at the short telomere length. This indicates that in sheep
cells, telomerase may maintain but cannot elongate shortened telomeres, at least in this
setting. This contrasts with human cells (Delhommeau et al., 2002) and may reflect
intrinsic differences between hTERT expression in human cells and hTERT expression
in sheep cells.
In summary, these results support the notion that telomere maintenance requires a
functional telomerase complex with hTERT monomers likely interacting in an inter¬
dependent manner. Furthermore the result demonstrates that although hTERT non-
catalytic domains may be necessary for telomerase assembly and processivity at the
telomere substrate, they are not rate-determining. Catalytic hTERT domains appear to be
a crucial rate-determining factor regarding processivity. In addition the study highlights
the complexity of telomerase and telomere interplay; a discrepancy arose regarding one
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clone, which demonstrated high levels of mutant hTERT expression that resulted in
telomerase inhibition. Rather than aggravated telomere attrition as may have been
predicted, average telomere length was maintained at a length comparable to mock
controls. This emphasizes the limitations of using telomerase assays that incorporate a
single-strand telomeric substrate. Double-strand telomeric binding proteins cannot exert
a regulatory role at the telomere substrate as a result. As telomere length homeostasis is
regulated by a number of associated factors such as those that constitute the Shelterin
Complex, differences in expression level of these factors may account for discrepancies
such as these. A more systemic approach, which regards a composite of data with
respect to all these factors, will prove more beneficial in furthering our understanding of
telomere length regulation. The data presented here is consistent with many lines of
recent direct and indirect evidence which implicates hTERT to be functional as an inter¬
dependent homodimeric complex at the telomere substrate. It will be important to
elucidate the minimal number of hTERT complexes that act to maintain senescence
bypass, particularly in a tumour setting. Correspondingly it will be crucial to determine
how many molecules of a dominant-negative hTERT protein are sufficient to inhibit
active telomerase in tumour cells. Real time qPCR may provide an accurate picture of
the minimal threshold below which telomerase is compromised, by providing molar
stochiometries with respect to mutant and wild-type hTERT monomers. This will be of
interest in determining the efficacy and targeting strategy of hTERT dominant-negative
approaches using gene therapy. Data presented here highlights the requirement of
sufficiently high levels ofmutant hTERT that will persist throughout treatment of cancer
patients. At present telomerase assays are not highly sensitive and therefore more subtle
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differences in telomerase activity are not detected. A recent development (Quantitative
Telomerase Detection Kit, Allied Biotech.) that is specifically designed for Real-time
PCR detection of telomerase activity, may prove an invaluable tool in future
measurement of telomerase activity.
7.2 Intrinsic regulation of telomere length
Seminal work in our laboratory has shown that the proliferative lifespan and telomere
shortening rate of primary sheep cells is conserved after nuclear transfer. Donor cell
lines at different ages and different proliferative capacities were used to clone fetuses
and animals, from which new primary lines were generated; these lines exhibited the
same proliferative capacities and rates of telomere shortening as the donor lines (Clark
A. J. et al, 2003). This work demonstrated the fact that at least certain aspects of
telomere length regulation are intrinsically determined. The classical view of telomeric
termini as passive structures subject to extrinsic regulation has been dismissed with
recent advances in telomere biology research. Advances in techniques such as Q-FISH
that allow measurement of telomere length at the chromosomal level have revealed that
individual telomeres shorten at different rates. This heterogeneity is now believed to be
crucial in determining the onset of replicative senescence, where telomere lengths of a
subset of the shortest telomeres most probably serve as an indicator of senescence
activation rather than average telomere length in the population as a whole. Furthermore
the 3'-OH of telomeric termini has been shown to form an end-capping T-loop
configuration which may be crucial in maintaining genome stability. Some groups have
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suggested that it is loss of this structure that is the causal trigger of replicative
senescence, but compelling evidence for this is lacking. Others have postulated the idea
of telomere shortening rate being determined by 3'-OH length; i.e. telomeres shorten by
an amount proportional to the size of the 3'-OH.
The current venture again uses primary sheep fibroblasts as an alternative mammalian
model system in which to descriptively analyze both telomere length heterogeneity and
alterations to the 3'-OH in a temporal manner as a consequence of replicative ageing.
Foetal fibroblast lines derived from the Black Welsh breed (BW6F2 and BWF1) were
previously shown to differ in their replicative lifespan by ~3-fold, although average
telomere length was similar both after derivation and at replicative senescence (Clark et
al., 2003). The considerable difference in replicative lifespan was directly attributed to a
~3-fold difference in average telomere shortening rate. The key limitation of the
previous study in our laboratory was that true telomere length heterogeneity was not
accounted for, taking into account telomere shortening at individual telomeres. It is
likely that average telomere shortening rate only indirectly indicates the functional
consequence of telomere attrition. For example, telomere shortening rate within only a
subset of telomeres may be directly correlated to the onset of replicative senescence
rather than average telomere length in the karyotype per se. Therefore it was of interest
to optimize Q-FISH methodology in the sheep system to attain a description of telomere
shortening in the Black Welsh fibroblasts that takes into account true telomere
heterogeneity and to calculate telomere shortening rate on this basis. The Q-FISH
methodology had previously been optimized for mouse and human chromosomes,
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conditions which were required to be modified prior to analysis on sheep metaphase
spreads. Nevertheless to our knowledge, this is the first documented demonstration ofQ-
FISH in ovine cells. Generally, both lines show a reasonably normal distribution of
telomere lengths; i.e. - a minority subset of telomeres with very long or very short
telomeres, with the majority of telomeres representing an intermediate length. Therefore
we can infer that average telomere length does not differ dramatically between these
lines. However, BWF1 exhibits a greater proportion of very short telomeres at each
snapshot of analysis. This suggests rather superficially that although replicative
senescence may be triggered at a comparable 'mean' telomere length, the telomere
shortening rate in a subset of telomeres within the BWF1 population may be a key
determinant of the much earlier onset of senescence activation in this line and provides
direct evidence of intrinsic differences in telomere shortening rate between the two lines.
This is certainly in accordance with the 'subset of shortest telomeres' hypothesis which
postulates that the mitotic clock is determined by a subset of telomeres with aggravated
telomere attrition rates relative to the whole population of telomeres (postulated by Shay
& Wright). This is an intriguing observation as these two lines were derived from the
same genetic breed; what is the molecular basis that determines telomere shortening
rate? how is this regulated? Using solely a descriptive study renders it difficult to
ascertain whether the more pronounced telomere shortening rate in BWF1 is a key
determinant of a shorter proliferative lifespan relative to BW6F2 or whether telomere
shortening rate in this context is consequential of alternative intrinsic and extrinsic
factors that determine proliferative lifespan? Some technical caveats regarding Q-FISH
will be required to be overcome before a more thorough understanding of telomere
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shortening that is of direct consequence, is permitted. Namely the method at present
cannot distinguish between very short telomeres and true signal free ends. If this issue is
resolved, the subset of individual telomeres which are true determinants of replicative
senescence could be observed. It will be interesting to determine whether it is telomeres
on the same subset of chromosomes that always correlate to senescence onset within a
particular cell type or even species. It may be possible to therefore predict replicative
lifespan of a cell line using a Q-FISH profile, thus providing a valuable tool to determine
a window of opportunity for approaches such as gene targeting via retroviral
transduction.
One determinant of telomere shortening rate that has been postulated (Wright & Shay)
states that telomere shortening rate is directly determined by 3'-OH length. In this
respect, telomere erosion would be predicted to be directly proportional to the amount
3'-OH loss after each round of cell division. However evidence to indicate that the 3'-
OH varies in length during successive rounds of cell division is not as yet compelling;
some have argued for erosion of 3-OH only at Ml stage senescence (Stewart et al.,
2003), whilst others have argued that this occurs as a consequence of M2 stage crisis
(Chai et ah, 2005). We again used the Black Welsh sheep fibroblasts to attempt to
resolve these issues. The Telomere-Oligonucleotide Ligation Assay (T-OLA) was
modified to investigate whether the G-rich 3'-OH alters during in vitro culture of normal
sheep fibroblasts and if so, whether this is a direct correlate to telomere shortening rate.
Telomeric overhang shortening paralleled mean telomere length shortening in both lines
and was found to be a significant correlate (r = 0.79). This indicated that the 3'-OH
alters during replicative ageing in these lines and may thus reflect species differences
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between sheep and human. However there was no evidence that there is a direct
correlation between telomere and 3'-OH shortening; telomere shortening per PD is
significantly more pronounced than 3'-OH shortening per PD, thus the data does not
provide evidence for telomere shortening rate being directly proportional to the size of
the 3'-OH. However 3'-OH length at the initial and late stage pre-senescent stage of
analysis is similar for both lines, although 3'-OH shortening rate is more pronounced in
BWF1. This is consistent with a more pronounced average telomere shortening rate in
BWF1. Therefore although telomeres in these lines do not shorten by the size of the 3'-
OH, both the 3'-OH and overall telomere length, shorten as a consequence of cellular
division. It is unclear as to the functional significance of 3'-OH length with respect to
replicative lifespan and senescence onset in these sheep fibroblast lines. One factor that
may determine intrinsic differences in telomere and 3'-OH shortening rate is response to
oxidative stress incurred during culture conditions. The von Zglinicki lab (Newcastle,
UK) have shown that peroxide levels rose significantly for both lines under conditions of
hyperoxia, where levels were 3-fold more pronounced in BWF1 than for BW6F2. This
indicates that BWF1 has much reduced anti-oxidative defence capabilities. We this
reasoned that culture of early passage BWF1 fibroblasts in a 2% oxygen chamber would
increase replicative lifespan to a duration comparable to BW6F2 due to a much lower
level of oxidative stress. Although culture in 2% oxygen failed to reduce the rate of
telomere shortening in this setting, this may be due to the BWF1 line being already
adapted to previous conditions of culture in our laboratory and so the result does not
exclude an important role of oxidative stress with respect to determining telomere and
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3'-OH shortening rates. A definitive experiment will require exposing mammalian cells
to various levels of oxidative stress immediately upon derivation of the lines.
We further investigated whether it there is a correlation between telomerase activity and
3'-OH in a normal cellular context. hTERT-immortalized Black Welsh sheep fibroblasts
were generated in our laboratory previously and it was reported that telomere
maintenance and karyotypic stability are directly correlated to levels of hTERT
expression (Cui et al., 2002). The current analysis of 3'-OH in this setting revealed a
significant correlation (r = 0.702) between maximal 3'-OH length and copies of hTERT
mRNA per cell. The longest 3'-OH length, concurrent with near maximal mean telomere
length and stable karyotype, was evident in lines exhibiting >300 copies of hTERT
mRNA per cell. Conversely, shortest 3'-OH length, concurrent with shortest mean
telomere length and grossly abnormal karyotype, was evident in lines exhibiting <0.5
copies of hTERT mRNA per cell. In particular, the lines that exhibited the lowest levels
of hTERT and shortest mean telomere length also exhibited the shortest 3'-OH length
and were the only lines to exhibit dicentric chromosomes. As the 3'-OH length is these
lines were shorter than the 3'-OH in the late pre-senescent stage of the parental
unmodified lines, this raises the question as to whether 3'-OH length in these lines is in
fact sufficient to form a telomere end-capping structure such as the T-loop. Dicentric
chromosomes provide evidence of end to end fusions presumably permitted by sufficient
loss of 3'-OH.
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The data presented on the basis of 3'-OH length in primary sheep fibroblasts suggests
that 3'-OH shortens and parallels telomere shortening. In the setting of hTERT-
immortalized fibroblasts, 3'-OH may correlate to hTERT expression-determined
telomere length, rather than hTERT expression per se. Although a correlation is
observed between 3'-OH shortening and overall average telomere shortening, length of
shortening in the latter is not directly proportional to the size of the overhang. Therefore
the precise determinant of telomere shortening rate in this setting remains unclear. The
correlation between 3'-OH shortening and average telomere length shortening leads us
to speculate whether the same or similar machinery (with respect to the plethora of
telomere-associated factors known to function at the telomere substrate) controls both
telomere length and 3'-OH length in mammalian cells.
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Concluding remarks
The experimental approaches and data presented in this project underline the complexity
of telomere length regulation in mammalian cells. Telomere length homeostasis is
governed by a plethora of inter-dependent factors, which act both intrinsically and
extrinsically at chromosomal termini. Data presented here indirectly supports the
concept of the telomerase complex functioning as an inter-dependent dimer at the
telomere substrate, where the reverse transcriptase domain of hTERT appears the key
rate-determining factor with respect to telomere maintenance. However certain
discrepancies within this study highlight the requirement to invoke studies of a multitude
of telomere- and telomerase-associated factors at telomeres. Expression levels of all
these factors may be crucial to determine both telomere shortening rates and telomere
maintenance capabilities at particular stages of analysis. A consilient approach from
groups investigating these factors will further our understanding of the complex
interplay at telomeres.
Advances in techniques to analyze telomere length heterogeneity and to measure the 3'-
OH, provide powerful tools to descriptively study the intrinsic factors that determine
and/or are determined by telomere length. Data presented here demonstrates that
telomere shortening rate and replicative lifespan are at least in part determined by
telomere shortening rates within a subset of short telomeres within a population, rather
than average telomere length. Moreover, the data provides evidence that the 3'-OH
shortens as a consequence of cellular division, but that telomere shortening rate is not
directly proportional to the size of the 3'-OH. However at present, measurement of the
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3'-OH is based on analysis on a population as a whole and does not resolve 3'-OH on
individual telomeres. Therefore further advances in the method of 3'-OH measurement
that permits the resolution of overhangs of individual telomeres will be crucial in
determining whether replicative senescence is triggered by the loss of an end-capping
structure in a subset of cells, once the 3'-OH has fallen below a critical minimum length
for that particular cell line. In this setting it will be important to visualize telomere ends
using EM technology to verify absence/presence of an end-capping structure. The
milestone for this avenue of research will be the conclusive understanding of the causal
and consequential progression from senescence activation at the Ml stage, through to
events at M2 crisis. At present, much of the argument is circular.
Current advances in telomere and telomerase biology will supplement novel ideas
regarding cancer cell biology. What is the complete spectrum regarding the role of
telomerase in tumour cells? Why are telomeres permitted to be shorter in many tumour
cells than corresponding wild-type cells? Do tumour cells have sufficient 3'-OH lengths
to enable a telomere-capping structure to exist? These questions will have to be regarded
with respect to the hierarchical model of tumour cells. It will be crucial to ask what the
key differences are in telomere length, 3'-OH length, and telomerase activity in tumour-
initiating populations when compared to their non-tumourigenic progeny. These factors
may be vital to maintain the unique status of a prospective cancer stem cell and therefore
may provide a means for a more targeted approach for cancer therapy, such as targeting
anti-telomerase drugs specifically to cancer stem cell populations.
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Appendix 1: Transgenic constructs used to transfect the GRN1-1 hTERT-
immortalized line. The ~4.6Kb EGFP mock vector control construct was initially sub-
cloned and placed under the control of a PGK promoter (B). The ~7.3Kb pWGB25
construct (A) was then created by replacing the EGFP transgene sequence with the
mutant hTERT transgene sequence under the control of a PGK promoter. Mutant
hTERT contains three independent amino acid substitutions ((R631A, D712A and
D868A) in the reverse transcriptase motif of hTERT. (Constructs were developed by Dr.
Wei Cui).
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TFU F1pS F1p13 F1p18 F2p4 F2p7
Category (rp380) (n=337) (n=286) (n=329) (n=323) ■SSSn
0 222 205 267 106 194 350 211
50 36 64 95 16 47 37 44
100 204 168 195 56 135 127 59
150 240 184 183 89 126 118 36
200 136 188 169 126 104 115 17
250 157 157 102 154 112 122 8
300 123 113 59 146 104 88 2
350 68 104 29 135 84 74 1
400 57 68 15 137 79 66 1
450 43 44 5 97 71 49 0
500 29 31 2 76 57 42 1
550 24 12 0 60 40 29 0
600 20 6 0 35 25 14 0
650 17 3 0 28 33 17 0
J0D 10 1 0 17 19 12 0
250 7 0 0 12 15 6 0
BOO 1 0 0 8 8 6 0
B5D 1 0 0 5 12 2 €
900 5 0 0 8 7 0 0
950 3 0 0 2 8 2 0
1000 2 0 0 3 2 5 0
1050 3 0 0 0 4 1 0
1100 3 0 0 0 1 1 0
1150 3 0 0 0 -J 0 0
1200 1 0 0 0 0 1 □
1250 0 0 0 0 0 0 0
1300 1 0 0 0 0 0 0
1350 1 0 0 0 0 0 0
1400 1 o 0 0 0 0 0
Appendix 2: Absolute Telomere Fluorescence Units (TFU) for the BWF1 and
BW6F2 sheep fibroblast lines as measured by Q-FISH analysis. TFU categories
represent arbitrary TFU which correspond to actual telomere length, n denotes the
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Appendix 3: Q-FISH profile for BW6F2. Q-FISH profiles showing percentage of
telomere ends per TFU category for the BW6F2 line, including the pre-senescent
passage 37 stage. This passage was excluded from the main body of analysis due to the
low number of quality metaphase spreads obtained from this line. Profiles are shown as
a histogram (above) and line graph (below).
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Appendix 4: Q-FISH histogram profiles showing Signal Free Ends (SFE). The SFE
category was excluded from the main body of analysis so as not too confound data
regarding telomere shortening rate. This represents a limitation to the Q-FISH method
applied to the sheep model system; SFE detected by the Q-FISH software do not
necessarily reflect true telomere SFE, but moreover, due to the quality of sheep
metaphase spreads, many telomere ends remain hidden due to overlapping chromosome




















Appendix 5: Response to oxidative Black Welsh normal primary sheep fibroblasts.
Actual units of peroxide released in normoxic and hyperoxic in vitro culture conditions.
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Abstract
Telomerase catalytic subunit (TERT) seems a key factor controlling telomerase activity, telomere length, and cell growth. To further
address this issue, we forced expression of a catalytically inactive mutant human TERT (hTERT) in hTERT-immortalised sheep fibro¬
blasts to examine its effects. Expression ofmutant hTERT compromised telomerase activity reconstituted by wild-type hTERT in a man¬
ner directly attributable to mutant hTERT expression level. High levels ofmutant hTERT expression inhibited cell growth with a subset
of cells entering replicative senescence. Furthermore, significant telomere attrition was evident in two of three clones with high levels of
mutant hTERT expression. Our findings are consistent with the notion that hTERT homodimers are necessarily required to form a func¬
tional telomerase complex at the telomere substrate. We also highlight the requirement of a more thorough understanding of telomerase-
and telomere-associated factors to understand fully the interplay that governs telomere homeostasis in vitro and in vivo.
© 2006 Elsevier Inc. All rights reserved.
Keywords: hTERT; Telomerase; Telomere; Senescence; Dominant-negative telomerase
Eukaryotic telomeres are specialised structures located
at the ends of linear chromosomes, consisting of proteins
and reiterated G-rich repeats that are conserved in all
vertebrae as TTAGGG [1], Telomeres function to protect
chromosomal termini from degradation and fusion,
thereby contributing to genomic stability [2,3], In most
eukaryotes, telomeric DNA is replenished by the action
of telomerase—a specialised cellular ribonucleoprotein
reverse transcriptase that synthesizes telomeric repeats
onto chromosomal ends [4-6], Telomerase consists of
two main components that are required for core enzy¬
matic activity, a telomerase RNA (TR) as a template
for the addition of de novo telomeric repeats, and a cat¬
alytic protein subunit with reverse transcriptase activity
(TERT). It has been reported that human telomerase
structure is that of a multimer containing two cooperat¬
ing hTR molecules [7,8] and most likely two hTERT
Corresponding author. Fax: +44 20 759 42192.
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molecules [9]. hTERT has been shown to consist of
two physically separable functional domains: a polymer¬
ase domain, containing RNA interaction domain 2
(RID2), reverse transcriptase (RT) motifs, and C-termi-
nal sequences, and a major accessory domain, RNA
interaction domain 1 (RID1) [10]. In humans, telomerase
is preferentially expressed in germ-line cells and early
embryonic tissues, but is not detected in most somatic
cells [11], Therefore, somatic cells progressively lose their
telomere repeats after each round of cell division. Even¬
tually when the telomeres on one or more chromosomes
become critically short, cells stop dividing and enter an
irreversible state termed replicative senescence [12-14],
However, telomerase is active in the majority of cancer
cells; thereby inhibition of active telomerase could be a
way to treat cancer.
TERT has been implicated as a key factor limiting telo¬
merase activity as the RNA subunit is constitutively
expressed at a low basal level [15] and ectopic expression
of hTERT restored telomerase activity, extended
0006-291X/S - see front matter © 2006 Elsevier Inc. All rights reserved,
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telomeres, and indefinitely prolonged cellular lifespan
[16,17], It has been hypothesised that dimeric TERT mole¬
cules are required to form a functional telomerase complex
[8], However, telomere length is not always maintained in
cells with active telomerase and many tumour cell lines
are shorter than those of corresponding normal cells, indi¬
cating that telomerase activity does not necessarily imply
telomere maintenance [18,19], It has been accepted general¬
ly that telomere length in mammalian telomeres is regulat¬
ed by a homeostatic mechanism that is governed in part by
telomerase and a telomere-specific protein complex recent¬
ly termed 'Shelterin', which consists of TRF1, TRF2,
TIN2, Rapl, TPP1, and POT1 [20],
To further address the function of telomerase catalytic
subunit TERT in relation to telomerase activity, telomere
length, and cell growth, we expressed a catalytically dys¬
functional hTERT in an hTERT-immortalised primary
sheep foetal fibroblast line in which telomeres stabilise at
an average length shorter than that of the untransfected
parental line. This system enables us to study if hTERT
non-catalytic domains have any effect on telomerase activ¬
ity and telomere maintenance. Conversely the presence of a
catalytically dysfunctional hTERT most likely results in
both mutant/wild-type telomerase heterodimers and
mutant/mutant telomerase homodimers, both of which
may compete with and compromise wild-type/wild-type
telomerase homodimers.
Our results showed that overexpression of non-catalytic
domain decreased telomerase activity, inhibited cell prolif¬
eration, and did not enhance telomere maintenance, which
may result from competitive binding to sheep TR mole¬
cules and/or disruption of hTERT homodimeric structure.
Therefore, our results suggest that telomere maintenance
requires a functional telomerase complex which contains
hTERT homodimeric structure.
Materials and methods
Cell culture, plasmids, and transfection. Sheep fibroblasts, BW6F2, and
their hTERT immortalised clonal line, GRN1-1, were prepared and cul¬
tured as described previously [19],
The mock plasmid (pWGB23) was constructed by inserting a mouse
phosphoglycerate kinase (PGK) promoter into EcoRl/Pstl site of the
pEGFP-1 vector (Clontech). The mutant hTERT construct (pWGB25)
was then generated by replacing the EGFP fragment in pWGB23 with a
mutant hTERT cDNA which was kindly provided by Geron Corporation,
which contains three point mutations at reverse transcriptase motifs,
resulting in three amino acid substitutions from Arginine (631) and
Aspartic acid (712 and 868) to Alanine (Fig. 1A). Both vectors were lin¬
earised with Bgtll and transfection was performed as previously described
[19] with 800 pg/ml G418 for selection.
RNA extraction and RT-PCR. Total RNA was extracted using the
RNeasy kit (Qiagen) according to the manufacturer's guidelines and
digested with DNase I. RT-PCR was performed as previously described
[19], The expression levels were quantified by densitometry and normalised
to GAPDH. Relative stoichiometry was inferred by assigning a value of 1
to the parental GRN1-1 and GRN23(C1) mock vector control.
Telomerase activity and telomere length assays. Telomerase activity was
analysed by telomeric repeat amplification protocol (TRAP) assay with a
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Fig. 1. Expression of mutant hTERT in primary sheep fibroblast. (A)
Schematic map of transgenic constructs. pWGB25: mutant hTERT cDNA
(7.3 kb) with three amino acid substitutions as indicated; pWGB23: mock
EGFP vector. The PGK promoter, SV40 polyadenylation signal, and
neomycin selection cassette are indicated. (B) BW6F2(25)-7 and -8 are two
clones derived from parental BW6F2 sheep fibroblasts transfected with
mutant hTERT, showing high levels of mutant hTERT expression (left)
but no detectable telomerase activity (right).
resolved on a 10% polyacrylamide gel and visualised with a Phospholm-
ager (Amersham Biosciences). Telomere length was determined by telo¬
mere restriction fragment (TRF) Southern blot analysis and mean
telomere length was calculated [21] and statistics done by Student's r-tesl.
Senescence-associated fl-galactosidase staining. Cells were fixed in 3%
formaldehyde for 5 min, then incubated for 16 h with freshly prepared
senescence-associated P-gal solution after washing with PBS [22],
Results
Expression ofmutant hTERT in sheep fibroblasts does not
reconstitute telomerase activity
Primary cultures of sheep foetal fibroblasts show similar
characteristics to those of human fibroblasts in that no tel¬
omerase activity is detectable and cells undergo a limited
number of cell divisions. Forced expression of human telo¬
merase catalytic subunit hTERT in sheep fibroblasts,
BW6F2, reconstituted telomerase activity and extended
their proliferative lifespan [6]. However, telomere lengths
were not maintained in all hTERT-immortalised lines,
rather they stabilised at various lengths dependent on
hTERT expression levels [19], To further address the effects
of telomerase function on telomere maintenance, we con¬
structed a mutant hTERT expression vector (pWGB25,
Fig. 1A) in which hTERT was mutated with three point
mutations at distinct reverse transcriptase motifs and its
expression was under the control of a mouse PGK
promoter.
To verify the functionality of this mutant hTERT, we
first transfected it into the BW6F2 cells. Several colonies
798 R. Rahman et al. / Biochemical and Biophysical Research Communications 350 (2006) 796-802
Fig. 2. Effects ofmutant hTERT expression on telomerase activity and cell growth. (A) RNA expression analysis in mutant hTERT-transfected GRN1-1
clones. Passage number post-transfection is indicated. Parental BW6F2 and GRN1-1 were used as controls. (B) Histogram of densitometric analysis
showing expression levels of the hTERT transgenes. (C) TRAP analysis on selected mutant hTERT positive clones shows that telomerase activity is
inhibited in all three mutant hTERT positive lines in comparison to the GRN23-C1 mock vector control clone, with GRN25-1 exhibiting the highest
inhibition and GRN25-9 the least. (D) Growth curve ofmutant hTERT clone GRN25-7 showed a period of significant slower proliferation with PD time
of 40 h. In contrast, hTERT control cells (GRN1-1 and 23-C1) exhibited steady proliferation throughout with approximately 19 h PD time. Expression of
mutant hTERT alone did not bypass senescence (BW6F2 25-8). (E) Senescence-associated P-galactosidase staining on GRN25-7 cells. Scale bar represents
250 and 100 pm, respectively.
formed after selection but only two clones (BW6F2 25-7
and 25-8) were able to be expanded to obtain enough cells
for transgene analysis. RT-PCR confirmed that the mutant
hTERT transgene was expressed and TRAP assay showed
no detectable telomerase activity (Fig. IB). The cells did
not proliferate vigorously and senesced after several pas¬
sages (Fig. 2D). These results confirmed that the three
point mutations in reverse transcriptase motifs of hTERT
have abolished its catalytic function so that the mutant
hTERT does not have the ability to reconstitute telomerase
activity.
High levels ofmutant hTERT expression compromise
telomerase repeat addition processivity
Mutant hTERT does not reconstitute telomerase activi¬
ty in sheep fibroblasts. However, what effect does it have on
active telomerase activity? To test this, we transfected
mutant hTERT into the hTERT-immortalized foetal sheep
fibroblast line GRN1-1, in which the hTERT expression
level is sufficient to immortalise the cells but not to main¬
tain the full telomere length [19]. Ten clones were isolated
after selection. We also transfected GRN1-1 with a mock
vector in which mutant hTERT was replaced by EGFP.
All the colonies were expanded up to T25 flasks and 2/3
cells were frozen down and the rest further expanded for
expression analysis.
The transgene expression was validated by RT-PCR.
Due to only three base pairs differing between wild- and
mutant-hTERT, we were unable to differentiate between
their expression levels. Thus, expression of total hTERT
mRNA was analysed by semi-quantitative RT-PCR. As
they were all derived from clonal cell line GRN1-1 and
have similar levels of wild-type hTERT, the excess of
TERT above that of the controls was mainly attributed
to mutant hTERT levels. The results showed that eight
of 10 clones (GRN25-1, -2, -3, -4, -5, -6, -7, and -9)
expressed higher levels of hTERT (Fig. 2A, lanes 2-11)
than the original GRN1-1 (Fig. 2A, lane 1) and that
hTERT expression in mock controls, GRN23-C1, and
GRN23-C4 was similar to that in GRN1-1 (data not
shown). We calculated that clone GRN25-1, -6, and -7
exhibited over 3-fold higher mutant hTERT expression
than the wild-type (Fig. 2B) and clone 25-3, -5, and -9 over
2-fold. Therefore, they were grouped as the high and medi¬
um expression, respectively.
To test effects ofmutant hTERT expression on telome¬
rase activity, we carried out TRAP assay on some of these
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clones, GRN25-1, 25-7, and 25-9. The results showed that
telomerase activity was inhibited in all three lines in com¬
parison to GRN23-C1 mock vector control clones
(Fig. 2C). The levels of inhibition seemed related to mutant
hTERT expression levels, with GRN25-1 exhibiting the
highest inhibition and GRN25-9 the least, indicating that
the mutant hTERT functions dominant-negatively to
inhibit telomerase activity.
Effects of high mutant hTERT-expression on cell
proliferation and senescence
Since the TRAP assay results showed that telomerase
activity in the mutant clones was inhibited, we next exam¬
ined the effect ofmutant hTERT on cell growth and prolif¬
eration. We resuscitated clones exhibiting medium and
high levels of mutant hTERT expression (GRN25-1, 25-
5, 25-6, 25-7, and 25-9) and monitored their proliferation
by recording their growth curves. All the clones, except
clone GRN25-1 and GRN25-7, grew uncompromised with
a steady rate of proliferation during the 160 days of cul¬
ture, with about one population doubling every 19 h. There
is no significant difference to the overall proliferation pro¬
file between these clones and control GRN23 clones which
only expressed wild-type hTERT.
In clones GRN25-1 and GRN25-7 (particularly clone
GRN25-7), however, a period of slower proliferation was
evident at around 3 weeks of continuous culture, in which
population doubling rate slowed to over 40 h (Fig. 2D).
Concurrent with this, a subset of cells within the popula¬
tion adopted morphology of bigger and flat appearance
with clearly visible microtubules, a characteristic of the
senescent phenotype. This subset of cells represented
around 30% of the total population. To further confirm
that these cells were senescent, we applied the senescence-
associated -galactosidase (SA-P-gal) staining assay to the
GRN25-7 cells and the results indicated positive staining
as expected (Fig. 2E). No such phenomenon was found
in GRN23 control cells. Since these phenomena only
appeared in high expressing mutant hTERT clones, it is
suggested that the high expression ofmutant hTERT might
play a critical role leading to cellular senescence.
However, it is interesting why not all the cells were
affected as they came from a clonal population. We noticed
that after a period of time of in vitro culture, even a clonal
cell population will exhibit heterogeneity, particularly with
regard to transgene expression. In some cells, the transgene
expression was silenced. This occurred in both GRN23
clonal GFP clones and GRN25 mutant hTERT clones.
In the former case, some cells lost GFP expression, result¬
ing in a mosaic GFP expression pattern in the cell popula¬
tion even though they all expressed GFP at the beginning
of in vitro culture. Nevertheless, GFP expression does not
affect cell growth and both silenced and expressing cell
types probably proliferate at a similar rate, thus maintain¬
ing the mosaic pattern for a long time. By contrast, in the
latter case, the silenced mutant hTERT transgene relieved
inhibition pressure in the cells, giving them a growth
advantage over the cells expressing mutant hTERT. There¬
fore, after long-term culture and propagation, the silenced
mutant hTERT cells would have been selected for and thus
overwhelm the whole population. This was confirmed by
RT-PCR and TRAP assay to test mutant hTERT expres¬
sion and telomerase activity at early and late passage cells.
The results showed a dramatic downregulation of total
hTERT expression, to levels similar to wild-type hTERT
levels in GRN1-1, indicating almost complete silencing of
mutant hTERT (Fig. 3A). Correspondingly, the telomerase
activity was restored to similar levels as in control cells
(Fig. 3B).
The relationship between telomerase expression, telomerase
activity, and telomere maintenance is complex
We also examined the effects of mutant hTERT expres¬
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Fig. 3. Loss of mutant hTERT expression upon long-term culture. (A) Histogram of RT-PCR densitometric analysis of hTERT in early and late passage
transfected clones showed a dramatic reduction in levels of total hTERT expression in mutant hTERT clones (GRN25-1 and -7) at late passage, indicating
almost complete silencing of the mutant hTERT transgene. (B) Inhibition of telomerase activity in GRN25-1 and 25-7 was also lost after long-term culture
(100 days), showing all GRN clones exhibiting comparable telomerase activity.
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Fig. 4. Telomere length analysis in mutant hTERT clones. (A) All clones showed telomere erosion after 70 population doublings with clones GRN25-1
and -7 exhibiting the most telomere attrition. All other clones (GRN25-5, 6, 9, and 10) had similar telomere shortening in comparison to the mock controls
(GRN23-C1 and C4). (B) Telomere length stabilised at a length in each clone after long-term culture. GRN25-1 and -7 still showed significantly shorter
mean telomere lengths compared to the others. PD, population doublings.
were measured at multiple time points (0, 70, and 130 days)
during long-term culture. The results showed that after
~70 days in culture, telomere lengths shortened in all cell
lines (Fig. 4A). However, GRN25-1 and GRN25-7 exhibit¬
ed significantly shorter mean telomere length (6.7 and
7.7 kb, respectively) in comparison with GRN23 control
cells (9.2 and 10.1 kb, p < 0.05). The remaining GRN25
clones showed similar telomere shortening as GRN23 con¬
trols (p > 0.1).
This pattern of telomere shortening persisted through¬
out the culture period and mean TRF lengths in all GRN
clones were stabilised after approximately 100 population
doublings post-transfection. Stabilised mean TRF length
in clones GRN25-5, -6, and -9 were within the range of
6.6-7.1 kb and did not differ significantly to the 7.0 and
7.2 kb of GRN23 mock controls (/? > 0.1), whereas the
mean TRF lengths in GRN25-1 and -7 were eventually sta¬
ble at 5.2 and 6.3 kb, significantly shorter than that in the
mock controls (p < 0.0005) (Fig. 4B). These results indicate
that high levels of mutant hTERT expression might have
accelerated the telomere shortening, probably as a conse¬
quence of inhibited telomerase activity. However, the other
high expressing mutant hTERT clone GRN25-6 did not
exhibit this faster telomere shortening in spite of the clear
inhibition of telomerase activity. And, although telomerase
activity was restored to levels comparable to the control
GRN23 cells at late passage due to transgene silencing,
we did not observe telomere lengthening in the GRN25-1
and 25-7 cells. These results suggest that telomere length
regulation is more complicated and consideration has to
be given to the plethora of factors involved.
Discussion
In this report, we forced expression of a catalytically
inactive mutant hTERT in hTERT-immortalised primary
sheep fibroblasts to examine its effects on telomerase activ¬
ity, telomere length, and cell proliferation. We showed that
clones exhibiting high levels of mutant hTERT expression
inhibited telomerase activity, whereas, clones exhibiting
lower levels did not. These results indicate that the inhibi¬
tion effect of mutant hTERT has a threshold and this is
likely due to a dominant-negative and/or competitive inhi¬
bition effect between the wild-type and mutant hTERT
proteins. Thus mutant hTERT expression compromised
wild-type telomerase activity in a manner directly attribut¬
able to mutant hTERT expression level. When mutant
hTERT expression is sufficiently higher than the wild-type,
it competitively inhibits the binding of wild-type hTERT to
telomerase RNA or the formation of TERT homodimers,
hence inhibition of telomerase activity. However, we
noticed that when TRAP assay was conducted using
0.5 pig rather than 0.1 pg protein lysate, low levels of telo¬
merase activity were detectable in cells with high expressing
mutant hTERT. This low level of telomerase activity could
be due to a small number of cells in which mutant hTERT
was silenced or expressed at low levels.
We also found that high levels of mutant hTERT
expression in these immortalised cells not only inhibited
telomerase activity but also affected cell proliferation and
telomere length, which could be the consequence of telome¬
rase inhibition. After a short-term in culture, a subset of
cells in the high mutant hTERT expressing clones exhibited
a senescent phenotype and expressed SA-|3-gal. This is
reflected in the growth curves, as these cells went through
a period of slower growth. Unfortunately, a small number
of cells lost mutant hTERT expression shortly after cultur-
ing and these cells therefore had a growth advantage over
the high mutant hTERT expressing cells. Therefore, during
cell propagation, they gradually took over the population.
After long-term culture, hardly anymutant hTERT expres¬
sion was detected.
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Significant telomere attrition was evident in two of three
clones with high levels of mutant hTERT expression
(GRN25-1 and GRN25-7). Telomeres in these clones even¬
tually reached mean stabilised lengths much shorter than
those in mock controls. These results seem to be directly
attributable to mutant hTERT expression. Mutant
hTERT/mutant hTERT and mutant hTERT/wild-type
hTERT dimeric complexes are likely to be in much greater
abundance than wild-type/wild-type dimers within these
lines. Inhibition of telomerase activity and increased telo¬
mere attrition are therefore likely to be due to the compro¬
mising of wild-type homodimeric function at the telomere
substrate due to the molar ratio imbalance of hTERT com¬
plexes. This is consistent with the notion that hTERT
homodimers are necessary to form a functional telomerase
complex at the telomere substrate [9], where catalytic
domains of both hTERT molecules may function inter-de-
pendently. Surprisingly one clone with high mutant
hTERT expression level and subsequent abrogation of tel¬
omerase activity showed comparable stabilised mean telo¬
mere length to mock controls. We believe this highlights
the limitation of in vitro based telomerase activity assays
to assess proper telomerase function on telomere regula¬
tion; Telomere length is not controlled by telomerase
(TERT and TR) alone but requires other telomerase asso¬
ciated proteins and telomere binding proteins, such as
POT1, TRF1, and TRF2 [20]. Therefore differences in
expression level of these factors may account for this
discrepancy.
It is interesting to note that in spite of the loss ofmutant
hTERT expression in the late passage of GRN25-1 and
GRN25-7, the telomere length in these two clones did
not recover to the length comparable to the mock controls
after long-term culture, rather they stabilised at the short
telomere length. The mechanism behind it is not clear. It
was reported that loss of dominant-negative hTERT trans-
gene expression in human leukaemia cells resulted in telo¬
mere lengthening in human leukaemia cells [23]. This
discrepancy could be due to the species differences between
hTERT in human cells and hTERT in sheep cells.
In summary, our results support the notion that telo¬
mere maintenance requires a functional telomerase com¬
plex with hTERT monomers likely interacting in an
inter-dependent manner. Furthermore the result demon¬
strates that although hTERT non-catalytic domains may
be necessary for telomerase assembly and processivity at
the telomere substrate, they are not rate-determining. Cat¬
alytic hTERT domains appear to be a crucial rate-deter¬
mining factor regarding processivity; however, a more
thorough understanding of telomerase- and telomere-asso-
ciated factors will be required to understand fully the inter¬
play that governs telomere homeostasis in vitro and in vivo.
Consistent with the work from other laboratories, our
results also showed a potential interest of using anti-telo-
merase gene therapy to treat cancer but consideration has
to be taken on how to overcome the transgene silencing
in a small number of cells.
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